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SUMMARY 
 
In this work, we address two major problems in pharmaceutical supply chains. One is 
the planning problem that involves outsourcing and new product introductions. The 
other is the scheduling problem of operating multipurpose plants.  
A pharmaceutical plant repeatedly needs to resolve whether it can or should 
undertake to produce a new intermediate or product, or should outsource some tasks to 
enable it to do so. We present a multi-period, continuous-time, mixed-integer linear 
program (MILP) model that addresses this important problem for a pharmaceutical 
plant using multiple parallel production lines in campaign mode, and producing 
products with multiple intermediates. Given a set of due dates, demands of products at 
these due dates, several operational, and cleaning requirements, the aim is to decide the 
optimal production levels of various intermediates (new and old) or the optimal 
outsourcing policy to maximize the overall gross profit for the plant, while considering 
in detail the sequencing and timing of campaigns and material inventories. The effects 
of new product introductions on plant production plans, the benefits of outsourcing, 
and the ability to react to sudden plant/demand changes are illustrated using few 
examples. 
Scheduling of multipurpose batch plants like pharmaceutical plants is a 
challenging problem for which several formulations exist in the literature. In this work, 
we present a new, simpler, more efficient, and potentially tighter, MILP formulation 
using a continuous-time representation with synchronous slots and a novel idea of 
several balances (time, mass, resource, etc.). The model uses no big-M constraints, and 
is equally effective for both maximizing profit and minimizing makespan. Using 
extensive, rigorous numerical evaluations on a variety of test problems, we show that 
  vi 
 
  Summary 
in contrast to the best model in the literature, our model does not decouple tasks and 
units, but still has fewer binary variables, constraints, and nonzeros, and is faster. In 
addition, we propose some minimal criteria for any model comparison exercise. 





AI/API Active Ingredients/Active Pharmaceutical Ingredients 
G&G Giannelos and Georgiadis (2002) 
GCP Good Clinical Practice 
GLP Good Laboratory Practice 
GMP Good Manufacturing Practice 
GRD Generalized Recipe Diagram 
M&G Maravelias and Grossmann (2003a) 
MILP Mixed Integer Linear Program 
PFD Process Flow Diagram 
POMA Pharmaceutical Outsourcing Management Association 
RD Recipe Diagram 
R&D Research and Development 
RMILP Relaxed Mixed Integer Linear Program 
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Chapter 1 
INTRODUCTION 
Global competition requires every pharmaceutical company to enhance its economic 
performance. These companies are undergoing major retrofits in their business practice 
in order to survive the new challenges of the modern economy. The globalization of 
the business, the variety and complexity of new drugs, and the shortening patent 
protections are some of the factors driving these changes. Usually, pharmaceutical 
companies produce several high-profit, low-volume products. Of these, only 
flagship/dominant products under patent protections are the major contributors to the 
growth of these companies. Hence, high product turnover is crucial to the continued 
economic survival and growth of a pharmaceutical company.  
Pharmaceutical companies often have several facilities, which are 
geographically distributed.  These companies tend to have their Research and 
Development (R&D) in some location and production facilities in some other 
locations. Such distributions of facilities are based on several global factors like market 
demands, economies of scale, logistics and so on. Mostly, the business activities in 
different locations are not sufficiently integrated to achieve the best possible solutions.  
The pharmaceutical industry is distinctive from many other industries in the 
amount of attention paid to it by the regulatory authorities. Since these industries 
produce health care products, stringent work practices like Good Manufacturing 
Practice (GMP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP) 
and so on are followed in the production sites. Most of the operations in 
pharmaceutical production are batch, and hence quality check must be performed by 
keeping track of each batch. In addition, thorough cleaning must be performed 
whenever product changeover occurs. This is mainly to avoid cross contamination of 
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products during the changeovers. All these work practices, which are inevitable, lessen 
the overall productivity. Hence, these companies are under great pressure to utilize 
their production resources efficiently. 
Pharmaceutical companies aspire to introduce new products in order to revive 
their business with the early profits. The time to market and the quick reap of the 
profits from the new products before their shortened life cycles are the keys to the 
success of these companies.  Hence, a lot of money and time are invested on the 
research and development of new products.  
1.1 Life Cycle of a Pharmaceutical Product 
A pharmaceutical product has four different phases in its life cycle as shown in Figure 
1.1. In the Birth phase, an active molecule with a curative effect on a target disease 
group is discovered. Then, several studies are performed to enhance its efficacy. As a 
result, the most active molecule is structured, which is then tested for toxicological 
results in rats or mice. If no worrisome toxic endpoints are observed, then this 
molecule becomes a candidate for further development. 
In the Development phase, the candidate undergoes a series of processes such 
as sampling, testing, patenting etc. Enormous amounts of money and resources are 
invested in these tedious processes. In addition, process costs and durations, their 
success probabilities, and their potential revenues are not known with confidence in the 
initial stage of this phase. If a process fails, all work on that candidate is halted, and the 
investment in previous processes may be futile. Hence, risk levels are high in these 
development processes. If the candidate does succeed out of these complex processes, 
then it is approved for the commercial production under a patent coverage. 
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BIRTH DEVELOPMENT PRODUCTION DEATH 
Figure 1.1: Life cycle of a typical pharmaceutical product. 
 
In the Production/Launch phase, promising markets are identified for a 
successful launch of the new product. The launch strategy could be either forecast-
driven or response-based. In either case, if the new product succeeds technically as 
well as financially, then it may survive actively in the market, until its patent expires. 
The product is no longer new, when it reaches the Death phase. The patent has 
expired, and the target markets are now open to generics. Hence, the demand of the 
product either stagnates or declines. If the product is no more fruitful, then its 
production is stopped. 
Of the four phases of the product’s life cycle, Development (conceptualization, 
design, promotion, and pricing) and Production/Launch (physical positioning in the 
market via commercial production) are the major ones. The product launch phase 
consumes a significant amount of costs, often exceeding the combined expenditures in 
all previous development stages (Beard and Easingwood, 1996). Launch phase 
includes identifying the right place to market, right production site to produce, and 
optimizing the planning and scheduling of the production of new products. Mistakes, 
miscalculations, and oversights in any of these product launch activities can become 
fatal obstacles to new product success. Hence, the optimal planning of new product 
introductions into the appropriate production sites so as to target the right market is of 
paramount importance to any pharmaceutical company.  
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1.2 Pharmaceutical Supply Chain 
Most pharmaceutical products undergo two levels of production (Bennett and Cole, 
2003): primary and secondary. While the primary production involves making the 
basic molecules called the active ingredients (AI) or active pharmaceutical ingredients 
(API), the secondary production involves formulating them into final drugs and 
supplying them to various customers. Figure 1.2 shows the different layers in a typical 
pharmaceutical supply chain. 
The first layer comprises suppliers that provide raw materials and/or 
intermediates to the primary and/or secondary production sites. It also includes third 
party contractors who may supply some intermediates or even APIs.  
The second layer includes the primary production facilities that perform 
various chemical synthesis steps and downstream separations in the case of traditional 
pharmaceuticals, and fermentation, product recovery, and purification in the case of 
biopharmaceuticals. Production of an API typically requires complex chemistry 
involving multiple stages or intermediates. The stringent requirements for cleaning and 
the need for avoiding cross contamination result in long transition times during product 
changeovers, which necessitate long campaigns for effective utilization of plant 
equipment. If the existing production facilities cannot meet all the demands, a 
company may even outsource some intermediates from third party contractors. 
A primary production site is driven mainly by the medium- and long-term 
forecasts and is less responsive to the changes in the demands of end/finished products. 
It holds inventories of AIs to ensure good service levels and to maintain smooth 
operation at the downstream production sites. Thus, anticipatory logistics (or “push” 
process) dominates the primary production, and primary production is often the rate-
limiting step in pharmaceutical supply chains. 
 4
 




The third layer includes the secondary production sites that add inert materials 
such as fillers, coloring agents, sweeteners, etc. to the AIs, and formulate and package 
them to produce finished products such as tablets, capsules, syrups etc. Their 
processing steps include milling, granulation, compression (to form pills), coating, 
packaging etc. Relatively short campaigns or batches of huge size are common in the 














 Warehouses / 
Wholesalers / 
Retailers / End-Users 
Figure 1.2: A typical pharmaceutical supply chain. 
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of AIs from external contractors is common. Most often secondary production sites 
outnumber the primary ones, are geographically separate from the latter ones, and are 
closer to the markets. A response-based logistics (or “pull” process) based on customer 
orders dominates the secondary production, and this layer is more responsive to the 
market fluctuations. 
The fourth layer includes the various customer nodes such as distribution 
warehouses, wholesalers, retailers, and end-users. These nodes are normally 
geographically distributed, and separate from the production sites. 
Pharmaceutical companies have long been looked as the laggards of supply 
chain practice. Given their huge profits from proprietary blockbuster drugs, these 
companies have always made product availability a greater priority than supply chain 
efficiency. In the past, pharmaceutical companies have neglected supply chain 
management because its costs are insignificant compared to sales and marketing or 
R&D. But now, a number of factors like (a) increased competition from generics, (b) 
shorter patent life cycle, (c) increased pressure to reduce health care costs, (d) 
consolidation of industries and proliferation of products and so on are putting pressure 
on pharmaceutical companies to change their traditional ways of doing business.  
1.3 Planning and Scheduling 
Both planning and scheduling aim at the optimal performance of an industry. 
However, they do differ mainly in terms of the time frames involved and the level of 
decisions taken. Planning normally has longer time horizon (order of months/years) 
and includes higher level management objectives, policies, etc. besides immediate 
production requirements. It represents aggregated objectives and usually does not 
include more details. Accordingly, the models used are either abstract or take 
simplifying assumptions making them more conceptual. If the assumptions 
 6
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overestimate the facility performance giving very little allowances, the resultant plan 
can become unrealistic. On the other hand, if assumptions underestimate the plant's 
efficiency, the plan thus obtained might lead to under-utilized production capacities. 
Therefore, for planning operations, one has to include the key detailed constraints and 
their interdependencies in order to get an optimal plan and hence a sound basis for 
undertaking further scheduling.  On the other hand, scheduling is the link between the 
production and the customer. The issues addressed by the scheduling vary with the 
characteristics of the production process and the nature of market served. Hence, 
scheduling can be formally defined as the specification of what each stage of 
production is supposed to do over short scheduling horizon ranging from several shifts 
to weeks. The objective of scheduling is to implement the plan, subject to the 
variability that occurs in the real world. This variability can be in raw materials 
supplies, product quality, production process, customer requirements or logistics.  
Planning and Scheduling play a vital role in the pharmaceutical supply chain. 
Optimal plan is required in both primary and secondary production sites of the 
pharmaceutical plants. Mostly, primary and secondary sites exercise own production 
plan for the reasons discussed in the previous section. Hence, a plan that does not 
address the key issues of the plants may often lead to suboptimal or infeasible 
schedule. In addition, planning is very important while introducing new products in a 
plant. One has to consider several global issues before launching new products for 
commercial production. Moreover, the development stages of the new product 
candidates also require the scheduling of various testing tasks that involve high levels 
of uncertainty. 
The objective of the planning is mostly based on economic criteria like 
maximizing the net profit or revenue, minimizing the cost and so on. Some of the 
 7
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factors that drive planning in pharmaceutical plants are: 
1. Meeting the forecasted demand fully. 
2. Optimal introduction of new products in the production facilities. 
3. Keeping low tie-up of Working capital (minimal inventory). 
4. Meeting demands even during planned shutdowns of the plants. 
The objective of scheduling is often based on operational criteria like 
minimizing the makespan, maximizing the production, minimizing the 
tardiness/earliness and so on. The factors that drive scheduling in pharmaceutical 
plants are: 
1. Meeting the demands in the face of high volatility. 
2. Reacting to the uncertainties in plants. 
3. Better utilization of resources (production units, utilities, manpower and so on) 
in plants. 
4. Maintaining the safe inventory levels.  
1.4 Research Objective  
It is clear from the above discussion that planning and scheduling play an important 
role in pharmaceutical plants. The optimal plan and schedule of production activities 
can tremendously improve the economic performance of these plants. Planning and 
scheduling can find their application in R&D, facility expansion, production and so on. 
However, the objective of this work is to present the optimization models for the 
optimal planning and scheduling of production in pharmaceutical plants. 
 The planning model should provide decision support for the plant management 
in selecting which existing products to produce in what quantities so that new 
products, if any, can be produced in the plant. As the pharmaceutical industry focuses 
more on the discovery and development activities, outsourcing of some of its testing or 
 8
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production tasks to the external contractors is becoming growingly important. 
However, the decision to outsource requires several considerations. A production 
facility may consider outsourcing an intermediate, when it is unable to meet the 
demands of its products with the existing facility. It may also consider outsourcing, 
when it is more profitable to use the facility to produce a new product rather than a 
nearly off-patent product. Hence, the planning model should also address the above 
issues in outsourcing. 
 The scheduling model is expected to resolve the problems that could arise due 
to dynamic demands of products in pharmaceutical plants. Since the available units in 
a plant are limited, the optimal scheduling is required to better utilize these units in 
order to meet the demands of several products. Scheduling model considers many real-
life operational and supply constraints. 
1.5 Outline of the Thesis 
This thesis consists of two major sections. The first (Chapters 3-4) and second 
(Chapters 5-6) sections respectively deal with the planning and scheduling of 
production activities in pharmaceutical plants. In Chapter 3, we develop a 
mathematical model for the planning of production in pharmaceutical plants. The 
planning model also includes scheduling aspects to make the plan realistic. Though we 
develop the model for planning primary production, we discuss its flexibility to 
address the planning in secondary production as well. In Chapter 4, we evaluate the 
performance of the proposed planning model using few examples. Here, we study 
various business practices like outsourcing, new product introduction and so on using 
our model. 
In Chapter 5, we present a novel mathematical formulation for scheduling in 
pharmaceutical plants. In Chapter 6, we assess the performance of our scheduling 
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model using several scenarios of three examples. We also compare the performance of 
our model with those of two other scheduling models existing in the literature. Here, 
we present some required minimal criteria for the comparison works.  
In Chapter 7, we summarize the conclusions of our work, and then provide 




The industries producing specialty chemicals such as pharmaceuticals, cosmetics, 
polymers, food products, and electronic materials produce several products, and often 
introduce new products. However, the pharmaceutical industry has the longest product 
development period of all. A lot of money and time is invested in the development of 
pharmaceutical products. If a new product fails at any stage of its development, then 
all the remaining work on that product is halted and the investment in the previous 
tests is wasted. Hence, the scheduling of these highly uncertain development activities 
is increasingly receiving attention. 
2.1 New Product Development 
Pharmaceutical plants routinely introduce new products in order to revive their 
business with the early profits. The need for introducing new products early to the 
market and the uncertainties inherent with the development processes necessitated 
much research to focus on the portfolio selection a priori to development and 
scheduling of product development tasks. Schmidt and Grossmann (1996) address the 
problem of scheduling testing tasks in new product development. They assume that 
unlimited resources are available for the testing tasks. In reality, these testing tasks 
often tend to be resource-constrained, and may involve outsourcing of some tests. 
Hence, Jain and Grossmann (1999) extend the above work and develop a MILP model 
that performs the sequencing and scheduling of testing tasks for new product 
development under resource constraints. Blau et al. (2000) use probabilistic network 
models to capture all the testing activities and their uncertainties involved in the 
development of new products. They address the issue of managing risk in the selection 
of new product candidates. Following this work, Bose and Blau (2000) use graph-
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theoretic techniques to translate a probabilistic network model of a sequence of process 
activities into a spreadsheet model. 
           Subramanian et al. (2000) present an integrated simulation-optimization 
framework, sim-opt, that combines mathematical programming and discrete event 
system simulation to evaluate the uncertainty and control the risk present in the R&D 
pipeline. Mockus et al. (2000) propose a two-level approach to address the problem of 
planning and scheduling in a pharmaceutical pilot plant. They decompose the above 
problem into long-term planning of resources and short-term scheduling of operations. 
Mockus et al. (2002) extend the previous work (Mockus et al., 2000) and explore the 
techniques for combining the production plan and daily operation schedule in a single 
model. Maravelias and Grossmann (2001) propose an MILP model that integrates the 
scheduling of testing tasks with the design and production planning decisions. A 
common assumption in all the above works is that the resources are constantly 
available throughout the testing period. In practice, the existing resources may not be 
sufficient to launch the new products in a timely fashion. Hence, the company may 
often prefer outsourcing of tests at a high cost. To address these issues, Maravelias and 
Grossmann (2003) present an MILP model that optimizes the overall costs. 
2.2 Planning in Pharmaceutical Supply Chains 
Chemical manufacturing processes can be broadly classified into two types based on 
their modes of operation: batch and continuous. A continuous process or unit is the one 
which produces the product incessantly, whereas a batch unit or process is the one that 
produces in discrete batches. A semicontinuous unit is a continuous unit that runs 
intermittently with starts and stops. Continuous process, in most cases, is dedicated to 
produce a fixed product with little or no flexibility to produce another. In contrast, 
batch processes are flexible to produce multiple products and are best suited for 
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producing low-volume, high value products requiring similar processing paths and/or 
complex synthesis procedures as in the case of specialty chemicals such as 
pharmaceuticals, cosmetics, polymers, food products, electronic materials etc. The 
latter is also referred as multipurpose batch processes in the literature.  
Batch plants operate in either batch or campaign mode. Many pharmaceutical 
plants producing large amounts of active pharmaceutical ingredients (APIs) employ 
either multiproduct or multiplant structure (use production lines) and operate in 
campaign mode. The APIs serve as feeds to the downstream or secondary processing 
facilities producing final drugs. As long as a plant employs long, single-product 
campaigns of identical batches, one can model its operation in a manner similar to that 
of a semicontinuous plant producing products such as polymers, papers, etc., in large 
quantities. Therefore, the research on batch plants as well as semicontinuous plants is 
of interest. In the campaign mode of operation, timings and durations of campaigns 
and their allocation to various production lines over a relatively long period (several 
months) are the major operational decisions, so the operation management problem 
falls in the category of planning rather than scheduling. 
The early work on campaign planning in general has addressed the production 
planning of a single facility with one or more noncontinuous production lines or 
multiple distributed facilities. While Sahinidis and Grossmann (1991) assumed cyclic 
campaigns in an infinite horizon, the most recent works (McDonald and Karimi, 1997; 
Karimi and McDonald, 1997; Ierapetritou and Floudas, 1999; Gupta and Maranas, 
1999; Gupta and Maranas, 2000; Oh and Karimi, 2001a; Oh and Karimi, 2001b; 
Lamba and Karimi, 2002a; Lamba and Karimi, 2002b; Lim and Karimi, 2003b; 
Jackson and Grossmann, 2003) have focused on acyclic campaigns in a finite horizon. 
The latter works are more realistic from a practical viewpoint and more suitable for 
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time-varying demand scenarios. Furthermore, they subsume the extremely unlikely 
scenario that the optimal solution involves cyclic campaigns. 
McDonald and Karimi (1997) presented a realistic mid-term planning model 
for parallel semicontinuous processors. Although they incorporated minimum 
campaign length constraints in their formulation, they did not consider the detailed 
timings of campaigns. However, in their second paper, Karimi and McDonald (1997) 
presented two novel multi-period continuous-time formulations for the detailed timings 
of campaigns using time slots. In both works, the product demands were due at the end 
of each period. Ierapetritou and Floudas (1999) applied their event-point based 
formulation on this problem, but the recent works (Sivanandam, 2004; Balla, 2004) 
reveal that several issues in their comparison are unpersuasive. Gupta and Maranas 
(1999) develop an efficient decomposition procedure for solving the same problem 
based on Lagrangean relaxation. In their subsequent work (Gupta and Maranas, 2000), 
they proposed a two-stage stochastic programming approach to incorporate demand 
uncertainty.  
Recently, Oh and Karimi (2001a, 2001b) addressed the production planning of 
a single processor with sequence-dependent setups and given finite horizon. Later, 
Lamba and Karimi (2002a, 2002b) and Lim and Karimi (2003b) addressed the 
campaign planning of multiple parallel processors with shared resource constraints. 
While Lamba and Karimi (2002a, 2002b) used synchronous time slots to satisfy shared 
resource constraints, Lim and Karimi (2003b) showed improvement by using 
asynchronous slots. 
Some recent work has also addressed some supply chain management issues 
related to the production planning and product distribution of multiple facilities. 
Jackson and Grossmann (2003) proposed spatial and temporal decomposition methods 
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to solve the multi-period nonlinear programming model. Singhvi et al. (2003) used 
pinch analysis for aggregate planning in supply chains. 
It is clear from the above review that the optimal planning of campaigns in 
general has received some attention in the literature. However, the same is not true, 
when it comes to the pharmaceutical industry. As Shah (2003) remarked, the research 
that directly addresses the issues faced by the pharmaceutical sector is scant and the 
optimal planning of campaigns within the context of pharmaceutical supply chain has 
not received due attention. The majority of the work (see section 2.1) has attended to 
the product pipeline management problem arising in the new product development 
phase of the life cycle (see Figure 1.1) of pharmaceutical products.  However, there is 
a paucity of research that addresses the planning issues related to new product 
introductions. Gjendrum et al. (2001) presented a simulation approach to foresee the 
supply chain dynamics in pharmaceutical plants after the introduction of new products. 
Papageorgiou et al. (2001) applied mathematical programming techniques to facilitate 
the strategic supply chain decision-making process in the pharmaceutical industry. 
They presented an approach to allocate investment and facilities to new products. They 
used an aggregate approach for decisions such as which products to develop, where to 
introduce them, and so on. However, their work did not consider outsourcing as an 
option, and did not account for the impact of new product introductions on the existing 
products at a facility in detail. In particular, the disruption in the existing production 
plan resulting from the introduction of a new product at a facility, and the effect on the 
customer service and production levels of existing products remained unaddressed. 
Whether it is feasible or even profitable to introduce a new product at a given facility 
is a very important issue facing many pharmaceutical plants, and this has received little 
attention so far in the literature. 
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2.3 Scheduling in General Multipurpose Plants 
Scheduling of multipurpose batch plants has received considerable attention in the last 
decade. Early attempts (Kondili et al., 1993, Shah et al., 1993) used MILP formulations 
based on the uniform discrete-time representation. However, as the advantages of 
alternate representations such as non-uniform discrete-time (Mockus and Reklaitis, 
1994; Lee et al., 2001) and continuous-time became clear, the recent trend (Ierapetritou 
and Floudas, 1998; Castro et al., 2001; Giannelos and Georgiadis, 2002; Maravelias 
and Grossmann, 2003a) has favored continuous-time representations. 
The research efforts using continuous-time representation in batch process 
scheduling have opted to tag themselves with two flavors. The so called slot-based 
formulations (Karimi & McDonald, 1997) represent time in terms of ordered blocks of 
unknown variable lengths. The so called event-based formulations (Ierapetritou and 
Floudas, 1998; Giannelos and Georgiadis, 2002) use unknown points in time at which 
events such as starts of tasks may occur. Maravelias and Grossmann (2003a) recently 
attempted to rationalize the different types of time representation. 
Both slot-based and event-based representations can be further classified into 
two types: synchronous (or common) and asynchronous (or uncommon). In the 
synchronous representation (Lamba & Karimi, 2002a; Lamba & Karimi, 2002b; 
Giannelos and Georgiadis, 2002; Maravelias and Grossmann, 2003a), slots (or event 
points) are synchronized or identical or common across all units (or sometimes 
resource) in a plant, while in the asynchronous (full or partial) representation (Karimi 
and McDonald, 1997; Ierapetritou and Floudas, 1998; Lim and Karimi, 2003b), they 
differ from one unit (or resource) to another. Although both representations can in 
principle handle shared resources such as materials, it is more natural and easier for the 
former. As shown by Giannelos and Georgiadis (2002) and Maravelias and Grossmann 
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(2003a), some asynchronous representations may possess errors in (for example) mass 
balances. Karimi and McDonald (1997) and Lamba and Karimi (2002a, 2002b) had 
long recognized this pitfall of asynchronous slots for handling shared resources, 
however Lim and Karimi (2003b) showed that they can still be used successfully and 
can sometimes be advantageous. To avoid the discrepancy of mass balance in the 
asynchronous event-based formulation of Ierapetritou and Floudas (1998), Giannelos 
and Georgiadis (2002) used synchronous event points with some extra 
timing/sequencing constraints and a concept of buffer time. However, their approach 
leads to suboptimal solutions, as it seems to hinder the optimal timings of tasks. 
Recently, Maravelias and Grossmann (2003a) used synchronous time points in their 
formulation for multipurpose batch plant scheduling and avoided the extra 
timing/sequencing constraints that Ierapetritou and Floudas (1998, 1999) and 
Giannelos and Georgiadis (2002) used explicitly. 
It is obvious from the above review on scheduling in multipurpose batch plants 
that there is a need for an efficient model that can generate schedules for the 
production in multipurpose batch plants like pharmaceutical plants.  
2.4 Research Focus 
As seen from the above survey, none of the works address the planning problems 
involving both new product introductions and outsourcing practices in pharmaceutical 
plants. In addition, no existing scheduling model can efficiently solve the scheduling 
problems in these plants. In this work, we focus on these two major problems in 
pharmaceutical plants. 
 Whether it is profitable or even feasible to introduce a new product at a given 
facility is a routine but crucial decision for a pharmaceutical company. To address this, 
we consider pharmaceutical plants operating in campaign mode. We develop a 
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planning model to evaluate in detail the operational and financial effects of new 
product introductions at such plants. We also address how outsourcing of existing 
products can lessen these effects and thus make the introduction of high-margin new 
products more attractive. In other words, we specifically address the supply chain 
dynamics at the plant level as they relate to the new product introductions in a 
pharmaceutical plant, and optimize the production, inventory, and outsourcing 
decisions to maximize gross profit. Here, we focus on the planning of one primary 
multiplant production site that consumes raw materials, produces and/or outsources 
intermediates and active ingredients (AIs), maintains necessary inventories, and 
supplies AIs to secondary production sites. Given a set of due dates, demands of 
products at these due dates, several operational and cleaning requirements, the aim is 
to decide the optimal production levels of various intermediates (new and old) and the 
optimal outsourcing policy to maximize the overall gross profit for the plant, while 
considering in detail the sequencing and timing of campaigns and material inventories. 
For scheduling in pharmaceutical plants, we present a new, simpler and more 
efficient continuous-time MILP formulation using synchronous slots.  We divide the 
scheduling horizon into a number of variable length slots. To handle the sharing of 
production units easily and ensure the material balance at any point in horizon, we 





PLANNING IN PHARMACEUTICAL PLANTS 
In this chapter, we address some important aspects of planning in pharmaceutical 
supply chains. As discussed in the introduction, pharmaceutical plants are often 
situated at different geographical locations. These plants face dynamic demands of 
several end products. Which product to produce in which plant, how much of each 
product to produce in each plant, which plant should produce the new product(s) and in 
what quantity are some of the major challenging decisions faced by the pharmaceutical 
industry. In addition, since the production of primary manufacturing plants is in 
campaign mode, much of working capital is usually tied up in the inventories of active 
ingredients. Hence, a proper planning model that can account for several, if possible 
all, of the above issues is in great demand. Furthermore, Pharmaceutical Outsourcing 
Management Association (POMA) suggests that the practice of outsourcing can 
greatly enhance the performance of pharmaceutical supply chains. It is clear from the 
above discussion that a planning model that can handle the production, inventory, 
distribution, and outsourcing issues effectively would be a significant contribution to 
the economic performance of pharmaceutical industry. In what follows, we describe 
the scope of the planning problem, then develop the formulation and finally present 
some remarks on the planning model. 
3.1 Problem Description 
We focus on a primary multiplant production site F that consumes raw materials, 
produces and/or outsources intermediates and active ingredients, maintains necessary 
inventories, and supplies AIs to the secondary production sites. We use recipe 
diagrams to describe the manufacturing processes in F. A recipe diagram (RD) is 
simply a directed graph in which nodes represent the recipe tasks, arcs represent the 
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various materials with unique properties, and arc directions represent the task 
precedence. Here, the term material refers to a unique material-state combination. In 
other words, a chemical A at 60 C is a different material from A at 90 C. Similarly, a 
task performed on two different materials also means two different tasks. For instance, 
heating A from 60 C to 90 C is one task, and heating B from 60 C to 90 C is another, 
although the plant may perform both in the same unit but at two different times. By 
using different types of arcs to denote different resources, and defining equipment, 
labor, material, utility, etc. all as resources of various types, we can easily generalize 
RD (Generalized Recipe Diagram or GRD) to depict resource (like utilities, manpower 




Figure 3.1 shows the recipe diagram for an example facility producing two AIs 
through six tasks. In this example, m1 (same as m = 1) and m5 are the raw materials; m2, 
m3, m6, and m7 are intermediates; m4 and m8 are the products (AIs); and m9 is a waste 
material associated with the production of m8. Tasks 3 and 6 share one intermediate 
m7. Hence, the production of m4 requires three intermediates and m8 requires two 
 
 Task 2Task 1 Task 3
m1 m2 m3 m4
20%
m7





Figure 3.1: Recipe diagram for an example facility producing two products.
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intermediates. As we can see, the recipe diagram in Figure 3.1 does provide an 
unambiguous representation of the recipe without the need to use separate nodes for 
states. Alternate forms and further discussion of the RDs can be seen in Chapter 5. 
The facility F employs L production lines (l = 1, 2, …, L). Each production line 
l comprises multiple stages of noncontinuous equipment and can perform a set Il of 
tasks in the recipe diagram using long, single-product campaigns. We use i for tasks 
and m for materials. Each task i consumes or produces some materials.  Let Mi denotes 
the set of materials (m ∈ Mi) that task i consumes or produces. Note that Mi includes 
all the different states of raw materials, intermediates, final products, and even waste 










where, σmi is analogous to the stoichiometric coefficient of a species in a chemical 
reaction except that it is in kg/kg units instead of mol/mol. Thus, σmi < 0, if task i 
consumes material m ∈ Mi and σmi > 0, if it produces m ∈ Mi. Furthermore, for each 
task i, we designate a primary material µi, with respect to which we define the 
productivity of a line for task i. 
Quality controls are highly stringent in pharmaceutical plants. Due to 
contamination concerns, thorough flushing/cleaning of production lines during the 
transition from one intermediate to another is mandatory. Moreover, hardware/process 
changes may also be required between the campaigns of different tasks. Thus, every 
change of campaign on l may require a considerable changeover time. 
Given the above details, our goal is to determine the tasks that each production 
line should perform, the start/end timings of each task, and the inventory profiles of 
materials over the planning horizon. The planning objective is to maximize the gross 
profit of F. To this end, we assume the following. 
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1. Each single-product campaign is sufficiently long with a stipulated minimum 
campaign length MCLil for task i on line l. Therefore, we can treat each production 
line as semicontinuous with a variable production rate (kg or mu/day, where mu 
stands for mass unit). Let LilR  and 
U
ilR  respectively denote the lower and upper 
limits on the rate at which line l produces (> 0) or consumes (< 0) the primary 
material µi of task i. 
2. All intermediate materials are stable. 
3. Inventory costs for raw materials are negligible, as the plant procures them as and 
when needed. F has limited capacity for storing the intermediates and final 
products. 
4. All material demands are prespecified point demands. The planning horizon H has 
NT discrete, distributed due dates (DDt, t = 1, 2, …, NT) as shown in Figure 3.2 
with DD0 = 0 and DDNT = H. In other words, although the production can occur at 
any time between due dates, the product shipments occur only at the due dates. 
5. Campaign changeover times are sequence-independent, but task-dependent and 
line-dependent. Thus, we use CTil to denote the time required to begin a campaign 
of task i on line l. 
We now develop a continuous-time MILP formulation for the above planning 
problem. 
3.2 Formulation 
We view the planning horizon H to consist of NT periods, where we define the interval 
[DD(t–1), DDt] as period t. We use a separate local time-axis for each period, so DD(t–1) 
in real time corresponds to time zero for period t, while DDt to time DDt–DD(t–1). Let 
Hlt denote the total available production time on line l during period t. We break this 
production time in each period on line l into NKl = |Il| slots of variable lengths, where 
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|Il| is the cardinality of Il. For instance, line 1 can perform four different tasks in Figure 
3.2, so NK1 = 4. Similarly, NK2 = 2 and NK3 = 3. Thus, each period has NKl slots on 
line l, and a line can have at most one campaign for a task during a period. This is 
mainly to minimize the time wasted during campaign transitions, but it may also result 
in higher inventory costs. The profit boost due to the former may outweigh the loss due 
to the latter. We number the slots in each period as k = 1, 2, …, NKl as shown in Figure 
3.2 and define  and  respectively as the start and end times of slot k during 







DDNT–DD(NT–1)0 DD2–DD1 0 0 DDt–DD(t–1)  0 
H
t = 1                  t = 2    t = t t = NT 
DD1
   k = 1           k = 2                k = 3                 k = 4 
        k = 1                       k = 2                       k = 3             
               Line 2 k = 1                                       k = 2                     
Line 1 
Line 3 
Figure 3.2: Schematic of time periods and slots within a time period.  
The supply chain planning model features two classes of constraints: intra-
facility and inter-facility. The former deal with the assignment and sequencing of tasks 
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on lines and their timings, while the latter deal with the flow of materials in and out of 
the facility, material stocks, and demand fulfillment. Unless otherwise stated, we write 
each constraint for all the valid values of its defining indexes. 
3.2.1 Intra-Facility Constraints 
The first block of constraints in this class assigns tasks to slots. 
3.2.1.1 Task Assignments and Campaign Lengths. To assign tasks to slots, we use 
the following binary variable: 
1 if line performs task  in slot of period 
0 otherwiseiklt
l i k t
Y ⎧= ⎨⎩  

















=∑  i ∈ Il (3.2) 
As we allow at most one campaign per task in a period, we need NCilt ≤ 1. 
Let CLklt denote the length of slot k on line l in period t, and CLiklt denote the 
time that we devote to task i within that slot length. Since the sum of such times must 









Similarly, if a task i does not occur in a slot k of period t on line l, then we set its start 
time  and time usage CLSikltT iklt in that slot to zero. Therefore, 
1( )
S
iklt iklt t t ikltT CL DD DD Y−+ ≤ −  i ∈ Il (3.4) 
Slot length represents the actual time for which a task uses a line, so the sum of slot 
lengths must not exceed the total available production time on each line. In other 
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≤∑  (3.5) 
As discussed earlier, long campaign lengths are desirable in practice to avoid 
lengthy and costly changeovers in pharmaceutical plants. When a period has several 
campaigns, a campaign may have continued from the previous period, or a campaign 
may continue into the next. To model the continuation of the last campaign in a period 
into the next period, we define the following continuous 0-1 variable: 










A campaign can spill over a DDt, only if it is the last in period t and the first in (t+1). 
In other words, 
ilt ikltYS Y≤  i ∈ Il, k = NKl (3.6) 
1 ( 1)ilt i l tYS Y +≤  i ∈ Il (3.7) 










Now, to ensure minimum campaign lengths, we demand, 
( 1)[iklt il iklt il t iltCL MCL Y YS YS−≥ − −  i ∈ Il (3.9) 
Note that the above constraint relaxes as desired, if the task campaign continues from 
the previous period or into the next period. If this does happen, then we force the sum 
of the two consecutive campaign lengths for that task to exceed the minimum length as 
follows: 
( 1) 1 ( 1)ikl t i lt il il tCL CL MCL YS− + ≥  i ∈ Il, k = NKl (3.10) 
We assume that if a campaign spans more than two periods, then its length would 
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automatically exceed the minimum and we do not impose an extension of eq. 3.9 to 
more than two campaigns. 
3.2.1.2 Timing and Precedence. A production plan devoid of timing considerations 
could be unrealistic. Hence, we must impose constraints on the exact timings (  and 
) of the campaigns as well. Firstly, we relate the start time of a slot k of period t on 
















If a task i does not take place in slot k, then eq. 3.4 will make  zero, so eq. 3.11 will 





klt klt kltT T CL= +  (3.12) 
Thirdly, a campaign cannot start on a line, until the preceding one has ended, so, 
( 1)
S E
k lt kltT T+ ≥  k < NKl (3.13) 
An important timing consideration involves the precedence relationships 
among various tasks in the recipe diagram. If a task i precedes another task i′ in the 
recipe diagram, then the latter cannot start until the former has produced sufficient 
amounts of intermediates that the latter needs. When the latter occurs in a period later 
than the former’s period, we ensure this by means of inventory constraints discussed 
later. However, if the two occur in the same period, then we need constraints to ensure 
that the latter starts and ends after the former. In order to impose these task orderings, 
we demand that the start (end) time of task i on any line l precede the start (end) time 





ii ilt i l t iklt i kl t
k k
d NC NC T T′ ′ ′
= =
+ − + ≤∑ ∑  i ∈ Il, i′∈ Il′ (3.14) 
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1 1
( 1) ( ) (
l lNK NK
S S
ii ilt i l t iklt iklt i kl t i kl t
k k
d NC NC T CL T CL′ ′ ′ ′ ′
= =
+ − + + ≤ +∑ ∑ )′ ′  i ∈ Il, i′∈ Il′ (3.15) 
3.2.1.3 Production Amounts. The campaign lengths CLiklt include the changeover 
times, which are usually significant in pharmaceutical plants. To compute the useful 
production time of task i, we must subtract the changeover times from the campaign 
lengths. To this end, we define PTilt as the actual time for which task i produces on line 





ilt iklt il ilt il t
k
PT CL CT NC YS −
=
= − −∑  i ∈ Il (3.16) 
where CTil denotes the changeover time required for task i on line l. Note that the 
assumption of at most one campaign per task is pivotal to the above constraint. 
Furthermore, the constraint assumes that changeovers cannot split between periods. 
Although we can remedy this assumption, we would need to double the binary 
variables. For a planning problem, this seems excessive detail, as the scheduling 
problem will fix the actual campaign timings precisely. Now, the amount PQmlt of 





mlt il ilt ilt
i m i i
PQ R PT DQ
µ
]σσ∋ ∈ ∈= ∑M I +   (3.17) 
( )U Lilt il il iltDQ R R PT≤ −  i ∈ Il (3.18) 
3.2.1.4 Validation Time. In practice, when a pharmaceutical plant introduces a new 
product, it must undergo a scale-up phase of 2 to 3 months before it can begin 
commercial production of that product. During this period, the plant personnel tune the 
tasks of the new product to achieve the desired quality targets. Once this scale-up is 
completed, the plant must produce 4 to 5 batches of the new product to get a regulatory 
approval for commercial production. The material produced during this validation 
period cannot be sold to the customers. Hence, this time resembles a changeover time 
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and we must subtract it from the campaign length to get the actual production time. Let 
QTil be this validation time required for task i on line l. To account for this time in 
computing the actual production time, we introduce a continuous 0-1 variable as 
follows: 












ilt iklt il ilt il t il iklt
k k
PT CL CT NC YS QT Z−
= =
= − − −∑  i ∈ Il (3.16a) 








≤∑∑  i ∈ Il (3.19) 




iklt iklt ik lt
t t k
Z Y Z ′ ′
′ ′< =
≥ −∑∑  i ∈ Il (3.20) 
This completes the intra-facility constraints in our model. We now discuss the inter-
facility constraints. 
3.2.2 Inter-facility Constraints 
If Imt denotes the inventory of material m at the end of period t, then 
( 1)mt m t mt mlt mct
l c
I I OQ PQ SQ−= + + −∑ ∑  (3.21) 
where, OQmt is the amount of m outsourced during t and SQmct is the amount of m 
supplied to customer c during t. Note that the inventory position is after the shipment 
of material. 
If the plant cannot meet the demand of a material m in any period t, then it 
carries this shortage over to the next period, i.e., 
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( 1)mct mc t mct mctI I D SQ
− −
−≥ + −  (3.22) 
where, Dmct is the demand of material m by customer c during period t and mctI
−  is the 
shortfall in supply of m to customer c during t. Furthermore, supply from a current 
period can fulfill the demand from previous periods, but the cumulative supply up to a 
period should not exceed the total demand until that period plus the initial backlog. 
Hence, 
0mct mct mc
t t t t
SQ D I −′ ′
′ ′≤ ≤
≤ +∑ ∑  (3.23) 
Plants usually keep some safety stocks for most materials, especially the raw materials 
and final products, as a buffer against unforeseen circumstances. Let *mtI  denotes the 
safety stock for material m during period t. In order to maintain the safety stock target, 
we penalize the deviations of inventory below the safety stock target. We obtain these 
deviations by using,  
*
mt mt mtI I I
∆ ≥ −  (3.24) 
In the development so far, eqs. 3.1-3.20 deal with production tasks, whereas 
eqs. 3.21-3.24 deal with materials. The inventory balance of eq. 3.21 links these two 
sets of constraints. We have bounds on several variables such as inventory, backlog, 
supply, and slot start/end times. These are as follows: 
mt mI ST≤   (3.25) 
0mct mct mc
t t
I D I− ′
′≤
≤ +∑ −   (3.26) 
0mct mct mc
t t
SQ D I −′
′≤
≤ +∑   (3.27) 
( 1)
S
klt t tT DD DD −≤ −   (3.28) 
( 1)
E
klt t tT DD DD −≤ −   (3.29) 
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3.2.3 Planning Objective 
Maximization of gross profit (revenue – costs) is normally the preferred objective of 
plant management, as it lets the management produce the most profitable products. 
The facility F derives its revenue by selling the APIs or intermediates, while its costs 
arise from changeovers, purchase of materials, production, inventory, material 
transportation, and penalties for supply and target level shortages. 
Let CCil denotes the changeover cost for starting a campaign of task i on line l. 
We can estimate this from the time, labor, and materials required to clean/flush the 
lines and units. In addition, it would also include the cost of waste disposal. For the 
purchase of materials, we assume a fixed price pm for material m. This includes the 
purchase, transport, and insurance costs. Let pcml denotes the cost of producing a unit 
of material m on line l. We do not use exact time-averaged inventory, as it results in a 
nonlinear objective function. Instead, we approximate the inventory costs by a linear 
function. Let hcmt denotes the cost of holding a unit amount of material m for the entire 
length of period t. We compute the inventory cost at the end of a period t based on the 
amount present at the period’s start, and that produced during the period. We assess the 
penalty for the inventory shortfall from target levels at the end of period t as mt mta I
∆ . In 
addition, we take the supply shortage cost of a product as the revenue of that product 
gmc. With this, the objective of our planning model is: 
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This completes our formulation for the supply chain planning in 
pharmaceutical plants. It comprises the objective function (eq. 3.30), constraints (eqs. 
3.1-3.24), and bounds (eqs. 3.25-3.29).  
3.3. Remarks 
Though we assume that our model is deterministic in nature, it can handle unexpected 
events during a planning horizon by means of a rolling horizon strategy. These events 
may include line failures, unexpected requests for testing/launching of new products, 
extreme changes in the demand forecasts, and so on. A new product is quite likely to 
face a situation when its demand may go up or down suddenly. In either extremity, the 
current production plan would need a revision. Such revisions could minimize the 
costs arising from a failure or high backlog of a new product. In order to revise the 
production plan, we redefine periods from the current time onwards and simply update 
the model with the current status of the facility. This includes initial inventory levels 
(Im0), initial backlogs ( 0mcI
− ) to various customers, campaign lengths (CLikl0) of the 
tasks that currently spill over to next periods, and initial values of spill-over binaries 
(YSil0). This updating ensures the continuity of production activities in the new plan. 
With slight modifications, we can apply our model to several extensions. So 
far, we focused on primary production alone. Secondary production involves mostly 
semicontinuous operations such as coating, granulation, packaging etc. As discussed 
earlier, the production is largely order-driven, so transitions are more frequent, but 
easier. We can assume the campaign mode of operation in the secondary production as 
well except that the period and campaign lengths will generally be shorter than those in 
the primary production will. The minimum campaign lengths may also be shorter. 
However, with appropriate data, our model can easily address the secondary 
production as well. 
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We also assumed that the scale-up procedures are complete before a new 
product enters facility F for commercial production. Hence, we incorporated only the 
validation times explicitly in our model. However, the scale-up of a new product may 
also accompany its introduction. Our model can easily include such scale-up tasks as 
well. In this case, the lines would perform the new tasks to meet the scale-up targets 
instead of customer needs. 
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Chapter 4 
PLANNING - MODEL EVALUATION 
In this chapter, we present three examples to evaluate the performance and illustrate 
the application of our planning model that we developed in the previous chapter. 
Example 1 demonstrates the impact of a new product introduction on the operation of a 
facility. Example 2 highlights the benefits of outsourcing an intermediate, when a 
facility is overloaded. Lastly, Example 3 shows the results for the re-run model that 
accounts for the current state of the facility. 
4.1 Examples 
The following are common for all three examples: 
(i) Minimum production rate LilR  of task i on line l is 
U
ilR /4. 
(ii) Penalty amt for violating target inventory is twice the holding cost hcmt. 
(iii) Only one secondary production site exists, so all the active ingredients are shipped 
to only one site. Hence, index c is redundant. 
(iv) Raw materials are available as and when required, so the inventory cost for storing 
the raw materials is not important. 
(v) Gross profits reported are those for the entire horizon 
We display the production plans in the examples via Gantt charts with the following 
format. The rectangles in the Gantt charts represent time slots. The label within each 
rectangle denotes the material produced in that slot. The slot start/end times are shown 
underneath each rectangle. The start/end times are with respect to the start of period as 
time zero. If a task on a line continues across DDt, then the last slot in period t and the 
first slot in (t+1) on that line are merged to show the continuity of production across 
DDt. 
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We used GAMS (Brooke et al., 1998)/CPLEX 7.5 on a Dell PWS650 
workstation with Windows 2000 to solve the three examples. Table 4.4 lists the model 
and solution statistics. All solutions are optimal solutions with 0% gap. All solution 
times are within 50 s. The runs that involve new product introductions take 
substantially more CPU times than those without the introductions. 
 
Table 4.1: Maximum production rates, minimum campaign lengths, changeover times, 
















1 1 20 100 - 2.0 40
2 2 15 110 - 2.0 50
3 3 25 140 - 3.0 70
4 1 15 110 - 3.0 50
5 2 10 120 - 3.0 60
6 3 20 130 - 2.0 65
7 2 20 100 15 2.0 55
8 3 25 125 10 3.0 80
1 1 20 - - - -
2 2 8 - - 2.0 50
3 7 - - 1.5 45
3 4 15 - - 3.0 70
4 2 5 - - 2.0 40
3 5 - - 2.0 40
5 4 20 - - 3.0 80
1 1 20 - - 3.0 45
2 2 16 - - 2.0 50
3 7 - - 1.5 45
3 4 15 - - 3.0 70
4 2 10 - - 2.0 40
3 5 - - 2.0 40
5 4 20 - - 3.0 80
6 1 20 - 10 3.0 50
7 2 16 - 12 2.0 45
3 7 - 12 1.5 50
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Table 4.2: Available production times in periods, and demands, revenues and 
safety stock targets for products in the examples. 
 
1 2 3 4
4 2000 1500 6000 5000 1.2 1500
8 1000 1500 6000 2500 0.8 1000
12 1000 1000 1200 1500 2.3 1000
4 1000 1500 6000 2500 1.2 1500
6 2000 1500 6000 5000 0.8 1000
4 1500 6000 2500 - 1.2 1500
6 1500 6000 5000 - 0.8 1000
11 1000 1500 2000 - 2.3 1000
Example 3
Available production times in periods are H l 1 = 360 h, H l 2 = 
360 h, H l 3 = 720 h, and H l 4 = 720 h for all lines except that H 13 
= 600 h for Example 3.











Table 4.3: Holding costs, storage capacities, and initial inventories of materials 

























1 AA 0.00 AA 0.00 AA AA 0.00
2 3500 1.30 3500 1.30 1276.4 3500 1.30
3 3000 1.23 3000 1.23 233.5 3000 1.23
4 UL 1.76 UL 1.76 0.0 UL 1.76
5 AA 0.00 4000 1.36 0.0 4000 1.36
6 4000 1.60 UL 1.60 352.0 UL 1.60
7 5000 1.40 3000 1.40 261.0 3000 1.40
8 UL 1.82 - - AA AA 0.00
9 3000 1.50 - - 0.0 3500 1.35
10 AA 0.00 - - 0.0 4000 1.28
11 3000 1.28 - - 0.0 UL 1.80
12 UL 1.90 - - - - -
Example 1 Example 2 Example 3
UL = Unlimited, AA = Available as and when required. Delays required between task 
pairs in Examples 2 and 3 are d 12 = d 14 = 4 h, d 23 = 2 h, d 43 = d 45 = 3 h, d 67 = 4 h, and 
d 78 = 3 h.  
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4.1.1 Example 1 
This example illustrates the impact of a new product introduction on the production of 
an existing facility. We consider the facility in Figure 3.1 (see previous chapter) that 
produces two active ingredients using six production tasks. F has three production 
lines, and cannot treat more than a certain amount of the waste material m9 in each 
period. The planning horizon is one quarter (2160 h) and comprises four periods. The 
first two periods are 15 days (360 h) each, and the last two are 30 days (720 h) each. 
Thus, DD1 = 360 h, DD2 = 720 h, DD3 = 1440 h, and DD4 = 2160 h. Tables 4.1-4.3 list 
the required data. In this example, we take minimum campaign lengths to be line-
dependent and assume dii′ = 0. In addition, we assume that the initial inventories of all 
materials other than the raw materials (m = 1 and 5) are zero. 
m1075%
 
Figure 4.1: Recipe diagram for Example 1 with new product m12. 
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Figure 4.2(a) shows the current production plan for F with a gross profit of 
$20108.1 (Example 1a in Table 4.4). A new product m12 is under consideration for 
production at F. Figure 4.1 shows the recipe diagram for F including m12. The 
production of m12 requires two new tasks i = 7 and 8. Note that line 2 is fully utilized 
in Figure 4.2(a), so line 2 has no room to produce m11. Therefore, it is clear that F must 
sacrifice the production of some existing products to accommodate m12. Therefore, the 
plant management faces several questions: (1) Is it profitable to produce m12, and if so 
how much to produce? (2) How should the production levels of other products reduce 
to accommodate m12? (3) What will be the new production plan? Thus, the goal of our 
model is to decide the optimal combination of products to produce, which will 
naturally determine if F should or should not produce m12. 
In practice, the safety stock level usually depends on the importance of a 
product and the volatility of its demand. For the flagship/dominant products with well-
established markets and high service levels (required), these would be high. However, 
the same is not true for new products. A new product is highly susceptible to 
technical/financial failures in spite of the warm welcome assured by the market 
intelligence. Thus, in spite of their importance to any organization, one must consider 
the high cost of inventory reclamation in case of new product failures, and cannot risk 
maintaining high inventories during the initial launch periods. Bowersox et al. (1999) 
studied the so-called lean-launch strategies based on response-based logistics. They 
suggested that a lean-launch could cut losses in launch failures by reducing the 
inventory exposure. Because primary production is the slowest responsive part of the 
entire pharmaceutical supply chain, it cannot exercise response-based logistics. Hence, 
a proper combination of the response-based inventory and that required for demand 
volatility is a better inventory scheme for new products. 
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(b) After the introduction of m12
Figure 4.2: Production plans before and after the introduction of m12 in Example 1.
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To effect a lean-launch, we set the inventory target for m12 as the minimum of 
all target inventories as discussed later in the remarks section. Figure 4.2(b) shows the 
revised production plan for F after the introduction of m12. The shaded slots represent 
the new tasks (i = 7 and 8) for m12. Because F performs the new tasks for the first time 
in period 1, it has to validate them, but in period 1 only. The black color in Figure 
4.2(b) highlights these validation times. The gross profit for the new production plan is 
$25068.9 (Example 1b in Table 4.4), thus the introduction of m12 at F can boost profit 
by 25% ($4960.8). Expectedly, the productions of m4 and m8 suffer. Their backlogs 
increase and inventories decrease (see Table 4.5). m12 is so lucrative that the new plan 
meets its demands in each period at the expense of m4 and m8. Clearly, this represents a 
compelling reason for the management to accommodate m12 at F. 
 
Table 4.4: Model and solution statistics for the examples. 
1a 0.5 129 2745 21066.6 20108.1 48 872 1047 2163
1b 28.9 4149 199545 26739.0 25068.9 88 919 1061 3987
2a 1.2 206 7287 17986.0 13688.8 52 605 761 2613
2b 1.5 153 8057 21158.9 16573.4 52 605 761 2617
2c 1.6 213 9388 21864.6 20729.3 52 605 761 2617
2d 1.6 140 8679 21864.6 20729.3 52 605 761 2621
2e 2.0 192 12709 21841.2 20473.2 52 605 761 2621
3 47.7 4816 280687 30400.1 28646.8 93 872 1047 4131
Example CPU 
Time (s)










4.1.2 Example 2 
This example highlights the value of outsourcing under suitable conditions. We 
consider a facility similar to that in Example 1, but with some changes in the 
production recipe as shown in Figure 4.3. The facility in this case produces two 
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products using five tasks. It employs four production lines. Tables 4.1-4.3 also list the 
data for this example. As in Example 1, we use DD1 = 360 h, DD2 = 720 h, DD3 = 
1440 h, DD4 = 2160 h, identical minimum campaign lengths for all tasks, and zero 
initial inventories for all but the raw materials. However, we do consider nonzero 
delays dii′ (see Table 4.3) for a task i preceding i′ in the RD in a given period. 
 
Table 4.5: Inventory and backlog details for the examples. 
 
Period Before After Period Before After Period Before After
4 1 587.5 217.5 - - - - - -
- 2 1500.0 0.0 - - - - - -
8 1 487.3 76.85 2 0.0 99.4 4 1310.0 3596.0
- 2 506.0 0.0 3 1945.0 3556.0 - - -
4 2 1546.4 3112.7 1 - 278.2 - - -
6 1 352.0 569 2 1148.0 931.0 4 3548.3 1335.0
- - - - 3 2970.3 757.0 - - -
4 1 0.0 305.7 - - - - - -
- 2 1546.4 1886 - - - - - -
- 3 0.0 727 - - - - - -
6 1 352.0 2500 2 1148.0 0.0 4 3548.3 0.0
- 2 0.0 1000 3 2970.3 0.0 - - -
- 3 0.0 11 - - - - - -
4 2 1546.4 1771.7 - - - - - -
6 1 352.0 1252 2 1148.0 0.0 4 3548.3 0.0
- - - - 3 2970.3 0.0 - - -
4 1 480.0 - 2 1764.8 - 3 2030.2 -
6 - - - 1 181.4 - 3 2235.6 -
- - - - 2 1715.0 - - - -
Example 3 (Inventory and backlog profiles)
Backlog (mu)
Example 1a,b (before & after introdution of m 12)
Inventory (mu)
Example 2c,d (before and after outsourcing m 5 only or both m 3 and m 5)
Example 2a,b (before and after outsourcing m 3 only)





Figure 4.4(a) shows the current production plan with no outsourcing. The plan 
has a gross profit of $13688.8 (Example 2a in Table 4.4). In the current plan, lines 2 
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and 3 are the bottlenecks and make it impossible to meet the demand of m6 in periods 
2, 3 and 4 (see Table 4.5). By outsourcing m3 or m5 or both, it should be possible to 
increase the production of m6, for which line 4 has unused capacity. The plant 
management faces the decision of which intermediates to outsource and in what 
amounts. Given the choices of outsourcing, our model can identify the optimal 
decision including which intermediates should be outsourced, when and in what 
amounts. However, to study the impact of outsourcing each intermediate or all of them 
at a time, we consider three scenarios. In the first scenario, F can outsource only m3, in 
the second, it can outsource only m5, and in the last, it can outsource both. In all three 
cases, the optimal outsourcing quantity is the one that gives the maximum gross profit. 
Hence, we impose no upper limit on the outsourcing quantity. For these studies, we use 
a price of $0.5 per mu (mass unit) for both m3 and m5. 
80%










Figure 4.3: Recipe diagram for Example 2.
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(a) Before outsourcing m5
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(b) After outsourcing m5
Figure 4.4: Production plans before and after outsourcing m5 for Example 2.
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In the first case, where F can outsource m3 only, backlogs (see Table 4.5) of m6 
in periods 2, 3, and 4 reduce to 931, 757, and 1335 mu respectively. However, period 1 
still shows a backlog of 278.2 mu for m4. Although outsourcing m3 does not eliminate 
the backlogs fully, it does reduce them. The quantities of m3 outsourced in periods 1 
and 2 are 389 and 3825 mu respectively, while the gross profit for this scenario 
increases by roughly 21% to $16573.4 (Example 2b in Table 4.4).  
In the second case, where F can outsource m5 only, the backlogs (see Table 4.5) 
of both m4 and m6 disappear in all periods. The outsourced quantities of m5 are 2652 
and 1246 mu in periods 1 and 3 respectively. The gross profit of F increases by 
roughly 50% to $20729.3 (Example 2c in Table 4.4). This is roughly 25% higher than 
the first case, so outsourcing m5 is more profitable than outsourcing m3. Figure 4.4(b) 
shows the resulting production plan after outsourcing m5. In the optimal plan, the 
campaign of m6 on line 4 starts immediately after that of m4 in period 2. However, 
because the campaign length of m6 is just 3 h in period 2, this portion of the campaign 
is invisible in period 2. However, the same campaign continues with a discontinuity 
due to the delay time required between m5 and m6 in period 3. This delay is 
inconsequential as far as the actual production schedule is concerned and one can 
suitably eliminate this while doing detailed production scheduling. 
In the third case, F can outsource any or both m3 and m5, but the optimal 
outsourcing solution (Example 2d in Table 4.4) is identical to that in the second case. 
Given the options of outsourcing both m3 and m5, the model outsources m5 only and no 
m3. Because both m4 and m6 share m5 (see Figure 4.3), outsourcing m5 elevates the 
production levels of both m4 and m6. 
If F can outsource only a limited amount of m5 but unlimited amount of m3, 
then one may want to know the amounts of backlogs that F can avoid. To study this 
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case, we impose a maximum limit of 1000 mu per period on m5. In this case, F 
outsources 1000 mu of m5 in periods 1, 2, and 3, and 642 mu in period 4. Moreover, it 
outsources 592 mu of m3 in period 2. Interestingly, this eliminates the entire backlog of 
m6 (see Table 4.5). The gross profit in this case is $20473.2 (Example 2e in Table 4.4), 
which although comparable to cases 2 and 3 is still less. We expected this, as the 
optimal solution is the one in cases 2 and 3.  
The decision to outsource requires several considerations. A facility may 
consider outsourcing an intermediate, when it is unable to meet the demands of its 
products with the existing equipment. It may also consider outsourcing, when it is 
more profitable to use the facility to produce a new product rather than a nearly off-
patent product. However, at times, it may not be acceptable to outsource some 
intermediates due to business reasons. In any case, only the intermediates produced by 
the bottleneck lines are the potential candidates for outsourcing. 
4.1.3 Example 3 
In this example, we consider several plant changes that force a revision of the 
production plan. We consider a facility very similar to the one in Example 2. At the 
end of period 1, we assume that the following changes occur in the facility: 
(i) The plant wishes to introduce a new product m11 as shown in Figure 4.5. 
(ii) The capacity of line 2 doubles due to a retrofit project. 
(iii) 120 h are required near the end of period 3 on line 1 to test a new product. Hence, 
the available production time on line 1 in period 3 is 600 h instead of 720 h. 
The end of period 1 or t = 360 h now becomes the start of the scheduling horizon, and 
the state of the facility at this point (see Figure 4.4a) becomes current state. Thus, 
period 2 becomes period 1, period 3 becomes period 2, and so on. Tables 4.1-4.3 
provide the remaining data. 
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Figure 4.5: Recipe diagram for Example 3 with new product m11. 
Figure 4.6: Production plan for Example 3.
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Figure 4.6 shows the revised production plan that incorporates the above 
changes in the facility. The slots with slanted line-pattern represent the new tasks 
related to m11, while those filled with black represent the validation times. The gaps 
that occur in the performance of new tasks across the DD2 are due to the delay times 
(dii′) required between successive tasks in a recipe, when they take place in a given 
period. Based on the available inventories of the intermediates, the plant operation can 
remove these gaps easily during scheduling. Again, as in Example 1, the new product 
is highly lucrative, and its production is at the expense of existing products. The 
backlogs of m4 and m6 occur in all periods as shown in Table 4.5. However, the gross 
profit still increases to $28646.8 (Example 3 in Table 4.4) as compared to $13688.8. 
Thus, it is profitable for the plant to accommodate m11. 
4.2 Conclusion 
We have addressed an important and common supply chain planning problem to assess 
the feasibility as well as profitability of introducing new active ingredients or 
intermediates in a given pharmaceutical plant. In the previous chapter, we developed a 
single-plant-centric, multi-period, MILP model that allows complex API-recipes with 
multiple intermediates, outsourcing of existing intermediates, material movement 
among different production/supply/demand facilities, validation times for new tasks, 
minimum campaign lengths, line-dependent cleaning, and so on, and considers 
explicitly the details of campaign sequencing and timing on individual production lines 
in a pharmaceutical plant. In this chapter, we tested its efficacy on three examples that 
feature many of the real-life issues of a pharmaceutical plant. It is clear from the 
evaluation that our model gives reasonably quick solutions (< 50 s) for three examples 
(see Table 4.4) involving up to twelve materials (intermediates, products, wastes, etc.), 
four production lines, and up to three months of planning horizon. Hence, we conclude 
   46
 
 Chapter 4: Planning - Model Evaluation 
that our planning model can assist in quick, optimal assessments of new product 
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Chapter 5 
SCHEDULING IN PHARMACEUTICAL PLANTS 
It is common in pharmaceutical industry that the demands of products in a particular 
primary/secondary site vary quite often. In such cases, the operation management may 
not prefer the campaign mode of operation, instead it would resort to a batch mode of 
operation as the latter can effectively respond to the variable demands. Hence, the 
decision level lowers from planning to scheduling, where scheduling is more accurate 
as it accounts for the realistic constraints in the plants. Normally, the scheduling 
horizon is about few days to few weeks, whereas planning horizon could go up to few 
years. Now, the short-term demands of products dictate the operations in a plant, and 
much competition arises among different products. Since the pharmaceutical plants are 
multipurpose in nature, the major challenges that the plant management faces are how 
to utilize the available production units very efficiently, which products to produce 
from when to when so that the customer demands are met satisfactorily and so on. In 
this chapter, we describe an important scheduling problem for the pharmaceutical 
plants, present the motivation behind our scheduling work, develop a novel 
formulation for addressing this important problem, and present some remarks on the 
proposed formulation. 
5.1 Motivation 
Some recent attempts (Ierapetritou & Floudas, 1998, 1999; Giannelos & Georgiadis, 
2002; Maravelias & Grossmann, 2003a) at scheduling multipurpose batch plants base 
their MILP formulations on the idea of decoupling tasks from units, which entails 
replacing the key 3-index binary assignment variables (task on unit at event point or 
slot) into two sets of 2-index binary variables involving task to event point/slot or unit 
to event point/slot assignment decisions. The motivation for this decoupling is that it 
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appears to reduce the total number of binary variables in the formulation which in turn 
may reduce overall solution time. 
Although reducing the number of binary variables in a formulation is generally 
a desirable modeling objective, it is well known that this does not guarantee improved 
solution times. The ultimate proof in any specific case still lies in the hard evidence of 
computational performance. Furthermore, the following analysis shows that this type 
of decoupling strategy does not actually lead to the binary variable reduction that is 
intended. 
Consider an arbitrary (multipurpose or otherwise) batch plant with I tasks (i = 
1, 2, …, I) and J units. Whether one uses slots or events in a continuous-time 
formulation, a key scheduling decision is to assign tasks to units at various slots or 
events. One approach to model this decision is to directly use the following 
straightforward 3-index binary variables: 
1 if task  begins on unit  at event point
( , , )
0 otherwise
i j
y i j n ⎧= ⎨⎩
n
 
Under the decoupling strategy, the same decision is modeled using the following two 
2-index binary variables: 




w i n ⎧= ⎨⎩  




v j n ⎧= ⎨⎩
 
Let us refer to the above two approaches as non-decoupling and decoupling 
approaches respectively. Since the latter allows one to eliminate the v-variables from 
the formulation, it may be argued that it uses fewer binary variables. The justification 
is that the w-variables have only two indexes, hence their number is of O(I) per event 
point. In contrast, the y-variables have three indexes and hence their number is of 
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O(I×J) per event point, which is expected to be much higher. However, the key 
assumption that the decoupling approach uses to decouple tasks from units is that each 
task is performed by a unique unit. If several units can perform a task, then the 
decoupling approach replaces that task by several tasks that represent unique task-unit 
combinations. For instance, if units 1 and 2 can perform a task A, then the decoupling 
approach must define two tasks A-1 and A-2, which are nothing but A-performed-on-
unit-1 and A-performed-on-unit-2 respectively. 
Now, let Ji denote the set of units that can perform task i. The decoupling 
approach would replace each task i by |Ji| new tasks, where |Ji| is the cardinality of set 
Ji. Therefore, the total number of tasks in this approach would not be I, but |J1| + |J2| + 
… + |JI| and the number of w-variables required would be |J1| + |J2| + … + |JI| per 
event point. The non-decoupling approach would define one binary per event point for 
each unit that can perform a task i. So, the non-decoupling approach would require |J1| 
+ |J2| + … + |JI| y-variables per event point. Clearly, the number of binary variables is 
the same in both approaches. 
When we assume a unique unit for each task, the index j becomes fixed as soon 
as we fix i. Then, y(i, j, n) in fact becomes y[i, j(i), n], which is fully equivalent to the 
2-index binary variable w(i, n). As we saw earlier, the assumption of a unique unit for 
each task increases the number of actual tasks to that of O(I×J), hence the number of 
w-variables is still the same as the O(I×J) of y-variables. Another way of viewing this 
is that since any given plant operation has some inherent degrees of freedom for 
assigning tasks to units and event points, any complete formulation cannot reduce this 
inherent freedom. If a formulation were to do so, it may lead to suboptimal solutions. 
The only difference between the 3-index y-variables and the 2-index w-variables is that 
the former display the unit information explicitly in terms of j, while the latter hide the 
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same behind i. The number of binary variables per event point must be the same; 
otherwise the formulation cannot give the optimal solution. The decoupling of tasks 
from units increases the number of binaries by increasing the number of tasks, and at 
the same time decreases them by eliminating the v-variables, but the net effect of these 
two actions is zero in terms of the number of binary variables. 
The aim of this work is to propose a simple and novel formulation that does not 
decouple tasks from units and uses a slot-based continuous-time formulation for 
scheduling multipurpose batch plants. As we show later conclusively, in spite of using 
3-index binary assignment variables, our formulation requires fewer variables, uses 
fewer constraints and nonzeros, solves significantly faster, and has the potential to 
yield tighter relaxed objective than any other existing model (even-based or 
otherwise). Furthermore, it should not have any problems in addressing several key 
features of resource-constrained multipurpose batch plants. 
5.2 Problem Description 
We consider a pharmaceutical batch plant F that produces multiple products using a 
number of shared production units that constrain the plant operation. We use recipe 
diagrams (RDs) to describe the production in F, which we feel are a more 
straightforward extension of Process Flow Diagram (PFD) concept to a batch process. 
In chapter 3, we discussed about the representation of RD with an example. Here, we 
use an alternate representation of RD, which provides unit information in addition to 
the task sequence. In a RD, nodes represent the tasks, arcs represent the various 
materials, and arc directions represent the task precedence. Hence, RD uses only one 
set of nodes that denote tasks and obviates the need for using a second set to represent 
material states. In this sense, RD is a simpler and unambiguous depiction of recipes 
using only task nodes. A plant in general may involve one or more disjoint RDs. 
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Figure 5.1 shows the RD for an example pharmaceutical plant producing one product 
that requires two intermediates. In the figure, D denotes the final product, B and C 
intermediates, and A the raw material. Each rectangle represents a task and shows 
information about the suitable units that can process the task. As mentioned above, we 
use arrows and their directions to represent the materials and task precedence 
respectively as shown in the figure. Further discussion on RDs appears in the examples 
section of the next chapter. 
A B C D 
(m=2) (m=3) (m=4)(m=1) 
Task 1 
(i=1) 








J2 = {Unit 3} 
 
  
Figure 5.1: Recipe diagram for the motivating example. Ji denotes the set of 
units that can perform task i.
 
The facility F houses J (j = 1, 2, …, J) units and performs I (i = 1, 2, …, I) 
tasks. Each unit j can perform a set Ij of tasks in the RD. Similarly, a set Ji of units can 
perform a task i. We use index m to represent materials in the RD. Let Mi denote the 
set of materials (m ∈ Mi) that a task i consumes or produces. Mi includes all the 
different states of raw materials, intermediates, and final products associated with task 










where, σmi is analogous to the stoichiometric coefficient of a species in a chemical 
reaction except that it can be in kg/kg units instead of mol/mol. Thus, σmi < 0, if task i 
consumes material m ∈ Mi and σmi > 0, if it produces m ∈ Mi. Furthermore, for each 
task i, we designate a primary material µi, with respect to which we define the extent 
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of task i. The batch size of a task i is defined as the amount of the primary material µi 
that task i consumes or produces in a batch. 
For the short-term scheduling of such a multipurpose batch plant, we need to 
determine: 
(i) the optimal sequence and schedule of different tasks on each unit 
(ii) the batch size of each batch of each task on each unit at various times 
using: 
(a) RD for the plant with material and unit requirements 
(b) Suitability of units (processing and storage) for tasks, their capacity limits, and 
batch processing time information 
(c) Time horizon H for profit maximization or fixed product demands Dm for 
makespan minimization 
(d) Final product revenues, net or otherwise 
Although, we consider only two scheduling objectives (maximizing the profit/revenue 
from the sales of finished products and minimizing the makespan) in this work, other 
objectives such as minimizing inventory, production, or setup costs and even 
minimizing the tardiness or earliness can readily be accommodated in the proposed 
formulation with minor modifications. 
 We assume the following for the scheduling formulation. 
1. Transfer and setup times are lumped into batch processing times of tasks. 
2. The batch processing time of task i on unit j is either a constant (τij) or varies 
linearly with its batch size as αij + βij(Batch size), where αij and βij respectively are 
known. 
3. Product revenues have accounted for various production costs. 
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We now develop a continuous-time MILP formulation for the above scheduling 
problem. 
5.3 Formulation 
In multipurpose batch plants, it is quite common that multiple tasks share a limited 
number of production units and resources. Therefore, we need a time representation 
that can handle the shared resources effectively. Although it is possible to use a 
representation using asynchronous slots (Lim and Karimi, 2003b) to handle shared 
resources, we use synchronous slots in this work because they simplify the treatment 
of shared resources. However, note that the former approach generally requires fewer 
slots than the latter for a given problem. In this chapter, we present a basic formulation 
for scheduling multipurpose plants, in which all units are batch units, and no resources 
other than materials and equipment are required for tasks. 
We divide the horizon H into K (k = 1, 2, …, K) slots of variable lengths SLk as 
in Figure 5.2, with k = 0 denoting the slot prior to time zero. The slots are common to 
or synchronized on all units (j = 1, 2, …, J), and we fix K a priori or gradually increase 
K until we have adequate slots. We denote Tk as the time at which slot k ends. T0 = 0 
represents the start of the horizon, while TK ≤ H may occur before H. Normally, each 
Tk corresponds to the start of a task on one or more units, but this need not be so. A 
task beginning at Tk can end before, at, or after T(k+1) as shown in Figure 5.2. Since a 
slot k runs from T(k–1) to Tk, we get, 
Tk = Tk–1 + SLk (5.1) 







∑ ≤ H (5.2) 
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The start of every new task on any unit triggers a slot. However, a new slot 
may begin, even without a task start. Similarly, several tasks may start at the same time 
on different units. This type of representation allows us to accommodate extra, 
redundant slots, when we overestimate K. Furthermore, we define a zero task (i = 0) to 
model the idling of units and to occupy extra, redundant slots. Thus, we have I+1 tasks 

















T 2 T (K -1) T KT 3
H
T 0 T 1
 
Figure 5.2: Schematic of slots and time points. 
 
With this preamble, we proceed with our primary aim of deciding which tasks 
to begin/end at what times, on which units, and in how much amounts.  
5.3.1 Task Assignments and Slot Lengths 
First, we define a binary variable for the start of a task as follows: 






 i ∈ Ij, 0 ≤ k < K 
If a task i merely continues on unit j at Tk, then Yijk = 0. Based on the binary Yijk, we 
define a continuous 0-1 variable Zjk to know if a unit j begins a new task at Tk: 
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Z ⎧= ⎨⎩  0 ≤ k ≤ K 
If Zjk = 0, then the current task on unit j at Tk continues. Since at most one task can start 
on a unit j at any Tk, we can write, 








We assume that all tasks must end at or before TK, and imagine that a new task will 
start on all units at TK, i.e. ZjK = 1 for all j in our formulation. 
Having modeled the starts of tasks, we now model their sizes and timings. Let 
Bijk (i ∈ Ij, 0 ≤ k < K) be the batch size of task i that unit j begins at Tk. This refers to 
the actual amount of primary material µi involved in the batch starting at Tk on unit j. If 
task i does not start at Tk, then Bijk = 0, and vice versa. Therefore, we have, 
L
ijB Yijk ≤ Bijk ≤ 
U
ijB Yijk i > 0 (5.4) 
where, UijB and 
L
ijB  respectively are the maximum and minimum batch sizes of task i 
on unit j. 
5.3.2 Different Balances 
Now, our formulation revolves mainly around four balances involving unit, 
time, and material inventories in units and storage: 
1. Status of a processing unit  
2. Processing time of a task in a unit 
3. Amount of batch material residing in a unit 
4. Inventory in each material storage 
We begin with the balance on the use of a processing unit. 
5.3.2.1 Balance on Units. We define the following 0-1 continuous variables: 





y ⎧= ⎨⎩  i ∈ Ij,0 ≤ k ≤ K  
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YE ⎧= ⎨⎩  i ∈ Ij, 0 ≤ k ≤ K 
A balance on the status of unit j simply means, 
yijk = yij(k–1) + Yij(k–1) – YEijk 0 < k < K (5.5) 
Note that yijk is zero, when task i is not precisely under progress in unit j at Tk. It is 
zero, when a task begins, ends or is not at all taking place. It becomes one, only after a 
task has begun, and becomes zero exactly when the task ends. In our formulation, we 
set yijK = 0, so no task can continue beyond the last slot K. Similarly, for an empty 
plant at the start, we set yij0 = YEij0 = 0. 
It is clear that unit j cannot start a new task, unless it ends the previous task. 
Since we have idle tasks, we assume that a new task always starts on a unit at the end 
of each task, that is, 








Note that since ZjK = 1 and YEij0 = 0, we do not enforce the above for k = K and k = 0. 
However, if a task i on unit j must discharge its batch at TK, then YEijK will be one, as 
that would favor the objective. Similarly, a unit j can start a new task only if it is not 








 + Zjk = 1 0 < k < K (5.7) 
Again, we do not enforce the above for k = K and k = 0, since ZjK = 1, and yijK = yij0 = 
0. Lastly, a unit may end a task i and start the same at the same time, but it cannot 
continue and end or continue and start at the same time. We write these as, 
yijk + Yijk ≤ 1 0 < k < K (5.8a) 
yijk + YEijk ≤ 1 0 < k < K (5.8b) 
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Eqs. 5.3, 5.5, 5.6, 5.7, and 5.8 force yijk and YEijk to be 0 or 1 only (even though we 
treat them as continuous 0-1), as long as Yijk are binary. In fact, it is easy to see that 
eqs. 5.3, 5.6, and 5.7 make eqs. 5.8a-b redundant. Also, with eq. 5.5 in effect, one of 
eqs. 5.3, 5.6, and 5.7 is redundant. We discuss the impact of eqs. 5.6 and 5.7 on model 
performance in the discussion section of the next chapter. 
5.3.2.2 Balance on Processing Times. Here, we keep track of the duration of a task in 
progress on a unit. Let tjk denote the time remaining at Tk to complete the task that was 
in progress during slot k on unit j. As we move from Tk to Tk+1, this time will either 
remain constant (task not in progress during slot k) or decrease (task in progress) by an 
amount equal to the slot length. Thus, a time balance at Tk+1 gives, 
tj(k+1) ≥ tjk + – SL( )
j






(k+1) k < K (5.9) 
The inequality allows a task to continue in a unit even after its completion. Unless a 
task is in progress at time zero, we set tj0 = 0. Also, if we do not allow a unit to 
continue processing beyond slot K, we also set tjK = 0. Whenever, a task completes its 
required duration on a unit, tjk must be zero. We could enforce this simply by using tjk 
≤ H(1–Zjk), but this results in a loose formulation. To get a tighter formulation, we 
need the third balance. 
5.3.2.3 Balance on Batch Amounts. Let bijk be the amount of primary material µi 
(batch size) that resides in unit j just before Tk and BEijk is the amount that task i 
discharges at its completion at Tk. A simple mass balance around unit j gives, 
bijk = bij(k–1) + Bij(k–1) – BEijk i > 0, k > 0 (5.10) 
If unit j is empty at time zero, then bij0 = BEij0 = 0. At TK, we want all units to be 
empty, so bijK = 0. Similarly, whenever a unit j is not performing a task i at Tk, bijk must 
be zero, and vice versa. In other words,  
L
ijB yijk ≤ bijk ≤ 
U
ijB yijk i > 0, 0 < k < K (5.11) 
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Furthermore, a unit can release a batch at Tk only if its task ends, i.e. YEijk = 1, and vice 
versa. In other words, 
L
ijB YEijk ≤ BEijk ≤ 
U
ijB YEijk i > 0, 0 < k < K (5.12) 
Finally, tjk can be nonzero only when both yijk and bijk are so. Therefore, 
tjk ≤ ( )  0 < k < K (5.13) 
j






Note that the above equation does not violate the maximum value possible for tjk, 
which is the batch processing time of the task in progress on unit j. Furthermore, it 
ensures that a task batch does not end, until its duration is over. As mentioned earlier, 
eq. 5.13 affects the tightness of our formulation considerably. 
5.3.2.4 Balance on Material Inventory. Execution of a task will consume and 
produce materials. We assume that (1) all materials are stored in a storage facility 
(imaginary or real), (2) the time to transfer to or from this storage is negligible or 
included in the processing time, (3) a task at its start withdraws the required materials 
from storage, and (4) a task at its end transfers product materials to storage. Then, the 
inventory balance for a material m at Tk is, 
Imk = Im(k–1) + 
, 0 , 0m i m ii i
mi mi
ijk ijk
i i j i i j
BE
µ µ
Bσ σσ σ∈ ≠ ∈ ∈ ≠ ∈+∑ ∑ ∑ ∑OI J II J  (5.14) 
where, Imk is the inventory of material m at Tk, OIm is the set of tasks that produce 
material m, IIm is the set of tasks that consume material m, and σmi is the stoichiometric 
yield coefficient of material m in the mass balance of task i, which is negative for the 
raw materials of task i and positive for its products. Eq. 5.14 ensures that a task is 
never performed, unless the required raw materials are present in their respective 
inventories. Indirectly, it also governs the precedence of tasks on various units. 
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Finally, imposing good upper and lower bounds on all variables in the 
formulation reduces the nodes in the branch & bound solution of MILPs. Therefore, 
we use the following upper bounds on SLk, tjk, Imk, and others. 
SLk ≤  (5.15) (max max
j
U
ij ij ijj i
Bα β
∈
⎡ +⎢⎣ ⎦I )⎤⎥
tjk ≤ ( )max
j
U
ij ij iji I
Bα β
∈
+  (5.16) 
Imk ≤ UmI  (5.17) 
Bijk, bijk, BEijk ≤ UijB  (5.18) 
where, UmI  is the maximum storage capacity for material m. In addition, all continuous 
variables are nonnegative, 
Zjk, yijk, YEijk, SLk, tjk, Bijk, bijk, BEijk, Imk ≥ 0 (5.19) 
In addition to the bounds (eqs. 5.15-5.19), eqs. 5.2-5.6 and 5.9-5.14 are all the 
constraints that we need for our scheduling problem. To complete our formulation, we 
need a suitable scheduling objective. 
5.3.3 Scheduling Objective  
Existing literature has used two scheduling objectives. One is the maximization of total 
revenue, net or otherwise, while the other is the minimization of makespan (Maravelias 
& Grossmann, 2003b; Shah et al., 1993). In most scheduling problems, the latter seems 
to be the more difficult objective (Lamba & Karimi, 2002a; Lamba & Karimi, 2002b; 
Maravelias & Grossmann, 2003a). 
Assuming that the plant can sell all the products that it produces, the net 
revenue or profit from selling the final product inventories at the end of the horizon is, 
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where, gm is the net revenue or profit per kg or mu (mass unit) of product. For this 
objective, our formulation for maximizing sales or net profit comprises eqs. 5.2-5.6, 
5.9-5.14, 5.20, and the bounds (eqs. 5.15-5.19). 
For minimizing the makespan, we modify the formulation slightly. Now, H 
ceases to be a given parameter. Instead, the plant must satisfy some minimum demands 
of products. If Dm denotes the demand for material m, then we have, 
ImK ≥ Dm (5.21) 
Furthermore, we do not need eq. 5.2. Instead, we minimize the makespan given by, 








Thus, the complete model for minimizing the makespan comprises eqs. 5.3-5.6, 5.9-
5.14, 5.21, 5.22, and the bounds (eqs. 5.15-5.19). 
5.4 Remarks 
Some features of our above formulation are noteworthy and distinct from the previous 
work. 
First, in contrast to all the existing continuous-time models of Ierapetritou & 
Floudas (1998), Giannelos & Georgiadis (2002), and Maravelias and Grossmann 
(2003a), our formulation has absolutely no big-M constraints. We believe that this is 
significant, because our experience shows that eliminating the big-M constraints 
generally improves MILP formulations. In general, event-based formulations in the 
literature have profusely used big-M constraints. Maravelias and Grossmann (2003a) 
require several big-M constraints in modeling the duration, finish-time, and time-
matching constraints. As in their case, the use of disjunctive programming also results 
in big-M constraints. In contrast, our formulation needs no ideas such as disjunctive 
programming or convex-hull reformulations. We believe that the lack of big-M 
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constraints gives our model a computational edge, as we show later in performance 
evaluation. 
Second, our model is much simpler than previous models. As we see in the 
examples of next chapter, it has substantially fewer constraints and nonzeros. It also 
uses fewer binary variables. For instance, Maravelias & Grossmann (2003a) use binary 
variables for the start, end, and continuation of tasks, while we use them only for the 




SCHEDULING - MODEL ASSESSMENT 
In this chapter, we assess the performance of our scheduling model, proposed in the 
previous chapter, comparing it with two other models (Maravelias and Grossmann, 
2003a; Giannelos and Georgiadis, 2002) in the literature. Firstly, we solve several 
example scenarios for different objectives to make an unambiguous conclusion. Then, 
we discuss some miscellaneous aspects of our model, and present some basic criteria 
required for any model comparison task. Finally, we make some concluding remarks. 
6.1 Examples 
For the sake of a fair comparison, we implemented our model and those of Maravelias 
& Grossmann (2003a) and Giannelos & Georgiadis (2002) in GAMS (Brooke et al., 
1998). We solved several examples using the three models on DELL GX 270 (Pentium 
IV 2.8 GHz CPU with 1 GB of RAM) running Cplex 8.1.0 in GAMS 21.2. We 
evaluate the three models for both scheduling objectives (profit maximization and 
makespan minimization) to get a better idea of which model is fundamentally better. 
Moreover, we compare them on several scenarios of each example to get a robust 
comparison. Furthermore, we compare them for the special case of constant batch 
processing times, as this case has appeared in the literature. While Table 6.1 gives the 
task and unit information for all the examples, Table 6.2 gives the material 
information. We begin with the first objective of profit maximization, and then 
consider the second of makespan minimization. For each case, we discuss each 
example individually. 
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Table 6.1: Limits on batch sizes of tasks and coefficients in the expressions for 













Task 1 1 Unit 1 Unit1 2.0 1.3330 0.013330 - 100
Unit 2 Unit2 2.0 1.3330 0.013330 - 150
Task 2 2 Unit 3 Unit3 1.5 1.0000 0.005000 - 200
Task 3 3 Unit 4 Unit4 1.0 0.6670 0.004450 - 150
Unit 5 Unit5 1.0 0.6670 0.004450 - 150
Heating H Heater HR 1.0 0.6670 0.006670 - 100
Reaction-1 R1 Reactor 1 RR1 2.0 1.3340 0.026640 - 50
Reactor 2 RR2 2.0 1.3340 0.016650 - 80
Reaction-2 R2 Reactor 1 RR1 2.0 1.3340 0.026640 - 50
Reactor 2 RR2 2.0 1.3340 0.016650 - 80
Reaction-3 R3 Reactor 1 RR1 1.0 0.6670 0.013320 - 50
Reactor 2 RR2 1.0 0.6670 0.008325 80
Separation S Separator SR 2.0 1.3342 0.006660 - 200
Heating-1 H1 Heater HR 1.0 0.6670 0.006670 - 100
Heating-2 H2 Heater HR 1.5 1.0000 0.010000 - 100
Reaction-1 R1 Reactor 1 RR1 2.0 1.3330 0.013330 - 100
Reactor 2 RR2 2.0 1.3330 0.008890 - 150
Reaction-2 R2 Reactor 1 RR1 1.0 0.6670 0.006670 - 100
Reactor 2 RR2 1.0 0.6670 0.004450 - 150
Reaction-3 R3 Reactor 1 RR1 2.0 1.3330 0.013300 - 100
Reactor 2 RR2 2.0 1.3330 0.008890 - 150
Separation S Separator SR 3.0 2.0000 0.006670 - 300
Mixing M Mixer 1 MR1 2.0 1.3330 0.006670 20 200






6.1.1 Profit Maximization 
The objective of the scheduling model is to maximize the profit or net revenue of the 
pharmaceutical plant. Here, the batch processing times are variable with the batch sizes 
of the tasks. Table 6.3 summarizes the model and solution statistics for various 
scenarios of all three test problems under profit maximization. 
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1 UL AA 0 UL AA 0 UL AA 0
2 200 0 0 UL AA 0 UL AA 0
3 250 0 0 UL AA 0 100 0 0
4 UL 0 5 100 0 0 100 0 0
5 - - - 200 0 0 300 0 0
6 - - - 150 0 0 150 50 0
7 - - - 200 0 0 150 50 0
8 - - - UL - 10 UL AA 0
9 - - - UL - 10 150 0 0
10 - - - - - - 150 0 0
11 - - - - - - UL AA 0
12 - - - - - - UL 0 5
13 - - - - - - UL 0 5
UL = Unlimited; AA = Available as and when required






3  (150 )
3  (50 )
2  (20 0 )
1 (8 4 .017)
1 (8 4 .017)
2 3
3  (84 .0 17)
3  (84 .0 17)
2  (168 .0 35)
4













Figure 6.1: Maximum-profit schedule for Example 1 with H = 8 h, K = 4, and variable 
batch processing times. The numbers within the parentheses denote the batch sizes 
(mu) of corresponding tasks. 
 
6.1.1.1 Example 1. We used the motivating example in Figure 5.1 (see chapter 5) as 
the first test example. We solved it for three scenarios. In the first scenario (call it 
Example 1a), we considered H = 8 h. Increasing K from 4 to 5 did not improve the 
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MILP objective, so we assumed the solution from K = 4 as the optimal. We will do the 
same for determining the minimum K in all examples. Note that although all the 
existing formulations in the literature have assumed this for this example, there is no 
way to generally guarantee that K = 6 and beyond will not give a better solution. 
Figure 6.1 shows the (presumably) optimal schedule from our model. In each figure 
displaying a schedule in this chapter, we show a separate row of slots that form the 
basis for each schedule. As mentioned earlier, these slots are common to or 
synchronized on all units. We use a rectangle to denote each slot. A batch may require 
more than one slot for its completion. Therefore, we merge these slots into one 
rectangle that represents the entire task duration. The label within each rectangle 
denotes the task that the unit performs and the number within the parentheses denotes 
the batch size (mu) of that task. Moreover, if a task ends before its last slot ends, then 
we show its exact end underneath the rectangle. Note that the RMILP and MILP 
objectives (see Table 6.3) are identical for all three models. In addition, the solution 
time is also almost the same for all three models. This is expected for a simple example 
such as this. In our opinion, it is foolhardy to claim computational superiority of a 
model over others based on such trivial examples, which incidentally has occurred 
commonly in the literature. One should compare models only on difficult problems. 
Therefore, we cannot conclude from Example 1a that all three models perform equally 
well. 
To make this trivial problem more difficult, we increased H. Thus, in the 
second scenario (call it Example 1b), we used H = 12 h. Our model required K = 8, 
whereas the M&G (Maravelias and Grossmann, 2003a) and G&G (Giannelos and 
Georgiadis, 2002) models required N = 9 and N = 6 (event points) respectively. Our 
model and the M&G model require almost the same order of solution times. However, 
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Table 6.3: Model and solution statistics for the maximum-profit examples with 
variable batch processing times. 
 
Our 4 0.06 12 2000.0 1840.2 40 216 192 643
M&G 5 0.09 1 2000.0 1840.2 50 221 613 1798
G&G 4 0.08 0 2000.0 1840.2 20 81 141 393
Our 8 23.50 22850 4481.0 3463.6 80 416 408 1359
M&G 9 34.05 28469 4563.8 3463.6 90 397 1089 3884
G&G 6 0.08 19 3890.0 3301.6 30 119 207 593
Our 11 4434.44 2655537 6312.6 5038.1 110 566 570 1896
M&G 12 39746.54 18868920 6332.8 5038.1 120 529 1446 5816
G&G 11 3.61 7339 6236.0 4840.9 55 214 372 1093
Our 4 0.11 5 1730.9 1498.6 48 291 251 930
M&G 5 0.17 11 1730.9 1498.6 80 421 988 3106
G&G 4 0.09 14 1812.1 1498.6 32 142 271 893
Our 7 112.86 72406 2690.6 1962.7 84 489 458 1686
M&G 8 381.76 137320 2690.6 1962.7 128 673 1567 5665
G&G 6 1.05 2443 3078.4 1860.7 48 208 399 1349
Our 6 1.22 524 3002.5 2610.1 72 423 389 1434
M&G 7 3.31 1232 3002.5 2610.1 112 589 1374 4756
G&G 6 0.36 517 3190.5 2564.6 48 208 399 1349
Our 5 37.19 49765 2100.0 1283.1 85 502 597 1816
M&G 6 84.94 71626 2100.0 1283.1 132 691 1627 5432
G&G 4 0.05 0 1571.9 1150.0 44 198 376 1183
Our 6 500.98 318290 2560.6 1583.4 102 606 629 2099
M&G 7 588.34 237565 2560.6 1583.4 154 806 1880 6617
G&G 5 0.38 600 2100.0 1274.5 55 244 465 1488
Our 7 32974.27 13638920 2712.1 1583.4 119 688 859 2598
M&G 8 67156.93 18515053 2712.1 1583.4 176 921 2159 7909
G&G 6 4.33 9057 2809.4 1274.5 66 290 554 1793
Our 7 139.85 42013 3464.0 2867.2 119 688 859 2598
M&G 8 461.77 75195 3464.0 2867.2 176 921 2159 7909
G&G 7 28.56 298927 3465.6 2443.2 77 336 643 2098
Example 2c (H = 12, Suboptimal K / N )
Example 3a (H = 8)
Example 3b (H = 12, Suboptimal K / N )
M&G = Maravelias & Grossmann (2003a), G&G = Giannelos & Georgiadis (2002)
Example 3a (H = 8)
Example 3a (H = 8)
Example 1a (H = 8)
Example 1b (H = 12)
Example 2a (H = 8)
Example 2b (H = 10)
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our model gives a better RMILP objective ($4481.0 vs. $4563.8) and requires fewer 
nodes (22850 vs. 28469) than the latter. This suggests that our model has the potential 
to be tighter. Although, the G&G model seems much faster than the other two and 
gives a better RMILP objective, it gives a suboptimal solution ($3301.6 vs. $3463.6). 
We observed no improvement in the objective from the G&G model even for N = 8. 
Throughout this numerical comparison, we do such confirmation, whenever the G&G 
model gives an objective inferior to the other two, except when we use suboptimal N 
deliberately. As we discuss later, suboptimal solutions are a serious flaw in the G&G 
model. Figure 6.2 shows the maximum-profit schedule from our model for this 
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Figure 6.2: Maximum-profit schedule for Example 1 with H = 12 h, K = 8, and 
variable batch processing times. The numbers within the parentheses denote the batch 
sizes (mu) of corresponding tasks. 
 
To make the problem even more difficult, we used a third scenario (call it 
Example 1c) with H = 16 h. However, we did not pursue its solution to the best 
possible, so we use K = 11 (suboptimal) for our model, N = 12 (suboptimal) for the 
M&G, and N = 11 (suboptimal) for the G&G. The longer H resulting in increased 
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solution difficulty brings about further resolution between three models, and our model 
proves clearly faster than the M&G model by almost one order of magnitude (4434 s 
vs. 39747 s) and uses far fewer nodes (2,655,537 vs. 18,868,920). In addition, as 
observed earlier, our model gives tighter RMILP objective than the M&G ($6312.6 vs. 
$6332.8). The G&G model is again faster, but gives a suboptimal schedule ($4840.9 
vs. $5038.1). 
For all three scenarios (1a, 1b & 1c) of this example, our model uses fewer 
binary variables (40 vs. 50, 80 vs. 90, 110 vs. 120), and has fewer constraints (192 vs. 
613, 408 vs. 1089, 570 vs. 1446) and nonzeros (643 vs. 1798, 1359 vs. 3884, 1896 vs. 
5816) than the M&G model. All these result in a faster performance by our model for 
this example. For reasons discussed at the end of previous chapter, our model requires 
fewer binary variables than the M&G model. Although this example, as used in the 
literature, is trivial, we made it difficult enough to conclude reliably that our model 
outperforms the other two models. 
6.1.1.2 Example 2. We now consider the example from Kondili et al. (1993), which 
has been used extensively in the literature. Figure 6.3 shows the RD for that example 
unambiguously without resorting to the state nodes as in the STN representation 
(Kondili et al., 1993). Note that we use a storage task to model the mixing or splitting 
of the same material streams. However, this storage task does not appear in the 
formulation, as it has a dedicated unit assigned for the entire horizon, and it has no 
specified task time. To differentiate this storage task from the normal processing task 
in the formulation, we use dashed rectangles for the storage tasks. However, we do 
assume that the transfer times to and from this storage unit are negligible, just as those 
between any two processing tasks. 
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Much fuss exists in the literature about the differences in the objective
arising from minor numerical round-offs in problem data with some re
claiming superiority of their models based on such minute differences. Hence
exactly the same parameter values that Maravelias & Grossmann (2003a) use
paper to make our comparison fair and reliable. As in Example 1, we conside
scenarios for this example. In first scenario (Example 2a), we used H = 8 h a




















Figure 6.3: Recipe diagram for Example 2. Ji denotes the set of units t
can perform task i.
H 
(i=1) 
J1 = {HR} 
(i=3) 








J2 = {RR1, RR2} 
R3 
(i=4) 










, we used 
d in their 
red three 







 Chapter 6: Scheduling - Model Assessment 
required. Figure 6.4 shows the optimal schedule for this scenario. All three models 
perform equally well for this scenario. In fact, G&G seems to be the best in terms of 
the RMILP objective. Again, we refrain from drawing any conclusion based on this 
trivial scenario. The statistics of the M&G and G&G models reported in Table 6.3 are 
different from those reported by Maravelias and Grossmann (2003a) and Giannelos 
and Georgiadis (2002). Since we implemented their models, there are some differences 
in the model and solution statistics. For this scenario, Giannelos and Georgiadis (2002) 
reported an MILP objective of $1480.06 (RMILP $1804.35), whereas we get $1498.60 
(RMILP $1812.10). This is due to the round-off errors in parameters αij and βij. To 
confirm this, we also used the same values of αij and βij as reported by them. 
Expectedly, we obtained the same MILP and RMILP values ($1480.06 & $1804.35 
respectively) as reported in Giannelos and Georgiadis (2002). 
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R1 (40 .50 7)
1
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Figure 6.4: Maximum-profit schedule for Example 2 with H = 8 h, K = 4, and variable 
batch processing times. The numbers within the parentheses denote the batch sizes 
(mu) of tasks. 
 
For the second scenario (Example 2b), we took H = 10 h. To get an optimal 
solution, our model needed K = 7 and the M&G needed N = 8, whereas the G&G 
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required N = 6 only. Our model is faster (113 s vs. 382 s) than the M&G. Again, in 
spite of being faster, the G&G model gives an inferior solution. In fact, it is reasonable 
to say that it is faster because it gives a suboptimal solution. Figure 6.5 shows our 

































Figure 6.5. Maximum-profit schedule for Example 2 with H = 10 h, K = 7, and 
variable batch processing times. The numbers within the parentheses denote the batch 
sizes (mu) of tasks. 
 
For the third scenario (Example 2c), we used H = 12 h, K = 6 for our model, 
and N = 7 and 6 for the M&G and G&G respectively. Maravelias & Grossmann 
(2003a) used this scenario to show the impact of their tightening constraints. Note that 
our formulation needed no additional tightening constraints. For this scenario, our 
model performs better than the M&G in terms of both solution time (1.22 s vs. 3.31 s) 
and model statistics (72 vs. 112 binary variables, 389 vs. 1374 constraints, and 1434 
vs. 4756 nonzeros). Again, the G&G model gives inferior RMILP and MILP 
objectives. Note that the statistics reported in Table 6.3 for this scenario differ from 
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those reported by Maravelias and Grossmann (2003a) again due to our own 
implementation of their model. 
From the above three scenarios of this widely studied example, we have 
demonstrated that our model is superior to the best existing model. However, to 

















J1 = {HR} 
R2 
(i=3) 
J3 = {RR1, RR2} 
R1 
(i=2) 
J2 = {RR1, RR2} 
S 
(i=4) 
J4 = {SR} 
M 
(i=6) 
J6 = {MR1, MR2} 
H2 
(i=5) 
J5 = {HR} 
R3 
(i=7) 







Int 6 Product 2
(m=9) (m=13)
Int 4 













Figure 6.6: Recipe diagram for Example 3. Ji denotes the set of units
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6.1.1.3 Example 3. This example is more complex and comprehensive than that of 
Kondili et al. (1993), because it involves more units (J = 6), tasks (I = 7), and materials 
(M = 13). It considers the most common characteristics of a multipurpose plant, 
namely (1) a unit can perform multiple tasks (2) a task can be performed in multiple 
units (3) several tasks suitable for a set of units and (4) only one task suitable for a 
unit. In addition, we assume nonzero initial inventories for some intermediates with I60 
= I70 = 50 mu. It also requires a storage task to imitate the mixing of material Int 2 
recycled from task S and produced by task R1. As discussed in Example 2, we assume 
the transfer times to and from this storage task to be negligible. 
For this example, we consider two scenarios. As this is a new example, we 
present the model and solution statistics for various values of K for the first scenario 
(Example 3a). We used H = 8 h for this scenario. We solved our model for K = 5, K = 
6, and K = 7, and observed that the objective did not improve from K = 6 to K = 7. 
However, as observed by Castro et al. (2001), the same objective value for two 
successive Ks does not mean optimality. Hence, we tried K = 8 and K = 9 and observed 
that the objective value did not improve. Thus, we can safely take the schedule in 
Figure 6.7 for K = 6 as the maximum-profit schedule. The solution statistics is almost 
the same for both the M&G and our model for K = 6. But, note that when we increase 
K to 7, our model is almost twice as fast as the M&G (32974 s vs. 67157 s). The G&G 
model again gives a suboptimal solution. 
In the second scenario (Example 3b), we solved the three models for H = 12 h, 
and used K = 7 in our model and N = 8 and 7 for the M&G and G&G models 
respectively. Our model is almost three times faster (140 s vs. 462 s) than the M&G 
model. Again, the G&G model gives poor RMILP and MILP values. This example 
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also demonstrates that our model handles the more complex problems better than the 








































Figure 6.7: Maximum-profit schedule for Example 3 with H = 8 h, K = 6, and variable 
batch processing times. The numbers within the parentheses denote the batch sizes 
(mu) of tasks. 
 
Having seen the performance of our model on the maximum-profit problems, 
we now consider the minimum-makespan problems. 
6.1.2 Makespan Minimization 
Maravelias and Grossmann (2003a) noted that the solution efficiency of their 
formulation deteriorated significantly while minimizing the makespan as compared to 
maximizing the profit. Recently, they (Maravelias and Grossmann, 2003b) addressed 
separately the minimization of makespan for multipurpose batch plants assuming 
constant processing times. They modified the discrete-time formulation of Shah et al. 
(1993), and used assignment binary variables without decoupling, i.e. 3-index binary 
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variables. They proposed an algorithm that can solve problems of medium size and 
complexity. As we see now, our model seems to maintain its efficiency even for the 
makespan problems with variable processing times, and can solve moderate-size 


































































2.66 5.33 7.99 10.66 13.3 15.99 18.66 21.32 23.99 26.6 28.6 29.772
4.66 7.33 9.99 12.66 15.3 17.99 20.66 23.32 25.994 28.6
9.33 11.99 14.665 17.33 19.99 22.66 25.32 27.996.66
11.99 14.219 22.66 24.88 27.54
  
 
Figure 6.8: Minimum-makespan schedule for Example 1 with K = 12. The numbers 
within the parentheses denote the batch sizes (mu) of tasks. 
 
To evaluate our model for minimizing the makespan, we compared it with 
those of Maravelias and Grossmann (2003a) and Giannelos and Georgiadis (2002) 
using the same three examples discussed earlier. All example data are same, except 
that fixed demands are now imposed, and H is no longer a parameter for our model. 
We solved each example for two demand scenarios. Table 6.4 summarizes the results 
of all the scenarios for all three models, while Figures 6.8-6.10 show the minimum-
makespan schedules of our model for the first scenario of each example. The statistics 
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for the second scenario of each example shown in Table 6.4 belong to the first feasible 
solution. 
Table 6.4: Model and solution statistics for the minimum-makespan examples with 
variable batch processing times. 
 
Our 12 - 1.00 217 27.13 29.77 120 616 627 2078
M&G 13 50 4.94 1237 27.13 29.77 130 574 1569 6641
G&G 12 50 0.08 0 27.13 29.77 60 234 409 1202
Our 22 - 94.16 22648 51.36 56.43 220 1116 1167 3868
M&G 23 100 16034.27 2000283 51.36 56.43 230 1014 2759 15786
G&G 22 100 0.17 0 51.36 56.43 110 424 739 2202
Our 8 - 14.20 5593 18.69 19.79 96 555 535 1945
M&G 9 50 23.08 5204 18.69 19.79 144 758 1769 6735
G&G 8 50 1.97 2982 12.56 19.79 64 275 536 1821
Our 22 - 136.13 4060 48.78 50.13 264 1479 1501 5473
M&G 23 100 798.90 6860 48.78 50.25 368 1934 4471 26279
G&G 22 100 5000.00 2555997 26.38 49.72 176 737 1432 5013
Our 7 - 1.09 439 12.40 14.37 119 688 871 2609
M&G 8 50 4.02 1203 12.40 14.37 176 922 2172 8053
G&G 7 50 1.47 2095 11.07 14.70 77 337 656 2121
Our 10 - 3042.17 337408 15.21 17.71 170 967 1264 3782
M&G 11 100 5000.00 316800 15.21 17.79 242 1267 2970 12427
G&G 10 100 27.19 30428 12.87 19.84 110 475 923 3036
NonzerosH
Example 1a (D 4 = 2000 mu)
1Relative gaps: Our = 2.69%, M&G = 2.92%, G&G = 24.16%














Example 2a (D 8 = D 9 = 200 mu)
Example 2b ( D 8 = 500 mu, D 9 = 400 mu, First feasible K / N )
1
Example 3a (D 12 = 100 mu, D 13 =  200 mu)
Example 3b (D 12 = D 13 = 250 mu, First feasible K / N )
2
M&G = Maravelias & Grossmann (2003a), G&G = Giannelos & Georgiadis (2002)
2Relative gaps: Our = 2.99%, M&G = 3.75%, G&G = 2.99%  
 
6.1.2.1 Example 1. In the motivating example, we first assume D4 = 2000 mu. For this 
trivial case, all three models perform equally well (see Table 6.4). However, when we 
increase the demand to 4000 mu, the M&G model performs very poorly (16034 s), 
whereas our model requires only 94.2 s for an optimal solution. The G&G model again 
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seems to be the fastest, but cannot guarantee an optimal solution, as we will again see 












































Figure 6.9: Minimum-makespan schedule for Example 2 with K = 8. The numbers 
within the parentheses denote the batch sizes (mu) of tasks. 
 
6.1.2.2 Example 2. In the first scenario, we set D8 = D9 = 200 mu. Again, the M&G 
model is inferior to the other two in solution time (23.1 s vs. 14.2 s & 1.97 s). Note that 
the G&G model gives a poor RMILP objective for this case. In the second scenario, we 
take D8 = 500 mu and D9 = 400 mu, as Maravelias and Grossmann (2003b) did. 
However, they solved this scenario for constant processing times. Instead, we use 
variable processing times to evaluate our model for this more difficult scenario. We set 
the termination criteria as 3% gap and 5000 s for all three models uniformly. 
Interestingly, our model performs much faster (136 s for 2.69% gap) than the other two 
models. The M&G model shows a gap of 2.92% after 799 s, while the G&G model 
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performs very poorly (5000 s for a gap of 24.16%). For the latter, even RMILP 
objective is inferior to those of the other two models. Again, our model outperforms 
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Figure 6.10: Minimum-makespan schedule for Example 3 with K = 7. The numbers 
within the parentheses denote the batch sizes (mu) of tasks. 
 
6.1.2.3 Example 3. For the first scenario of D12 = 100 mu and D13 = 200 mu, the 
solution statistics of all three models are similar. However, the G&G model fails to 
give an optimal solution. For the second scenario of D12 = D13 = 250 mu, we set the 
same termination criteria as in the second scenario of Example 2. The same story 
repeats even for this scenario. This time, the G&G model even gives an inferior 
RMILP objective. Our model is again faster than the M&G model. Our model shows a 
gap of 2.99% after 3042 s, while the M&G model requires 5000 s for a gap of 3.75%. 
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The G&G model requires only 27.2 s for a gap of 2.99%, but the objective is again 
inferior. 
From the above examples, it is clear that our model solves the makespan 
problems with variable processing times equally efficiently and optimally. Its 
performance does not seem to deteriorate in comparison to the profit objective. Unlike 
any other existing formulation, our model solves moderate-size problems quite 
effectively. Moreover, our model has no big-M constraints, so is not susceptible to the 
influences of parameter M on solution times. The other two models use big-M 
constraints and require some numerical value of the same. Hence, we conclude that our 
model is superior to the other two models. We now consider the case of constant 
processing times, as this has received attention in the literature. 
6.1.3 Constant Batch Processing Times 
The assumption of constant processing times should make the problems easier to solve. 
However, we do consider larger horizons to keep raise the difficulty.  Table 6.1 gives 
the constant processing times (τij) for all three examples. Table 6.5 summarizes the 
model and solution statistics, and Figures 6.11-6.13 show the maximum-profit 
schedules from our model for the first scenario of each example. For the first scenario 
(H = 12) of Example 1, all three models perform equally well as it is a trivial problem. 
We doubled the horizon for the second scenario (H = 24). Our model is an order of 
magnitude faster than the M&G model (440 s vs. 7572 s) whereas, the G&G results in 
an inferior objective though being attractive in terms of the statistics. For both 
scenarios (H = 12 and H = 16) of Example 2, our model is faster than the M&G model 
(0.38 s vs. 1.36 s and 81.3 s vs. 837 s) and the G&G model gives poor RMILP and 
MIP objectives. Finally, we solved Example 3 for H = 12. For this scenario, all models 
perform equally well. However, the G&G model fails to give an optimal solution. 
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Figure 6.11: Maximum-profit schedule for Example 1 with H = 12 h, K = 7, and 
constant batch processing times. The numbers within the parentheses denote the batch 
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Figure 6.12: Maximum-profit schedule for Example 2 with H = 12 h, K = 7, and 
constant batch processing times. The numbers within the parentheses denote the batch 
sizes (mu) of tasks. 
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Figure 6.13: Maximum-profit schedule for Example 3 with H = 12 h, K = 7, and 
constant batch processing times. The numbers within the parentheses denote the batch 
sizes (mu) of tasks. 
 
In summary, we conclude the following. Irrespective of the scheduling 
objective (makespan or profit), our model is faster than the other two models in the 
most difficult scenarios. In some scenarios, it provides tighter RMILP objectives. As 
compared to the other two models, the M&G model requires more constraints, 
variables, and nonzeroes. However, although computationally inferior, it is foolproof 
in that it does not give suboptimal solutions at all. The G&G model seems superior in 
model statistics and solution speed mainly because it uses explicit sequencing 
constraints as done by Ierapetritou & Floudas (1998), but it has some fundamental flaw 
that results in suboptimal solutions for some scenarios. In an attempt to ensure mass 
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balance, Giannelos and Georgiadis (2002) force the end or start times of tasks 
producing or consuming the same material to be equal. This can potentially restrict the 
freedom of task occurrences. The other two models (our & M&G) do not use such 
explicit sequencing constraints. 
Table 6.5: Model and solution statistics for the maximum-profit examples with 
constant batch processing times. 
 
Our 7 0.03 0 5000.0 5000.0 70 366 354 1115
M&G 8 0.05 0 5000.0 5000.0 80 353 970 3090
G&G 7 0.08 24 5000.0 5000.0 35 138 240 612
Our 15 440.41 145630 13000.0 12000.0 150 766 786 2467
M&G 16 7572.22 1373260 13000.0 12000.0 160 705 1922 8122
G&G 13 0.08 0 11000.0 11000.0 65 252 438 1140
Our 7 0.38 44 3799.4 3638.8 84 489 458 1582
M&G 8 1.36 252 3799.4 3638.8 128 673 1567 5313
G&G 7 0.25 370 3813.2 3638.8 56 241 463 1381
Our 10 81.27 16553 5586.7 5162.1 120 687 665 2290
M&G 11 837.42 118764 5586.7 5162.1 176 925 2146 8112
G&G 9 3.50 6532 5054.9 4937.1 72 307 591 1779
Our 7 5.25 2940 3465.6 3050.0 119 688 859 2455
M&G 8 9.53 3120 3465.6 3050.0 176 921 2159 7425
G&G 6 0.27 62 2871.9 2675.0 66 290 554 1583















Example 2a (H = 12)
Example 3 (H = 12)
M&G = Maravelias & Grossmann (2003a), G&G = Giannelos & Georgiadis (2002)
Example 2b (H = 16)
 
 
Having evaluated our model rigorously, we now discuss miscellaneous aspects 
of our model.  
6.2 DISCUSSION 
Here, we discuss about the unique features of our model, the impact of alternate 
constraints on the solution times, fixing the number of slots in slot-based or event-
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based formulations, and the basic criteria required for any comparison works. 
Table 6.6: Remaining processing times of batches on units at various times in the 
examples. 
 
T 1 T 2 T 3 T 4 T 5 T 6
Unit 1 - 1.999(2.666) - 0.631(1.964) - -
Unit 2 0.666(3.332) - 1.333(3.332) - 1.987(2.618) -
Unit 3 - - - 0.631(1.964) - -
RR1 - - - 0.613(1.333) - 1.856(2.146)
RR2 - - 0.720(1.964) - 0.290(0.903) -
SR - - - 0.903(1.623) 0.290(1.623) -
HR - 0.905(1.812) - - - -
RR2 0.907(1.730) - - - - -
SR - - - 0.830(2.596) - -
SR - - - 2.000(3.000) - -
RR2 - - - - 0.500(2.000) -
SR - - 1.500(3.000) - 1.500(3.000) -
MR1 - - - - 0.500(2.000) -
The numbers in parentheses are the total batch processing times
Example 1b (H = 12 & K = 8)
Example 2b (H = 10 & K = 7)
Example 3a (H = 8 & K = 6)
Makespan minimization
Example 3a (D 12 = 100 mu, D 13 =  200 mu & K  = 7)
Constant batch processing times
Example 3 (H = 12 & K  = 7)
Remaining batch processing time t jk  on j at T k (h)Unit
j
Variable batch processing times
 
 
6.2.1 Remaining Batch Processing Times 
In contrast to all the previous models, our model uses the novel idea of balances. For 
instance, it does a balance on the remaining batch processing times and materials in 
each unit. Table 6.6 lists the values of tjk (the time remaining in completing the current 
batch on unit j at Tk) for various units and time points in the three examples. It shows 
only the units that continue their production at different Tk. The numbers in the 
parentheses denote the times remaining to complete the batches. Consider Unit 1 in 
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Example 1b. It starts a batch of Task 1 at T1 (see Figure 6.2) with a batch size of 100 
mu and continues its production at T2. It needs 2.665 h to complete this batch. 
However, the start of Task 1 on Unit 2 and that of Task 2 on Unit 3 triggers a new slot 
3 at T2. Hence, the remaining batch processing time on Unit 1 at T2 is 2.666 + 2.665 – 
3.332 = 1.999 h, where 2.666 h is the start time of the batch on Unit 1. Most tjk values 
in Table 6.6 are the exact remaining batch processing times on units. However, note 
that tj1 for RR2 in Example 3a (see Figure 6.7) is the sum of the remaining batch 
processing time and the unit idle time. The exact remaining batch processing time for 
this case is 0 + 1.73 – 0.965 = 0.765 h, but the reported value is 0.765 + 0.142 = 0.907 
h, where 0.142 h is the unit idle time on RR2 after that batch. In the optimal schedule 
of Figure 6.10 also, unit S (separator) shows a remaining time tjk of 2 h at T4 instead of 
0.5 h. This is because eq. 5.9 being an inequality constraint allows such slack for tjk 
without affecting the solution. Alternatively, it is possible to avoid this slack by 
making eq. 5.9 an equality as follows. 
tj(k+1) = tjk + – SL( )
j






(k+1) k < K (6.1) 
However, this would force another slot to start at the end of each batch and the null 
task (i = 0) to take up any idle time. For eq. 6.1 to work, we must select α0j and β0j 
values carefully. In addition, one must properly set 0
U
jB , because SLk is common to all 
units and 0
U




jB  = ( ),maxj Uiji I j B∈  
However, we do not see any need for using eq. 6.1. In fact, we prefer eq. 5.9 instead of 
eq. 6.1, as the former should require fewer slots. 
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6.2.2 Alternate Constraints 
In proposed formulation (see previous chapter), eqs. 5.6 and 5.7 serve the same 
purpose. We may impose eq. 5.6 or 5.7 individually or both at the same time, and these 
options may affect the solution time. We observed that eq. 5.6 alone performs 
somewhat better in some scenarios, eq. 5.7 alone better in some scenarios, and both in 
some other scenarios. Consider Example 1b with H = 12 and K = 8 in Table 6.3. The 
solution time and nodes in Table 6.3 are for using eq. 5.6 alone. If we use eq. 5.7 
alone, then we get the solution in 26.75 s with 28431 nodes. If we use both eqs. 5.6 and 
5.7, we need 23153 nodes to find the optimal solution in 21.80 s. In most cases, 
however, eqs. 5.6 and 5.7 perform equally well, when used individually. We used eq. 
5.6 for all examples. 
6.2.3 Fixing the Number of Slots 
Previous work (Ierapetritou and Floudas, 1998) argued that the event-based models 
avoid the need for pre-fixing the numbers of slots as done by the slot-based models. 
For example, Ierapetritou and Floudas (1998) state: “The proposed formulation is 
based on a continuous-time representation that avoids the prepostulation of 
unnecessary time slots or intervals. It only requires the initial consideration of a 
necessary number of event points corresponding to either the initiation of a task or the 
beginning of unit utilization”. The difference between prepostulation and the initial 
consideration of a necessary number of event points is not obvious. The a priori 
selection of the number of time slots does not appear to be any less case-dependent 
than the initial consideration of a necessary number of event points. Indeed, there is no 
single, foolproof, general formula for prefixing the number event points in the event-
based formulations. The common approach has been to increase the number of event 
points one at a time, until the objective does not change any further. Even this 
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approach is not foolproof, as Castro et al. (2001) have shown that the objective may 
not change with an increment of one additional event point, but may change with an 
increment of two or more. It would seem therefore that in the event-based 
formulations, one can only estimate and conduct tests with varying numbers of N, the 
number of event points. It is also not clear whether it is better to prepostulate a 
generous value of N and solve the problem once, or solve the same problem repeatedly 
by varying N. Should not the computation time for the latter be the sum of the times 
for all repeated runs? Whatever the strategy used, it seems that the same strategy can 
also be used for fixing K (the number of slots) in the slot-based models. Most slot-
based models (e.g. Karimi and McDonald, 1997; Lim and Karimi, 2003b) have 
preferred to pre-postulate empirically a generous number of slots in order to avoid 
solving the problem repeatedly. Although not foolproof, heuristic formulas for fixing a 
priori the number of slots in slot-based formulations do exist and work reasonably well 
in many instances (Lim and Karimi, 2003a). However, as we have done in this paper, 
slot-based models can also use the same strategy of optimizing the number of slots by 
solving the problem repeatedly. 
In the case of profit maximization, we increase K gradually by one, until the 
solution does not change, even if we were to increase K by two or more. In the case of 
makespan problems, we increase K, until we first get a feasible solution. Then, we 
increase it further to get the optimal solution as in the profit problems. 
6.2.4 Effects of Computing Hardware and Software 
As discussed by Karimi et al. (2004), hardware and software can significantly affect 
the performance of different MILP formulations. Although they discuss this issue in 
more detail, we list here some minimum prerequisites to a sound comparison. 
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(i) Comparative model solution times must be based on the same version of the same 
solver/software. It is obvious that MIP solvers and software versions change 
rapidly, and it is not right to compare models based on different versions of a 
solver/software. For example, CPLEX and OSL will differ in solution times on the 
same problem. Moreover, different versions of the same solver may result in 
different solution statistics. Conclusions based on such times can never be reliable.  
(ii) Hardware, operating systems, and compilers have tremendous effects on the 
solution times of MILPs. In fact, as noted by Karimi et al. (2004), it is preferable to 
use multiple computing platforms to get a more robust evaluation of competing 
models. It is obvious that Random Access Memory (RAM) can play a vital role in 
computing speed. Moreover, the performance on a high-end workstation is 
normally better than that on a PC with the same CPU speed. It is even possible that 
machines of similar specifications but from different companies have different 
computing speeds. Clearly, attention to hardware and software details is must in 
comparing MILP models. 
(iii)Value of M in the Big-M constraints also has a notorious effect on MILP solution 
times as pointed by Gupta and Karimi (2003) and Lim and Karimi (2003a). Event-
based models use big-M constraints profusely. This is another factor conveniently 
ignored by the existing literature. For models involving the big-M constraints, one 
must average model performances over a range of M-values. 
In our opinion, comparisons made without due attention to any of the above 
basic criteria cannot be reliable. To reinforce the above discussion and to highlight the 
effects of software and hardware on solution times, we solved some scenarios of our 
examples using different hardware and software. Table 6.7 summarizes the results of 
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our, M&G and G&G models on different computers and with different versions of 
CPLEX. 
Table 6.7: Performance of models on different machines and with different CPLEX 
versions. 
 
CPLEX 7.5.0 CPLEX 8.1.0 Computer 2 Computer 3
Our 8 24.3 \ 21740 23.5 \ 22850 21.86 160.71
M&G 9 41.7 \ 34557 34.0 \ 28469 31.97 225.43
G&G 6 0.09 \ 24 0.08 \ 19 0.20 0.26
Our 6 205 \ 105130 501 \ 318290 461.66 3274.28
M&G 7 479 \ 169639 588 \ 237565 538.94 3784.09
G&G 5 0.30 \ 593 0.38 \ 600 0.41 1.95
Our 8 24.22 \ 9780 14.2 \ 5593 13.31 97.28
M&G 9 \ 50 105 \ 21822 23.1 \ 5204 21.44 152.14
G&G 8 \ 50 2.08 \ 3285 1.97 \ 2982 1.83 12.46
Our 7 0.61 \ 219 1.09 \ 439 1.09 7.20
M&G 8 \ 50 2.14 \ 650 4.02 \ 1203 3.89 27.56
G&G 7 \ 50 0.31 \ 238 1.47 \ 2095 1.42 8.69
Our 7 0.08 \ 23 0.03 \ 0 0.09 0.21
M&G 8 0.04 \ 120 0.05 \ 0 0.19 0.35
G&G 7 0.08 \ 36 0.08 \ 24 0.20 0.22
Our 10 149 \ 29902 81.3 \ 16553 74.92 560.17
M&G 11 1743 \ 263982 837 \ 118764 749.34 5532.46
G&G 9 3.27 \ 6667 3.50 \ 6532 3.02 22.50
CPU time (s) \ Nodesa
Variable batch processing times
Example 3b (H = 8)
Example 1b (H = 12)
Model K /N \ H Computer 1 CPLEX 8.1.0
Makespan minimization
Example 2a (D 8 = D 9 = 200 mu)
Example 3a (D 12 = 100 mu, D 13 =  200 mu)
Constant batch processing times
aThe number of nodes in Computer 2 and Computer 3 is same as that in Computer 1 
using CPLEX 8.1.0
Computer 2 = DELL PWS650 workstation (3.06 GHz CPU with 3.67GB of RAM)
Computer 3 = COMPAQ PC (Pentium III 448 MHz CPU with 256MB of RAM)
Example 1a (H = 12)
Example 2b (H = 16)
M&G = Maravelias & Grossmann (2003a), G&G = Giannelos & Georgiadis (2002)
Computer 1 = DELL GX 270 (Pentium IV 2.8 GHz CPU with 1GB of RAM)
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We considered the two objectives (maximum profit and minimum makespan) 
with variable processing times and two scenarios for maximum profit using constant 
processing times. We used three different computers (Computer 1 = the computer used 
in the last section; Computer 2 = DELL PWS650 workstation 3.06 GHz CPU with 
3.67 GB of RAM; Computer 3 = COMPAQ PC Pentium III 448 MHz CPU with 256 
MB of RAM) and two different versions of CPLEX (CPLEX 8.1.0 and CPLEX 7.5.0). 
Tables 6.3-6.5 also give the results for Computer 1 and CPLEX 8.1.0. We report only 
the solution statistics, as model statistics are the same as in those tables. In addition, 
the numbers of nodes do not change with the computers for the same version and 
operating system (e.g. Unix vs. Windows). Hence, we report the number of nodes only 
for the version comparison. 
In comparing the versions using Computer 1, we observe that CPLEX 7.5.0 
gives better solution statistics than CPLEX 8.1.0 for Example 3b (see Table 6.7) under 
profit maximization using variable batch processing times, Example 3a under 
makespan minimization, and Example 2b under profit maximization using constant 
batch processing times. For the remaining scenarios, CPLEX 8.1.0 performs better 
than CPLEX 7.5.0. Hence, it is clear from these results that the latest version need not 
always be faster. 
In comparing the hardware using CPLEX 8.1.0, we observe that Computer 1 
and Computer 2 perform almost the same. But, there is a significant difference in the 
solution time when we use Computer 3. Though it is obvious that workstation can 
easily outperform a PC, the difference in speed is appreciable. This clearly suggests 
that sufficient attention must be paid to the hardware used in comparing different 
models. 
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In light of the above, consider the numerical comparison of Ierapetritou and 
Floudas (1999) with the slot-based model of Karimi and McDonald (1997). The main 
point against their comparison and its subsequent conclusions is that they were based 
on the verbatim solution times reported by Karimi & McDonald (1997), and not on 
their own implementation of the model of Karimi & McDonald (1997). They 
compared the two models based on computations that used different hardware and 
software. While Karimi & McDonald (1997) used GAMS 2.25.087, Cplex 4.0, AIX 
operating system, and RS/6000P IBM workstation, Ierapetritou and Floudas (1999) 
used GAMS 2.25.??, Cplex 4.0.8, ?? operating system, and HP-C160 workstation. 
Firstly, it is quite likely that the two CPLEX versions differed in performance. 
Secondly, the difference due to the hardware, compilers, and operating systems can be 
substantial as we demonstrated above. Karimi et al. (2004) have shown that even the 
same version of CPLEX can perform quite differently on two different machines, 
compilers, or operating systems. In light of these basic flaws in their comparison, it is 
unclear how the differences in model solution times (0.72 s vs. 5.0 s, 0.31 s vs. 2.0 s, 
9.92 s vs. 15 s, and so on) used by Ierapetritou and Floudas (1999) can form the basis 
for fair and unambiguous conclusions. As seen earlier, such differences can easily 
arise, even when one solves the same model on different computers. Besides this 
aspect of their comparison, two aspects or results of their comparison further make 
their conclusions highly questionable. 
One aspect relates to the number of event points and also our discussion on 
fixing the number of slots. In their model, they adjusted and optimized the necessary 
number of event points. In contrast, the results reported by Karimi & McDonald (1997) 
assumed a fixed, generous number of slots without any optimization or adjustment. In 
other words, the results of Karimi & McDonald (1997) had some redundant slots, 
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which would not exist, if they had used the necessary number of slots. It is obvious 
that the number of slots affects the solution time significantly and a comparison based 
on disproportionate numbers of event points and slots would not lead to reliable 
conclusions. A fair comparison would be to use the optimized numbers for both event 
points and slots. 
The other aspect is the RMILP objective values of their model in comparison to 
those of Karimi and McDonald (1997). Their RMILP objective values were invariably 
and noticeably inferior (e.g. 3652 vs. 4292, 1287 vs. 3044, 1777 vs. 14233, and so on) 
for a minimization problem. Although, this does not necessarily imply that their model 
would be slower, it proves that the slot-based formulation of Karimi and McDonald 
(1997) is definitely tighter and could very well be a better formulation, if compared on 
an apple-to-apple basis. 
6.3 CONCLUSION 
The existing comparisons between the event-based and slot-based models lack 
thorough and rigorous analysis, thus the question of which is better still demands a 
convincing answer. We assessed the performance of our slot-based scheduling model 
in comparison with two other models (slot-based M&G and event-based G&G models) 
in the literature using three examples. From the assessment of three models, we 
conclude that our slot-based model can comfortably outperform the event-based G&G 
model and slot-based M&G model. In addition, we conclude that decoupling of tasks 
from units in a scheduling formulation cannot reduce the number of binary assignment 
variables. The novel continuous-time formulation presented in the last chapter uses 
synchronous slots and does not decouple tasks from units (i.e. uses 3-index binary 
assignment variables), but it still has fewer binary variables, constraints, and nonzeros, 
and at the same time it is simpler, more efficient, and potentially tighter than the best 
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models (event-based or otherwise) in the literature on short-term scheduling in 
multipurpose batch plants. In contrast to the existing models, it is equally efficient for 
both profit maximization and makespan minimization even with variable batch 
processing times, and has no big-M constraints. We believe that the latter may be a 
major contributor to our model’s better efficiency. Lastly, this work presents a novel 
idea of balances (time, mass, resource, etc.) in developing scheduling formulations, 
which can enable one to handle general resource-constrained scheduling problems 
using the proposed formulation. 
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CONCLUSIONS AND RECOMMENDATIONS 
7.1 Conclusions 
We addressed two common but important problems of planning and scheduling in 
pharmaceutical supply chains. Firstly, we addressed a supply chain planning problem 
to assess the feasibility or profitability of introducing new active ingredients or 
intermediates in a given pharmaceutical plant. We developed a single-plant-centric, 
multi-period, MILP model that allows complex production recipes with multiple 
intermediates, outsourcing of existing intermediates, material movement among 
different production/supply/demand facilities, validation times for new tasks, 
minimum campaign lengths, line-dependent cleaning, and so on, and considers 
explicitly the details of campaign sequencing and timing on individual production lines 
in a pharmaceutical plant. The planning model is able to give reasonably quick 
solutions for three examples involving twelve materials, four production lines, and up 
to three months of horizon. It can assist the plant management in making quick, 
optimal assessment of outsourcing and new product introductions in a pharmaceutical 
plant. Although we limited ourselves to only the primary production in the 
pharmaceutical supply chain, one can readily apply the proposed model to secondary 
production as well.  
Secondly, we addressed the scheduling problem in pharmaceutical supply 
chains. Here, we proved that decoupling of tasks from units in a scheduling 
formulation cannot reduce the number of binary assignment variables. In the literature, 
comparisons between the event-based and slot-based models lack thorough and 
rigorous analysis, thus the question of which is better still demands a convincing 
answer. We presented a novel continuous-time formulation that uses synchronous slots 
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and does not decouple tasks from units (i.e. uses 3-index binary assignment variables), 
but it still has fewer binary variables, constraints, and nonzeros, and at the same time it 
is simpler, more efficient, and potentially tighter than the best models (event-based or 
otherwise) in the literature on short-term scheduling in multipurpose batch plants. 
Moreover, we proposed a novel idea of balances (time, mass, resource, etc.) in 
developing scheduling formulations, which can enable one to handle general resource-
constrained scheduling problems using the proposed formulation. In contrast to the 
existing models, it is equally efficient for both profit maximization and makespan 
minimization even with variable batch processing times, and has no big-M constraints. 
We believe that the latter may be a major contributor to better efficiency of our model. 
Finally, our model is much simpler (almost one third reduction in binaries, two third 
reduction in constraints as well as nonzeros) and faster (almost an order of magnitude 
in most cases studied) than the most recent and the best model (Maravelias and 
Grossmann, 2003a) existing in the literature. 
7.2 Recommendations for Future Work 
The proposed planning model considers scheduling issues to make the plan realistic. 
However, we employed asynchronous slots to time campaigns in the production plan. 
From an assessment of the scheduling model, we anticipate that the use of 
synchronized slots accompanied with the novel balances could handle problems of 
large dimension. Hence, one can reformulate the proposed planning model using 
synchronized slots and compare its performance with the proposed model. 
As mentioned in Chapter 1, the productions in primary and secondary sites are 
characterized by their respective end demands. Primary production looks at the 
demands from only the secondary production whereas the secondary production caters 
the needs of the end customers. Hence, the latter is more flexible and responsive to the 
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varying demands of the end products. Moreover, secondary production acts as an 
opaque layer between the primary production and the end customers. As a result, the 
primary production becomes less responsive to the changes in supply chain. The 
overall performance of a supply chain is dependent on both primary and secondary 
productions.  Hence, future work can attempt to integrate these two production sites 
and present a more general planning and scheduling model. 
A major challenge facing the pharmaceutical industry is inventory 
management. To avoid the risk of running out of stock, pharmaceutical companies 
have historically created security cushions in the form of high inventory levels. Hence, 
a lot of working capital is tied up in the inventory of products. If one could devise an 
optimal inventory plan considering as much of the risk/uncertainty factors, then it will 
be useful for these companies. 
Another challenge facing the pharmaceutical industry is the process of 
selecting which new products to develop. R&D can deliver many new candidates. 
However, not all can be developed as each involves a lot of money and time. Hence, 
the management can invest on only selected potential candidates for further 
development processes.  Moreover, clinical trials or validation processes for the new 
products should co-ordinate with the production management. This clearly shows the 
need of models that can support a holistic approach to product portfolio management 
in the pharmaceutical industry. In addition, these models should also integrate 
production management, capacity management and trading structure. Hence, one can 
attempt to streamline the entire supply chain by integrating various corporate activities 
like R&D, production planning, new product introductions, outsourcing, validation, 
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APPENDIX A: Files for Chapter 4 
A.1 GAMS files for Examples 1-3 
A.1.1 Example 1 
A.1.1.1 Example 1a 
VARIABLES 
NC(i,l,t)  number of campaigns of i on l in t 
PQ(m,l,t) amount of m produced or consumed on l in t 
DQ(i,l,t) Differential production amount of i on l in t 
CL(i,k,l,t) campaign length of i in k of l in t 
PT(i,l,t) effective production time of i on l in t 
SL(k,l,t) length of k of l in t 
TS(k,l,t) starting time of k of l in t 
TE(k,l,t) ending time of k of l in t 
TTS(i,k,l,t) starting time of i in k of l in t 
INV(m,t) inventory of m at the end of t 
SQ(m,t) supply amount of m in t 
Ib(m,t) backlog amount of m in t 
Id(m,t) deviation below IL(m) in t 
Y(i,k,l,t) assignment variable 
YS(i,l,t) spill over variable 
GP net profit  ; 
POSITIVE VARIABLE DQ,CL,PT,NC,SL,TS,TE,TTS,INV,SQ,Ib,Id,YS ; 
BINARY VARIABLE  Y ; 
 
EQUATIONS 
Netprofit net profit to be maximized 
production(m,l,t)  amount of m produced or consumed on l in t 
effectcamp(i,l,t)    effective production time of i on l in t 
diffprod(i,l,t)      differential production amount of i on l in t 
camlength(i,k,l,t)   upper limit for campaign length of i in k of l in t 
ipers(k,l,t)         max no of i per k of l in t 
speri(i,l,t)         max no of k for i on l in t 
slotlen1(k,l,t)   length of slot k on l in t 
slotlen2(l,t)        sum of slot lengths 
numcamp(i,l,t)       number of campaigns of i on l in t 
relax1(i,k,l,t)      relaxation of mcl constraint-1 
relax2(i,k,l,t)      relaxation of mcl constraint-2 
spilla(i,k,l,t)      condition-1 for spill over 
spillb(i,*,l,t)      condition-2 for spill over 
maxspill(l,t)        constraint for the number of spill over per k of l in t 
startsame(k,l,t)     starting time of diff i on same l in t 
endsame(k,l,t)       ending time of diff i on same l in t 
starttask1(k,l,t)    starting time of task i assigned to slot k 
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start2diff(*,*,l,ll,t)    starting time of task 2 on diff l in t 
start3diff(*,*,l,ll,t)    starting time of task 3 on diff l in t 
start33diff(*,*,l,ll,t)  starting time of task 3 on diff l in t 
start4diff(*,*,l,ll,t)    starting time of task 4 on diff l in t 
start5diff(*,*,l,ll,t)    starting time of task 5 on diff l in t 
end2diff(*,*,l,ll,t)     ending time of task 2 on diff l in t 
end3diff(*,*,l,ll,t)      ending time of task 3 on diff l in t 
end33diff(*,*,l,ll,t)    ending time of task 3 on diff l in t 
end4diff(*,*,l,ll,t)      ending time of task 4 on diff l in t 
end5diff(*,*,l,ll,t)      ending time of task 5 on diff l in t 
inventory(m,t)      inventory balance equation 
backlog(m,t)        backlogging equation 
supply(m,t)         supply of m in t 
dip(m,t)            dip below target level of m in t ; 
 
 
netprofit.. GP =e= sum((m,t), g(m)*SQ(m,t))- sum((m,t), ho1(m,t)*INV(m,t))-
sum((m,l,t), PQ(m,l,t)*ho2(m,t)/2)- sum((m,t), a(m,t)*Id(m,t))- sum((m,t), 
g(m)*Ib(m,t))- sum((l,t),sum(i$il1(i,l), cc(i,l)*(NC(i,l,t)-YS(i,l,t-1)))); 
effectcamp(i,l,t)$(il1(i,l)).. PT(i,l,t) =e= sum(k$(kl(k,l)),CL(i,k,l,t))-CT(i,l)*(NC(i,l,t)-
YS(i,l,t-1)); 
production(m,l,t).. PQ(m,l,t) =e= sum(i$il1(i,l), sigma(m,i)*(RL(i,l)* PT(i,l,t)+ 
DQ(i,l,t))/meu(i)); 
diffprod(i,l,t)$(il1(i,l)).. DQ(i,l,t) =l= (RU(i,l)-RL(i,l))* PT(i,l,t); 
camlength(i,k,l,t)$(il1(i,l) and kl(k,l)).. TTS(i,k,l,t)+ CL(i,k,l,t) =l= H(l,t)*Y(i,k,l,t); 
ipers(k,l,t)$kl(k,l).. sum(i$il1(i,l), Y(i,k,l,t)) =l= 1; 
speri(i,l,t)$il1(i,l).. sum(k$kl(k,l), Y(i,k,l,t)) =l= 1; 
slotlen1(k,l,t)$(kl(k,l)).. SL(k,l,t) =e= sum(i$il1(i,l), CL(i,k,l,t)); 
slotlen2(l,t).. sum(k$kl(k,l), SL(k,l,t))=l= H(l,t); 
numcamp(i,l,t)$(il1(i,l)).. NC(i,l,t) =e= sum(k$kl(k,l), Y(i,k,l,t)); 
relax1(i,k,l,t)$(il1(i,l)and kl(k,l)).. CL(i,k,l,t) =g= MCL(i,l)*Y(i,k,l,t)- 
MCL(i,l)*(YS(i,l,t)$(ord(k)=nk(l))+YS(i,l,t-1)$(ord(k)=1)); 
relax2(i,k,l,t)$(il1(i,l)and kl(k,l) and ord(k)=nk(l)).. CL(i,k,l,t-1)+ CL(i,'1',l,t) =g= 
MCL(i,l)*YS(i,l,t-1); 
spilla(i,k,l,t)$(il1(i,l) and kl(k,l) and ord(k)=nk(l)).. YS(i,l,t) =l= Y(i,k,l,t); 
spillb(i,'1',l,t)$(il1(i,l)and kl('1',l)).. YS(i,l,t-1) =l= Y(i,'1',l,t); 
maxspill(l,t).. sum(i$il1(i,l), YS(i,l,t)) =l= 1; 
startsame(k,l,t)$(kl(k,l) and ord(k)< nk(l)).. TS(k+1,l,t) =g= TE(k,l,t); 
endsame(k,l,t)$(kl(k,l)).. TE(k,l,t)   =e= TS(k,l,t) + SL(k,l,t); 
starttask1(k,l,t)$(kl(k,l)).. TS(k,l,t)   =e= sum(i$il1(i,l), TTS(i,k,l,t)); 
start2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
start3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)) + dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
start33diff('5','3',l,ll,t)$(il1('3',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)) + dt('5','3')*(NC('3',l,t) + NC('5',ll,t)-1); 
start4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)) + dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
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start5diff('5','6',l,ll,t)$(il1('6',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('6',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)) + dt('5','6')*(NC('6',l,t) + NC('5',ll,t)-1); 
end2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)+ 
CL('2',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
end3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)+ CL('2',kk,ll,t)) + 
dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
end33diff('5','3',l,ll,t)$(il1('3',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)+ CL('5',kk,ll,t)) + 
dt('5','3')*(NC('3',l,t) + NC('5',ll,t)-1); 
end4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)+ 
CL('5',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)+ CL('4',kk,ll,t)) + 
dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
end5diff('5','6',l,ll,t)$(il1('6',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('6',k,l,t)+ 
CL('6',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)+ CL('5',kk,ll,t)) + 
dt('5','6')*(NC('6',l,t) + NC('5',ll,t)-1); 
inventory(m,t).. INV(m,t) =e= (I0(m))$(ord(t)=1)+(INV(m,t-1))$(ord(t)>1)+ sum(l, 
PQ(m,l,t))-SQ(m,t); 
backlog(m,t).. Ib(m,t) =g= Ib(m,t-1)$(ord(t)>1)+ D(m,t)-SQ(m,t); 
supply(m,t).. sum(tt$(ord(tt)<= ord(t)), SQ(m,tt)) =l= sum(tt, D(m,tt)); 
dip(m,t).. Id(m,t) =g= IL(m)- INV(m,t); 
 
CL.lo(i,k,l,t) = 0; 
PT.lo(i,l,t) = 0; 
SL.lo(k,l,t) = 0; 
TS.lo(k,l,t) = 0; 
TE.lo(k,l,t) = 0; 
TTS.lo(i,k,l,t) = 0; 
INV.lo(m,t) = 0; 
Ib.lo(m,t) = 0; 
Id.lo(m,t) = 0; 
NC.lo(i,l,t) = 0; 
CL.up(i,k,l,t) = H(l,t); 
PT.up(i,l,t) = H(l,t); 
SL.up(k,l,t) = H(l,t); 
TS.up(k,l,t) = H(l,t); 
TE.up(k,l,t) = H(l,t); 
TTS.up(i,k,l,t) = H(l,t); 
INV.up(m,t) = ST(m); 
SQ.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt)); 
Ib.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt)); 
Id.up(m,t) = IL(m); 
NC.up(i,l,t) = 1; 
 
OPTION 
SOLPRINT = OFF 
limrow = 120 
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optcr = 0 
reslim = 1000 
mip = cplex ; 
 
MODEL planning /all/ ; 
 
SOLVE  planning using mip maximizing GP ; 
 
DISPLAY GP.l,CL.l,PT.l,TS.l,TE.l,TTS.l,Y.l,YS.l,INV.l,PQ.l,Ib.l,Id.l,SQ.l; 
A.1.1.2 Example 1b 
VARIABLES 
NC(i,l,t)      number of campaigns of i on l in t 
PQ(m,l,t)      amount of m produced or consumed on l in t 
DQ(i,l,t)      differential production amount of i on l in t 
CL(i,k,l,t)    campaign length of i in k of l in t 
PT(i,l,t)      effective production time of i on l in t 
SL(k,l,t)      length of k of l in t 
TS(k,l,t)      starting time of k of l in t 
TE(k,l,t)      ending time of k of l in t 
TTS(i,k,l,t)   starting time of i in k of l in t 
INV(m,t)       inventory of m at the end of t 
SQ(m,t)        supply amount of m in t 
Ib(m,t)        backlog amount of m in t 
Id(m,t)        deviation below IL(m) in t 
Y(i,k,l,t)     assignment variable 
YS(i,l,t)      spill over variable 
Z(i,k,l,t)     scaleup variable 
GP             net profit  ; 
POSITIVE VARIABLE DQ,CL,PT,NC,SL,TS,TE,TTS,INV,SQ,Ib,Id,Z,YS ; 
BINARY VARIABLE  Y; 
 
EQUATIONS 
netprofit            net profit to be maximized 
production(m,l,t)    amount of m produced or consumed on l in t 
effectcamp(i,l,t)    effective production time of i on l in t 
diffprod(i,l,t)      differential production amount of i on l in t 
camlength(i,k,l,t)   upper limit for campaign length of i in k of l in t 
ipers(k,l,t)         max no of i per k of l in t 
speri(i,l,t)        max no of k for i on l in t 
slotlen1(k,l,t)      length of slot k on l in t 
slotlen2(l,t)        sum of slot lengths 
numcamp(i,l,t)       number of campaigns of i on l in t 
relax1(i,k,l,t)      relaxation of mcl constraint-1 
relax2(i,k,l,t)      relaxation of mcl constraint-2 
spilla(i,k,l,t)      condition-1 for spill over 
spillb(i,*,l,t)      condition-2 for spill over 
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maxspill(l,t)       constraint for the number of spill over per k of l in t 
scaleup1(i,k,l,t)       scaleup time required for i in k of l in t 
scaleup2(i,l)           scaleup time required for i on l in t 
startsame(k,l,t)     starting time of diff i on same l in t 
endsame(k,l,t)       ending time of diff i on same l in t 
starttask1(k,l,t)    starting time of task i assigned to slot k 
start2diff(*,*,l,ll,t)    starting time of task 2 on diff l in t 
start3diff(*,*,l,ll,t)    starting time of task 3 on diff l in t 
start33diff(*,*,l,ll,t)  starting time of task 3 on diff l in t 
start4diff(*,*,l,ll,t)    starting time of task 4 on diff l in t 
start5diff(*,*,l,ll,t)    starting time of task 5 on diff l in t 
start6diff(*,*,l,ll,t)    starting time of task 6 on diff l in t 
start7diff(*,*,l,ll,t)    starting time of task 7 on diff l in t 
end2diff(*,*,l,ll,t)      ending time of task 2 on diff l in t 
end3diff(*,*,l,ll,t)     ending time of task 3 on diff l in t 
end33diff(*,*,l,ll,t)    ending time of task 3 on diff l in t 
end4diff(*,*,l,ll,t)      ending time of task 4 on diff l in t 
end5diff(*,*,l,ll,t)      ending time of task 5 on diff l in t 
end6diff(*,*,l,ll,t)      ending time of task 6 on diff l in t 
end7diff(*,*,l,ll,t)      ending time of task 7 on diff l in t 
inventory(m,t)      inventory balance equation 
backlog(m,t)        backlogging equation 
supply(m,t)         supply of m in t 
dip(m,t)            dip below target level of m in t ; 
 
netprofit.. GP =e= sum((m,t), g(m)*SQ(m,t))- sum((m,t), ho1(m,t)*INV(m,t))-
sum((m,l,t), PQ(m,l,t)*ho2(m,t)/2)- sum((m,t), a(m,t)*Id(m,t))- sum((m,t), 
g(m)*Ib(m,t))- sum((l,t),sum(i$il1(i,l), cc(i,l)*(NC(i,l,t)-YS(i,l,t-1)))); 
effectcamp(i,l,t)$(il1(i,l)).. PT(i,l,t) =e= sum(k$(kl(k,l)),CL(i,k,l,t))-CT(i,l)*(NC(i,l,t)-
YS(i,l,t-1))- sum(k$kl(k,l), SUT(i,l)*Z(i,k,l,t)); 
production(m,l,t).. PQ(m,l,t) =e= sum(i$il1(i,l), sigma(m,i)*(RL(i,l)* PT(i,l,t)+ 
DQ(i,l,t))/meu(i)); 
diffprod(i,l,t)$(il1(i,l)).. DQ(i,l,t) =l= (RU(i,l)-RL(i,l))* PT(i,l,t); 
camlength(i,k,l,t)$(il1(i,l)and kl(k,l)).. TTS(i,k,l,t)+ CL(i,k,l,t) =l= H(l,t)*Y(i,k,l,t); 
ipers(k,l,t)$kl(k,l).. sum(i$il1(i,l), Y(i,k,l,t)) =l= 1; 
speri(i,l,t)$il1(i,l).. sum(k$kl(k,l), Y(i,k,l,t)) =l= 1; 
slotlen1(k,l,t)$(kl(k,l)).. SL(k,l,t) =e= sum(i$il1(i,l), CL(i,k,l,t)); 
slotlen2(l,t).. sum(k$kl(k,l), SL(k,l,t))=l= H(l,t); 
numcamp(i,l,t)$(il1(i,l)).. NC(i,l,t) =e= sum(k$kl(k,l), Y(i,k,l,t)); 
relax1(i,k,l,t)$(il1(i,l)and kl(k,l)).. CL(i,k,l,t) =g= MCL(i,l)*Y(i,k,l,t)- 
MCL(i,l)*(YS(i,l,t)$(ord(k)=nk(l))+YS(i,l,t-1)$(ord(k)=1)); 
relax2(i,k,l,t)$(il1(i,l)and kl(k,l) and ord(k)=nk(l)).. CL(i,k,l,t-1)+ CL(i,'1',l,t) =g= 
MCL(i,l)*YS(i,l,t-1); 
spilla(i,k,l,t)$(il1(i,l) and kl(k,l) and ord(k)=nk(l)).. YS(i,l,t) =l= Y(i,k,l,t); 
spillb(i,'1',l,t)$(il1(i,l)and kl('1',l)).. YS(i,l,t-1) =l= Y(i,'1',l,t); 
maxspill(l,t).. sum(i$il1(i,l), YS(i,l,t)) =l= 1; 
scaleup1(i,k,l,t)$(il1(i,l)and kl(k,l)).. Z(i,k,l,t) =g= Y(i,k,l,t)-
sum(tt$(ord(tt)<ord(t)),sum(kk,Z(i,kk,l,tt))); 
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scaleup2(i,l)$(il1(i,l)).. sum(t,sum(k$(kl(k,l)),Z(i,k,l,t))) =l= 1; 
startsame(k,l,t)$(kl(k,l)and ord(k)< nk(l)).. TS(k+1,l,t) =g= TE(k,l,t); 
endsame(k,l,t)$(kl(k,l)).. TE(k,l,t)   =e= TS(k,l,t) + SL(k,l,t); 
starttask1(k,l,t)$(kl(k,l)).. TS(k,l,t)   =e= sum(i$il1(i,l), TTS(i,k,l,t)); 
start2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
start3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)) + dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
start33diff('5','3',l,ll,t)$(il1('3',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)) + dt('5','3')*(NC('3',l,t) + NC('5',ll,t)-1); 
start4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)) + dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
start5diff('5','6',l,ll,t)$(il1('6',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('6',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)) + dt('5','6')*(NC('6',l,t) + NC('5',ll,t)-1); 
start6diff('1','7',l,ll,t)$(il1('7',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('7',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','7')*(NC('7',l,t) + NC('1',ll,t)-1); 
start7diff('7','8',l,ll,t)$(il1('8',l)and ill1('7',ll)).. sum(k$kl(k,l), TTS('8',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('7',kk,ll,t)) + dt('7','8')*(NC('8',l,t) + NC('7',ll,t)-1); 
end2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)+ 
CL('2',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
end3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)+ CL('2',kk,ll,t)) + 
dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
end33diff('5','3',l,ll,t)$(il1('3',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)+ CL('5',kk,ll,t)) + 
dt('5','3')*(NC('3',l,t) + NC('5',ll,t)-1); 
end4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)+ 
CL('5',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)+ CL('4',kk,ll,t)) + 
dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
end5diff('5','6',l,ll,t)$(il1('6',l)and ill1('5',ll)).. sum(k$kl(k,l), TTS('6',k,l,t)+ 
CL('6',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('5',kk,ll,t)+ CL('5',kk,ll,t)) + 
dt('5','6')*(NC('6',l,t) + NC('5',ll,t)-1); 
end6diff('1','7',l,ll,t)$(il1('7',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('7',k,l,t)+ 
CL('7',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','7')*(NC('7',l,t) + NC('1',ll,t)-1); 
end7diff('7','8',l,ll,t)$(il1('8',l)and ill1('7',ll)).. sum(k$kl(k,l), TTS('8',k,l,t)+ 
CL('8',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('7',kk,ll,t)+ CL('7',kk,ll,t)) + 
dt('7','8')*(NC('8',l,t) + NC('7',ll,t)-1); 
inventory(m,t).. INV(m,t) =e= (I0(m))$(ord(t)=1)+(INV(m,t-1))$(ord(t)>1)+ sum(l, 
PQ(m,l,t))-SQ(m,t); 
backlog(m,t).. Ib(m,t) =g= Ib(m,t-1)$(ord(t)>1)+ D(m,t)-SQ(m,t); 
supply(m,t).. sum(tt$(ord(tt)<= ord(t)), SQ(m,tt)) =l= sum(tt, D(m,tt)); 
dip(m,t).. Id(m,t) =g= IL(m)- INV(m,t); 
 
CL.lo(i,k,l,t) = 0; 
PT.lo(i,l,t) = 0; 
SL.lo(k,l,t) = 0; 
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TS.lo(k,l,t) = 0; 
TE.lo(k,l,t) = 0; 
TTS.lo(i,k,l,t) = 0; 
INV.lo(m,t) = 0; 
Ib.lo(m,t) = 0; 
Id.lo(m,t) = 0; 
NC.lo(i,l,t) = 0; 
Z.lo(i,k,l,t) = 0; 
YS.lo(i,l,t) = 0; 
 
CL.up(i,k,l,t) = H(l,t); 
PT.up(i,l,t) = H(l,t); 
SL.up(k,l,t) = H(l,t); 
TS.up(k,l,t) = H(l,t); 
TE.up(k,l,t) = H(l,t); 
TTS.up(i,k,l,t) = H(l,t); 
INV.up(m,t) = ST(m); 
SQ.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt)); 
Ib.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt)); 
Id.up(m,t) = IL(m); 
NC.up(i,l,t) = 1; 
Z.up(i,k,l,t) = 1; 
YS.up(i,l,t) = 1; 
 
OPTION 
SOLPRINT = OFF 
limrow = 60 
optcr = 0 
reslim = 10000 
mip = cplex ; 
 
MODEL planning /all/; 
 
SOLVE  planning using mip maximizing GP; 
 
DISPLAY       GP.l,CL.l,PT.l,TS.l,TE.l,TTS.l,Y.l,Z.l,YS.l,INV.l,PQ.l,Ib.l,Id.l,SQ.l; 
A.1.2 Example 2 
VARIABLES 
NC(i,l,t)      number of campaigns of i on l in t 
PQ(m,l,t)      amount of m produced or consumed on l in t 
DQ(i,l,t)      Differential production amount of i on l in t 
CL(i,k,l,t)    campaign length of i in k of l in t 
PT(i,l,t)      effective production time of i on l in t 
SL(k,l,t)      length of k of l in t 
TS(k,l,t)      starting time of k of l in t 
TE(k,l,t)      ending time of k of l in t 
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TTS(i,k,l,t)   starting time of i in k of l in t 
INV(m,t)       inventory of m at the end of t 
SQ(m,t)        supply amount of m in t 
OQ(m,t)        outsourcing amount of m in t 
Ib(m,t)        backlog amount of m in t 
Id(m,t)        deviation below IL(m) in t 
Y(i,k,l,t)     assignment variable 
YS(i,l,t)      spill over variable 
GP             net profit  ; 
POSITIVE VARIABLE DQ,CL,PT,NC,SL,TS,TE,TTS,INV,SQ,OQ,Ib,Id,YS ; 
BINARY VARIABLE Y ; 
 
EQUATIONS 
netprofit net profit to be maximized 
production(m,l,t)    amount of m produced or consumed on l in t 
effectcamp(i,l,t)    effective production time of i on l in t 
diffprod(i,l,t)      differential production amount of i on l in t 
camlength(i,k,l,t)   upper limit for campaign length of i in k of l in t 
ipers(k,l,t)         max no of i per k of l in t 
speri(i,l,t)         max no of k for i on l in t 
slotlen1(k,l,t)      length of slot k on l in t 
slotlen2(l,t)        sum of slot lengths 
numcamp(i,l,t)       number of campaigns of i on l in t 
relax1(i,k,l,t)      relaxation of mcl constraint-1 
relax2(i,k,l,t)      relaxation of mcl constraint-2 
spilla(i,k,l,t)      condition-1 for spill over 
spillb(i,*,l,t)      condition-2 for spill over 
maxspill(l,t)        constraint for the number of spill over per k of l in t 
startsame(k,l,t)     starting time of diff i on same l in t 
endsame(k,l,t)       ending time of diff i on same l in t 
starttask1(k,l,t)    starting time of task i assigned to slot k 
start2diff(*,*,l,ll,t)    starting time of task 2 on diff l in t 
start3diff(*,*,l,ll,t)    starting time of task 3 on diff l in t 
start33diff(*,*,l,ll,t)  starting time of task 3 on diff l in t 
start4diff(*,*,l,ll,t)    starting time of task 4 on diff l in t 
start5diff(*,*,l,ll,t)    starting time of task 5 on diff l in t 
end2diff(*,*,l,ll,t)      ending time of task 2 on diff l in t 
end3diff(*,*,l,ll,t)      ending time of task 3 on diff l in t 
end33diff(*,*,l,ll,t)    ending time of task 3 on diff l in t 
end4diff(*,*,l,ll,t)      ending time of task 4 on diff l in t 
end5diff(*,*,l,ll,t)      ending time of task 5 on diff l in t 
inventory(m,t)      inventory balance equation 
backlog(m,t)        backlogging equation 
supply(m,t)         supply of m in t 
dip(m,t)            dip below target level of m in t ; 
 
netprofit.. GP =e= sum((m,t), g(m)*SQ(m,t))- sum((m,t), ho1(m,t)*INV(m,t))-
sum((m,l,t), PQ(m,l,t)*ho2(m,t)/2)- sum((m,t), a(m,t)*Id(m,t))- sum((m,t), 
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g(m)*Ib(m,t))- sum((m,t), rc(m)* OQ(m,t))- sum((l,t),sum(i$il1(i,l), cc(i,l)*(NC(i,l,t)-
YS(i,l,t-1)))); 
effectcamp(i,l,t)$(il1(i,l)).. PT(i,l,t) =e= sum(k$(kl(k,l)),CL(i,k,l,t))-CT(i,l)*(NC(i,l,t)-
YS(i,l,t-1)); 
production(m,l,t).. PQ(m,l,t) =e= sum(i$il1(i,l), sigma(m,i)*(RL(i,l)* PT(i,l,t)+ 
DQ(i,l,t))/meu(i)); 
diffprod(i,l,t)$(il1(i,l)).. DQ(i,l,t) =l= (RU(i,l)-RL(i,l))* PT(i,l,t); 
camlength(i,k,l,t)$(il1(i,l) and kl(k,l)).. TTS(i,k,l,t)+ CL(i,k,l,t) =l= H(l,t)*Y(i,k,l,t); 
ipers(k,l,t)$kl(k,l).. sum(i$il1(i,l), Y(i,k,l,t)) =l= 1; 
speri(i,l,t)$il1(i,l).. sum(k$kl(k,l), Y(i,k,l,t)) =l= 1; 
slotlen1(k,l,t)$(kl(k,l)).. SL(k,l,t) =e= sum(i$il1(i,l), CL(i,k,l,t)); 
slotlen2(l,t).. sum(k$kl(k,l), SL(k,l,t))=l= H(l,t); 
numcamp(i,l,t)$(il1(i,l)).. NC(i,l,t) =e= sum(k$kl(k,l), Y(i,k,l,t)); 
relax1(i,k,l,t)$(il1(i,l)and kl(k,l)).. CL(i,k,l,t) =g= MCL*Y(i,k,l,t)- 
MCL*(YS(i,l,t)$(ord(k)=nk(l))+YS(i,l,t-1)$(ord(k)=1)); 
relax2(i,k,l,t)$(il1(i,l)and kl(k,l) and ord(k)=nk(l)).. CL(i,k,l,t-1)+ CL(i,'1',l,t) =g= 
MCL*YS(i,l,t-1); 
spilla(i,k,l,t)$(il1(i,l) and kl(k,l) and ord(k)=nk(l)).. YS(i,l,t) =l= Y(i,k,l,t); 
spillb(i,'1',l,t)$(il1(i,l)and kl('1',l)).. YS(i,l,t-1) =l= Y(i,'1',l,t); 
maxspill(l,t).. sum(i$il1(i,l), YS(i,l,t)) =l= 1; 
startsame(k,l,t)$(kl(k,l) and ord(k)< nk(l)).. TS(k+1,l,t) =g= TE(k,l,t); 
endsame(k,l,t)$(kl(k,l)).. TE(k,l,t)   =e= TS(k,l,t) + SL(k,l,t); 
starttask1(k,l,t)$(kl(k,l)).. TS(k,l,t)   =e= sum(i$il1(i,l), TTS(i,k,l,t)); 
start2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
start3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)) + dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
start33diff('4','3',l,ll,t)$(il1('3',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)) + dt('4','3')*(NC('3',l,t) + NC('4',ll,t)-1); 
start4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)) + dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
start5diff('1','4',l,ll,t)$(il1('4',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('4',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','4')*(NC('4',l,t) + NC('1',ll,t)-1); 
end2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)+ 
CL('2',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
end3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)+ CL('2',kk,ll,t)) + 
dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
end33diff('4','3',l,ll,t)$(il1('3',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)+ CL('4',kk,ll,t)) + 
dt('4','3')*(NC('3',l,t) + NC('4',ll,t)-1); 
end4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)+ 
CL('5',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)+ CL('4',kk,ll,t)) + 
dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
end5diff('1','4',l,ll,t)$(il1('4',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('4',k,l,t)+ 
CL('4',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','4')*(NC('4',l,t) + NC('1',ll,t)-1); 
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inventory(m,t).. INV(m,t) =e= (I0(m))$(ord(t)=1)+(INV(m,t-1))$(ord(t)>1)+ OQ(m,t)+ 
sum(l, PQ(m,l,t))-SQ(m,t); 
backlog(m,t).. Ib(m,t) =g= Ib(m,t-1)$(ord(t)>1)+ D(m,t)-SQ(m,t); 
supply(m,t).. sum(tt$(ord(tt)<= ord(t)), SQ(m,tt)) =l= sum(tt, D(m,tt)); 
dip(m,t).. Id(m,t) =g= IL(m)- INV(m,t); 
 
OQ.lo(m,t) = 0; 
CL.lo(i,k,l,t) = 0; 
PT.lo(i,l,t) = 0; 
SL.lo(k,l,t) = 0; 
TS.lo(k,l,t) = 0; 
TE.lo(k,l,t) = 0; 
TTS.lo(i,k,l,t) = 0; 
INV.lo(m,t) = 0; 
Ib.lo(m,t) = 0; 
Id.lo(m,t) = 0; 
NC.lo(i,l,t) = 0; 
YS.lo(i,l,t) = 0; 
 
OQ.up(m,t) = out(m); 
CL.up(i,k,l,t) = H(l,t); 
PT.up(i,l,t) = H(l,t); 
SL.up(k,l,t) = H(l,t); 
TS.up(k,l,t) = H(l,t); 
TE.up(k,l,t) = H(l,t); 
TTS.up(i,k,l,t) = H(l,t); 
INV.up(m,t) = ST(m); 
SQ.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt)); 
Ib.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt)); 
Id.up(m,t) = IL(m); 
NC.up(i,l,t) = 1; 
YS.up(i,l,t) = 1; 
 
OPTION 
SOLPRINT = OFF 
limrow = 40 
optcr = 0 
reslim = 1000 
mip = cplex ; 
 
MODEL planning /all/ ; 
 
SOLVE  planning using mip maximizing GP ; 
 
DISPLAY GP.l,CL.l,PT.l,TS.l,TE.l,TTS.l,Y.l,YS.l,INV.l,PQ.l,Ib.l,Id.l,SQ.l; 
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A.1.3 Example 3 
VARIABLES 
NC(i,l,t)      number of campaigns of i on l in t 
PQ(m,l,t)      mount of m produced or consumed on l in t 
DQ(i,l,t)      differential production amount of i on l in t 
CL(i,k,l,t)    campaign length of i in k of l in t 
PT(i,l,t)      effective production time of i on l in t 
SL(k,l,t)      ength of k of l in t 
TS(k,l,t)      starting time of k of l in t 
TE(k,l,t)      ending time of k of l in t 
TTS(i,k,l,t)   starting time of i in k of l in t 
INV(m,t)       inventory of m at the end of t 
SQ(m,t)        supply amount of m in t 
OQ(m,t)        outsourcing amount of m in t 
Ib(m,t)       backlog amount of m in t 
Id(m,t)        deviation below IL(m) in t 
Y(i,k,l,t)     assignment variable 
YS(i,l,t)      spill over variable 
Z(i,k,l,t)     scaleup variable 
GP            net profit  ; 
POSITIVE VARIABLE DQ,CL,PT,NC,SL,TS,TE,TTS,INV,SQ,OQ,Ib,Id,Z,YS ; 
BINARY VARIABLE Y ; 
 
EQUATIONS 
netprofit            net profit to be maximized 
production(m,l,t)    amount of m produced or consumed on l in t 
effectcamp(i,l,t)    effective production time of i on l in t 
diffprod(i,l,t)      differential production amount of i on l in t 
camlength(i,k,l,t)   upper limit for campaign length of i in k of l in t 
ipers(k,l,t)         max no of i per k of l in t 
speri(i,l,t)         max no of k for i on l in t 
slotlen1(k,l,t)      length of slot k on l in t 
slotlen2(l,t)       sum of slot lengths 
numcamp(i,l,t)       number of campaigns of i on l in t 
relax1(i,k,l,t)      relaxation of mcl constraint-1 
relax2(i,k,l,t)      relaxation of mcl constraint-2 
spilla(i,k,l,t)      condition-1 for spill over 
spillb(i,*,l,t)      condition-2 for spill over 
maxspill(l,t)        constraint for the number of spill over per k of l in t 
scaleup1(i,k,l,t)   scaleup time required for i in k of l in t 
scaleup2(i,l)        scaleup time required for i on l in t 
startsame(k,l,t)     starting time of diff i on same l in t 
endsame(k,l,t)       ending time of diff i on same l in t 
starttask1(k,l,t)    starting time of task i assigned to slot k 
start2diff(*,*,l,ll,t)    starting time of task 2 on diff l in t 
start3diff(*,*,l,ll,t)    starting time of task 3 on diff l in t 
start33diff(*,*,l,ll,t)  starting time of task 3 on diff l in t 
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start4diff(*,*,l,ll,t)    starting time of task 4 on diff l in t 
start5diff(*,*,l,ll,t)    starting time of task 5 on diff l in t 
start6diff(*,*,l,ll,t)    starting time of task 4 on diff l in t 
start7diff(*,*,l,ll,t)    starting time of task 5 on diff l in t 
end2diff(*,*,l,ll,t)      ending time of task 2 on diff l in t 
end3diff(*,*,l,ll,t)      ending time of task 3 on diff l in t 
end33diff(*,*,l,ll,t)    ending time of task 3 on diff l in t 
end4diff(*,*,l,ll,t)      ending time of task 4 on diff l in t 
end5diff(*,*,l,ll,t)      ending time of task 5 on diff l in t 
end6diff(*,*,l,ll,t)      ending time of task 4 on diff l in t 
end7diff(*,*,l,ll,t)      ending time of task 5 on diff l in t 
inventory(m,t)      inventory balance equation 
backlog(m,t)        backlogging equation 
supply(m,t)         supply of m in t 
dip(m,t)            dip below target level of m in t ; 
 
netprofit.. GP =e= sum((m,t), g(m)*SQ(m,t))- sum((m,t), ho1(m,t)*INV(m,t))-
sum((m,l,t), PQ(m,l,t)*ho2(m,t)/2)- sum((m,t), a(m,t)*Id(m,t))- sum((m,t), 
g(m)*Ib(m,t))- sum((l,t),sum(i$il1(i,l), cc(i,l)*(NC(i,l,t)-YS(i,l,t-1)$(ord(t)>1)-
YS0(i,l)$(ord(t)=1)))); 
effectcamp(i,l,t)$(il1(i,l)).. PT(i,l,t) =e= sum(k$(kl(k,l)),CL(i,k,l,t))-CT(i,l)*(NC(i,l,t)-
YS(i,l,t-1)$(ord(t)>1)-YS0(i,l)$(ord(t)=1))- sum(k$kl(k,l), SUT(i,l)*Z(i,k,l,t)); 
production(m,l,t).. PQ(m,l,t) =e= sum(i$il1(i,l), sigma(m,i)*(RL(i,l)* PT(i,l,t)+ 
DQ(i,l,t))/meu(i)); 
diffprod(i,l,t)$(il1(i,l)).. DQ(i,l,t) =l= (RU(i,l)-RL(i,l))* PT(i,l,t); 
camlength(i,k,l,t)$(il1(i,l)and kl(k,l)).. TTS(i,k,l,t)+ CL(i,k,l,t) =l= H(l,t)*Y(i,k,l,t); 
ipers(k,l,t)$kl(k,l).. sum(i$il1(i,l), Y(i,k,l,t)) =l= 1; 
speri(i,l,t)$il1(i,l).. sum(k$kl(k,l), Y(i,k,l,t)) =l= 1; 
slotlen1(k,l,t)$(kl(k,l)).. SL(k,l,t) =e= sum(i$il1(i,l), CL(i,k,l,t)); 
slotlen2(l,t).. sum(k$kl(k,l), SL(k,l,t))=l= H(l,t); 
numcamp(i,l,t)$(il1(i,l)).. NC(i,l,t) =e= sum(k$kl(k,l), Y(i,k,l,t)); 
relax1(i,k,l,t)$(il1(i,l)and kl(k,l)).. CL(i,k,l,t) =g= MCL*Y(i,k,l,t)- 
MCL*(YS(i,l,t)$(ord(k)=nk(l))+YS(i,l,t-1)$(ord(k)=1 and 
ord(t)>1)+YS0(i,l)$(ord(k)=1 and ord(t)=1)); 
relax2(i,k,l,t)$(il1(i,l)and kl(k,l)and ord(k)=nk(l)).. CL(i,'1',l,t) =g= MCL*(YS(i,l,t-
1)$(ord(t)>1)+YS0(i,l)$(ord(t)=1))-CL(i,k,l,t-1)$(ord(t)>1)-CL0(i,l)$(ord(t)=1); 
spilla(i,k,l,t)$(il1(i,l) and kl(k,l) and ord(k)=nk(l)).. YS(i,l,t) =l= Y(i,k,l,t); 
spillb(i,'1',l,t)$(il1(i,l)and kl('1',l)).. Y(i,'1',l,t) =g= YS(i,l,t-
1)$(ord(t)>1)+YS0(i,l)$(ord(t)=1); 
maxspill(l,t).. sum(i$il1(i,l), YS(i,l,t)) =l= 1; 
scaleup1(i,k,l,t)$(il1(i,l)and kl(k,l)).. Z(i,k,l,t) =g= Y(i,k,l,t)-
sum(tt$(ord(tt)<ord(t)),sum(kk,Z(i,kk,l,tt))); 
scaleup2(i,l)$(il1(i,l)).. sum(t,sum(k$(kl(k,l)),Z(i,k,l,t))) =l= 1; 
startsame(k,l,t)$(kl(k,l)and ord(k)< nk(l)).. TS(k+1,l,t) =g= TE(k,l,t); 
endsame(k,l,t)$(kl(k,l)).. TE(k,l,t)   =e= TS(k,l,t) + SL(k,l,t); 
starttask1(k,l,t)$(kl(k,l)).. TS(k,l,t)   =e= sum(i$il1(i,l), TTS(i,k,l,t)); 
start2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
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start3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)) + dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
start33diff('4','3',l,ll,t)$(il1('3',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)) + dt('4','3')*(NC('3',l,t) + NC('4',ll,t)-1); 
start4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)) + dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
start5diff('1','4',l,ll,t)$(il1('4',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('4',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)) + dt('1','4')*(NC('4',l,t) + NC('1',ll,t)-1); 
start6diff('6','7',l,ll,t)$(il1('7',l)and ill1('6',ll)).. sum(k$kl(k,l), TTS('7',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('6',kk,ll,t)) + dt('6','7')*(NC('7',l,t) + NC('6',ll,t)-1); 
start7diff('7','8',l,ll,t)$(il1('8',l)and ill1('7',ll)).. sum(k$kl(k,l), TTS('8',k,l,t)) =g= 
sum(kk$kkll(kk,ll), TTS('7',kk,ll,t)) + dt('7','8')*(NC('8',l,t) + NC('7',ll,t)-1); 
end2diff('1','2',l,ll,t)$(il1('2',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('2',k,l,t)+ 
CL('2',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','2')*(NC('2',l,t) + NC('1',ll,t)-1); 
end3diff('2','3',l,ll,t)$(il1('3',l)and ill1('2',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('2',kk,ll,t)+ CL('2',kk,ll,t)) + 
dt('2','3')*(NC('3',l,t) + NC('2',ll,t)-1); 
end33diff('4','3',l,ll,t)$(il1('3',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('3',k,l,t)+ 
CL('3',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)+ CL('4',kk,ll,t)) + 
dt('4','3')*(NC('3',l,t) + NC('4',ll,t)-1); 
end4diff('4','5',l,ll,t)$(il1('5',l)and ill1('4',ll)).. sum(k$kl(k,l), TTS('5',k,l,t)+ 
CL('5',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('4',kk,ll,t)+ CL('4',kk,ll,t)) + 
dt('4','5')*(NC('5',l,t) + NC('4',ll,t)-1); 
end5diff('1','4',l,ll,t)$(il1('4',l)and ill1('1',ll)).. sum(k$kl(k,l), TTS('4',k,l,t)+ 
CL('4',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('1',kk,ll,t)+ CL('1',kk,ll,t)) + 
dt('1','4')*(NC('4',l,t) + NC('1',ll,t)-1); 
end6diff('6','7',l,ll,t)$(il1('7',l)and ill1('6',ll)).. sum(k$kl(k,l), TTS('7',k,l,t)+ 
CL('7',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('6',kk,ll,t)+ CL('6',kk,ll,t)) + 
dt('6','7')*(NC('7',l,t) + NC('6',ll,t)-1); 
end7diff('7','8',l,ll,t)$(il1('8',l)and ill1('7',ll)).. sum(k$kl(k,l), TTS('8',k,l,t)+ 
CL('8',k,l,t)) =g= sum(kk$kkll(kk,ll), TTS('7',kk,ll,t)+ CL('7',kk,ll,t)) + 
dt('7','8')*(NC('8',l,t) + NC('7',ll,t)-1); 
inventory(m,t).. INV(m,t) =e= (I0(m))$(ord(t)=1)+(INV(m,t-1))$(ord(t)>1)+ sum(l, 
PQ(m,l,t))-SQ(m,t); 
backlog(m,t).. Ib(m,t) =g=  Ib0(m)$(ord(t)=1)+Ib(m,t-1)$(ord(t)>1)+ D(m,t)-SQ(m,t); 
supply(m,t).. sum(tt$(ord(tt)<= ord(t)), SQ(m,tt)) =l= sum(tt, D(m,tt))+Ib0(m); 
dip(m,t).. Id(m,t) =g= IL(m)- INV(m,t); 
 
CL.lo(i,k,l,t) = 0; 
PT.lo(i,l,t) = 0; 
SL.lo(k,l,t) = 0; 
TS.lo(k,l,t) = 0; 
TE.lo(k,l,t) = 0; 
TTS.lo(i,k,l,t) = 0; 
INV.lo(m,t) = 0; 
Ib.lo(m,t) = 0; 
Id.lo(m,t) = 0; 
   115
 
  Appendix A 
NC.lo(i,l,t) = 0; 
YS.lo(i,l,t) = 0; 
Z.lo(i,k,l,t) = 0; 
 
CL.up(i,k,l,t) = H(l,t); 
PT.up(i,l,t) = H(l,t); 
SL.up(k,l,t) = H(l,t); 
TS.up(k,l,t) = H(l,t); 
TE.up(k,l,t) = H(l,t); 
TTS.up(i,k,l,t) = H(l,t); 
INV.up(m,t) = ST(m); 
SQ.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt))+Ib0(m); 
Ib.up(m,t) = sum(tt$(ord(tt) <= ord(t)), D(m,tt))+Ib0(m); 
Id.up(m,t) = IL(m); 
NC.up(i,l,t) = 1; 
YS.up(i,l,t) = 1; 
Z.up(i,k,l,t) = 1; 
 
OPTION 
SOLPRINT = OFF 
limrow = 40 
optcr = 0 
reslim = 10000 
mip = cplex ; 
 
MODEL planning /all/; 
 




A.2 DATA files for Examples 1-3 
A.2.1 Example 1 
A.2.1.1 Example 1a 
SETS 
m materials /1*9/ 
i tasks /1*6/ 
k slots /1*2/ 
l lines /1*3/ 
t time periods /1*4/ 
il1(i,l) suitability of tasks to lines /(1,4).1,(2,5).2,(3,6).3/ 
kl(k,l)  slots on lines /(1,2).1,(1,2).2,(1,2).3/ 
ALIAS   (i,ii),(k,kk),(l,ll),(t,tt); 
SETS 
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iil1(ii,l)   suitability of tasks to lines /(1,4).1,(2,5).2,(3,6).3/ 
ill1(i,ll)   suitability of tasks to lines /(1,4).1,(2,5).2,(3,6).3/ 
iill1(ii,ll) suitability of tasks to lines /(1,4).1,(2,5).2,(3,6).3/ 
kkl(kk,l)    slots on lines /(1,2).1,(1,2).2,(1,2).3/ 
kll(k,ll)    slots on lines /(1,2).1,(1,2).2,(1,2).3/ 
kkll(kk,ll)  slots on lines /(1,2).1,(1,2).2,(1,2).3/ 
 
PARAMETERS 
I0(m) initial inventory of m 
/1 1000000,2 0,3 0,4 0,5 1000000,6 0,7 0,8 0,9 0/ 
IL(m) target level of m 
/1 0,2 0,3 0,4 1500,5 0,6 0,7 0,8 1000,9 0/ 
ST(m) storage limit of m 
/1 1000000,2 3500,3 3000,4 1000000,5 1000000,6 4000,7 5000,8 1000000,9 3000/ 
g(m)  revenue per unit of m 
/1 0,2 0,3 0,4 1.2,5 0,6 0,7 0,8 0.8,9 0/ 
period(t) time length of t in hrs 
/1 360,2 360,3 720,4 720/ 
nk(l) total number of slots on l 
/1 2,2 2,3 2/ 
meu(i) primary material of i 
/1*5 1,6 0.9/ ; 
 
TABLE 
dt(i,ii)  batch processing time of i on l 
        1*6 
1*6  0   ; 
TABLE 
ct(i,l)  changeover time of i on l 
      1    2    3 
1    2 
2         2 
3              3 
4    3 
5         3 
6              2    ; 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
        1     2     3    4    5    6 
1     -1     0     0    0    0    0 
2      1    -1     0    0    0    0 
3      0     1    -0.8  0    0    0 
4      0     0     1    0    0    0 
5      0     0     0   -1    0    0 
6      0     0     0    1   -1    0 
7      0     0    -0.2  0    1   -1 
8      0     0     0    0    0    0.9 
9      0     0     0    0    0    0.1   ; 
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TABLE 
D(m,t) demand for m in t 
        1        2         3         4 
4     2000   1500   6000   5000 
8     1000   1500   6000   2500 ; 
TABLE 
H(l,t) uptime of l in t(in hrs) 
     1      2      3      4 
1   360  360  720  720 
2   360  360  720  720 
3   360  360  720  720  ; 
TABLE 
RU(i,l) max rate of production for i on l 
 
     1    2    3 
1    20 
2         15 
3              25 
4    15 
5         10 
6              10  ; 
TABLE 
MCL(i,l) max rate of production for i on l 
 
     1    2    3 
1    100 
2         110 
3              140 
4    110 
5         120 
6              130 ; 
TABLE 
cc(i,l) changeover cost of i on l 
      1    2    3 
1    40 
2         50 
3              70 
4    50 
5         60 
6              65    ; 
TABLE 
hc(m,t)  holding cost of m per 1000 per day 
      1*4 
1    0 
2    1.30 
3    1.23 
4    1.76 
5    0 
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6    1.60 
7    1.40 
8    1.82 
9    1.50; 
 
PARAMETER 
RL(i,l) min rate of production for i on l; 
RL(i,l) = RU(i,l)/4; 
PARAMETER 
ho1(m,t)   holding cost of m during t+1; 
ho1(m,t)  = hc(m,t)* period(t+1)/(1000*24); 
PARAMETER 
ho2(m,t)   holding cost of m during t; 
ho2(m,t)  = hc(m,t)* period(t)/(1000*24); 
PARAMETER 
a(m,t) penalty cost of m for dipping below IL(m) in t ; 
a(m,t)= 2*ho1(m,t) ; 
 
A.2.1.2 Example 1b 
SETS 
m materials /1*12/ 
i tasks /1*8/ 
k slots /1*3/ 
l lines /1*3/ 
t time periods /1*4/ 
il1(i,l) suitability of tasks to lines /(1,4).1,(2,5,7).2,(3,6,8).3/ 
kl(k,l)  slots on lines /(1,2).1,(1,2,3).2,(1,2,3).3/ 
ALIAS   (i,ii),(k,kk),(l,ll),(t,tt); 
SETS 
iil1(ii,l)   suitability of tasks to lines /(1,4).1,(2,5,7).2,(3,6,8).3/ 
ill1(i,ll)   suitability of tasks to lines /(1,4).1,(2,5,7).2,(3,6,8).3/ 
iill1(ii,ll) suitability of tasks to lines /(1,4).1,(2,5,7).2,(3,6,8).3/ 
kkl(kk,l)    slots on lines /(1,2).1,(1,2,3).2,(1,2,3).3/ 
kll(k,ll)    slots on lines /(1,2).1,(1,2,3).2,(1,2,3).3/ 
kkll(kk,ll)  slots on lines /(1,2).1,(1,2,3).2,(1,2,3).3/ 
 
PARAMETERS 
I0(m) initial inventory of m 
/1 1000000,2 0,3 0,4 0,5 1000000,6 0,7 0,8 0,9 0,10 1000000,11 0,12 0/ 
IL(m) target level of m 
/1 0,2 0,3 0,4 1500,5 0,6 0,7 0,8 1000,9 0,10 0,11 0,12 1000/ 
ST(m) storage limit of m 
/1 1000000,2 3500,3 3000,4 1000000,5 1000000,6 4000,7 5000,8 1000000,9 3000,10 
1000000,11 3000,12 1000000/ 
g(m)  revenue per unit of m 
/1 0,2 0,3 0,4 1.2,5 0,6 0,7 0,8 0.8,9 0,10 0,11 0,12 2.3/ 
period(t) time length of t in hrs 
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/1 360,2 360,3 720,4 720/ 
nk(l) total number of slots on l 
/1 2,2 3,3 3/ 
meu(i) primary material of i 
/1*5 1,6 0.9,7*8 1/  ; 
 
TABLE 
dt(i,ii)  batch processing time of i on l 
       1*8 
1*8  0   ; 
TABLE 
ct(i,l)  changeover time of i on l 
      1    2    3 
1    2 
2         2 
3              3 
4    3 
5         3 
6              2 
7         2 
8              3   ; 
TABLE 
SUT(i,l)  changeover time of i on l 
     1    2    3 
7         15 
8              10   ; 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
        1     2     3    4    5    6     7     8 
1     -1     0     0    0    0    0     0     0 
2      1    -1     0    0    0    0    -0.25  0 
3      0     1    -0.8  0    0    0     0     0 
4      0     0     1    0    0    0     0     0 
5      0     0     0   -1    0    0     0     0 
6      0     0     0    1   -1    0     0     0 
7      0     0    -0.2  0    1   -1     0     0 
8      0     0     0    0    0    0.9   0     0 
9      0     0     0    0    0    0.1   0     0 
10     0     0     0    0    0    0    -0.75  0 
11     0     0     0    0    0    0     1    -1 
12     0     0     0    0    0    0     0     1  ; 
TABLE 
D(m,t) demand for m in t 
       1         2         3         4 
4     2000   1500   6000   5000 
8     1000   1500   6000   2500 
12    1000   1000   1200   1500   ; 
TABLE 
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H(l,t) uptime of l in t(in hrs) 
     1      2      3      4  
1   360  360  720  720 
2   360  360  720  720 
3   360  360  720  720  ; 
TABLE 
RU(i,l) max rate of production for i on l 
      1    2    3 
1    20 
2         15 
3              25 
4    15 
5         10 
6              10 
7         20 
8              25; 
TABLE 
MCL(i,l) max rate of production for i on l 
      1    2    3 
1    100 
2         110 
3              140 
4    110 
5         120 
6              130 
7         100 
8              125  ; 
TABLE 
cc(i,l) changeover cost of i on l 
      1    2    3 
1    40 
2         50 
3              70 
4    50 
5         60 
6              65 
7         55 
8              80  ; 
TABLE 
hc(m,t)  holding cost of m per 1000 per day 
      1*4 
2    1.30 
3    1.23 
4    1.76 
6    1.60 
7    1.40 
8    1.82 
9    1.50 
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11   1.28 
12   1.90  ; 
 
PARAMETER 
RL(i,l) min rate of production for i on l; 
RL(i,l) = RU(i,l)/4; 
PARAMETER 
ho1(m,t)   holding cost of m during t+1; 
ho1(m,t)  = hc(m,t)* period(t+1)/(1000*24); 
PARAMETER 
ho2(m,t)   holding cost of m during t; 
ho2(m,t)  = hc(m,t)* period(t)/(1000*24); 
PARAMETER 
a(m,t) penalty cost of m for dipping below IL(m) in t ; 
a(m,t)= 2*ho1(m,t) ; 
 
A.2.2 Example 2 
SETS 
m materials /1*7/ 
i tasks /1*5/ 
k slots /1*2/ 
l lines /1*4/ 
t time periods /1*4/ 
il1(i,l) suitability of tasks to lines /1.1,(2,4).(2,3),(3,5).4/ 
kl(k,l)  slots on lines /1.1,(1,2).(2,3),(1,2).4/ 
ALIAS   (i,ii),(k,kk),(l,ll),(t,tt); 
SETS 
iil1(ii,l)   suitability of tasks to lines /1.1,(2,4).(2,3),(3,5).4/ 
ill1(i,ll)   suitability of tasks to lines /1.1,(2,4).(2,3),(3,5).4/ 
iill1(ii,ll) suitability of tasks to lines /1.1,(2,4).(2,3),(3,5).4/ 
kkl(kk,l)    slots on lines /1.1,(1,2).(2,3),(1,2).4/ 
kll(k,ll)    slots on lines /1.1,(1,2).(2,3),(1,2).4/ 
kkll(kk,ll)  slots on lines /1.1,(1,2).(2,3),(1,2).4/ 
 
PARAMETERS 
I0(m) initial inventory of m 
/1 1000000,2 0,3 0,4 0,5 0,6 0,7 0/ 
IL(m) target level of m 
/1 0,2 0,3 0,4 1500,5 0,6 1000,7 0/ 
ST(m) storage limit of m 
/1 1000000,2 3500,3 3000,4 1000000,5 4000,6 1000000,7 3000/ 
out(m) outsourcing amount of m 
/1*4 0,5 0,6*7 0/ 
*/1*2 0,3 1000000,4*7 0/ 
*/1*4 0,5 1000000,6*7 0/ 
*/1*2 0,3 1000000,4 0,5 1000000,6*7 0/ 
*/1*2 0,3 1000000,4 0,5 1000,6*7 0/ 
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rc(m) purchase cost per unit of m 
/1*4 0,5 0,6*7 0/ 
g(m)  revenue per unit of m 
/1 0,2 0,3 0,4 1.2,5 0,6 0.8,7 0/ 
period(t) time length of t in hrs 
/1 360,2 360,3 720,4 720/ 
nk(l) total number of slots on l 
/1 1,2*4 2/ 
meu(i) primary material of i 
/1*4 1,5 0.9/ ; 
 
TABLE 
dt(i,ii)  batch processing time of i on l 
     1    2    3    4    5 
1         4         4 
2              2 
3 
4              3         3 
5                            ; 
TABLE 
ct(i,l)  changeover time of i on l 
     1    2    3    4 
1 
2         2    1.5 
3                     3 
4         2    2 
5                     3   ; 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
        1     2     3    4    5 
1     -1     0     0    0    0 
2      1    -1     0   -1    0 
3      0     1    -0.8  0    0 
4      0     0     1    0    0 
5      0     0    -0.2  1   -1 
6      0     0     0    0    0.9 
7      0     0     0    0    0.1   ; 
TABLE 
D(m,t) demand for m in t 
       1         2         3         4 
4     1000   1500   6000   2500 
6     2000   1500   6000   5000 ; 
TABLE 
H(l,t) uptime of l in t(in hrs) 
     1      2      3      4 
1   360  360  720  720 
2   360  360  720  720 
3   360  360  720  720 
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4   360  360  720  720 ; 
TABLE 
RU(i,l) max rate of production for i on l 
     1    2    3    4 
1    20 
2         8    7 
3                   15 
4         5    5 
5                   20        ; 
TABLE 
cc(i,l) changeover cost of i on l 
     1    2     3    4 
1 
2         50   45 
3                     70 
4         40   40 
5                     80        ; 
TABLE 
hc(m,t)  holding cost of m per 1000 per day 
      1*4 
2    1.30 
3    1.23 
4    1.76 
5    1.36 
6    1.60 
7    1.40 ; 
 
PARAMETER 
RL(i,l) min rate of production for i on l; 
RL(i,l) = RU(i,l)/4; 
PARAMETER 
ho1(m,t)   holding cost of m during t+1; 
ho1(m,t)  = hc(m,t)* period(t+1)/(1000*24); 
PARAMETER 
ho2(m,t)   holding cost of m during t; 
ho2(m,t)  = hc(m,t)* period(t)/(1000*24); 
PARAMETER 
a(m,t) penalty cost of m for dipping below IL(m) in t ; 
a(m,t)= 2*ho1(m,t) ; 
SCALAR MCL  minimum campaign length in hrs /100/ ; 
 
A.2.3 Example 3 
 
SETS 
m materials /1*11/ 
i tasks /1*8/ 
k slots /1*3/ 
l lines /1*4/ 
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t time periods /1*3/ 
il1(i,l) suitability of tasks to lines /(1,6).1,(2,4,7).(2,3),(3,5,8).4/ 
kl(k,l)  slots on lines  /(1,2).1,(1,2,3).(2,3,4)/ 
ALIAS (i,ii),(k,kk),(l,ll),(t,tt); 
SETS 
iil1(ii,l)   suitability of tasks to lines /(1,6).1,(2,4,7).(2,3),(3,5,8).4/ 
ill1(i,ll)   suitability of tasks to lines /(1,6).1,(2,4,7).(2,3),(3,5,8).4/ 
iill1(ii,ll) suitability of tasks to lines /(1,6).1,(2,4,7).(2,3),(3,5,8).4/ 
kkl(kk,l)    slots on lines  /(1,2).1,(1,2,3).(2,3,4)/ 
kll(k,ll)    slots on lines  /(1,2).1,(1,2,3).(2,3,4)/ 
kkll(kk,ll)  slots on lines  /(1,2).1,(1,2,3).(2,3,4)/ 
 
PARAMETERS 
I0(m) initial inventory of m 
/1 994876.778,2 1276.389,3 233.5,4*5 0,6 352,7 261.333,8 1000000,9*11 0/ 
IL(m) target level of m 
/1 0,2 0,3 0,4 1500,5 0,6 1000,7 0,8*10 0,11 1000/ 
ST(m) storage limit of m 
/1 1000000,2 3500,3 3000,4 1000000,5 4000,6 1000000,7 3000,8 1000000,9 3500,10 
4000,11 1000000/ 
g(m)  revenue per unit of m 
/1 0,2 0,3 0,4 1.2,5 0,6 0.8,7 0,8*10 0,11 2.3/ 
period(t) time length of t in hrs 
/1 360,2 720,3 720/ 
nk(l) total number of slots on l 
/1 2,2*4 3/ 
Ib0(m) initial backlog of m 
/1*11 0/ 
meu(i) primary material of i 
/1*4 1,5 0.9,6*8 1/ ; 
 
TABLE 
dt(i,ii)  batch processing time of i on l 
     1    2    3    4    5    6    7    8 
1         4         4 
2              2 
3 
4              3         3 
5 
6                                  4 
7                                       3 
8                                           ; 
TABLE 
ct(i,l)  changeover time of i on l 
     1    2    3    4 
1    3 
2         2    1.5 
3                   3 
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4         2    2 
5                   3 
6    3 
7         2    1.5 
8                   3   ; 
TABLE 
SUT(i,l)  changeover time of i on l 
      1    2    3    4 
6    10 
7         12   12 
8                     15   ; 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
        1     2     3     4    5     6     7     8 
1     -1     0     0     0    0     0     0     0 
2      1    -1     0    -1    0     0     0     0 
3      0     1    -0.8   0    0     0     0     0 
4      0     0     1     0    0     0     0     0 
5      0     0    -0.2   1   -1     0     0     0 
6      0     0     0     0    0.9   0     0     0 
7      0     0     0     0    0.1   0     0     0 
8      0     0     0     0    0    -1     0     0 
9      0     0     0     0    0     1    -1     0 
10     0     0     0     0    0     0     1    -1 
11     0     0     0     0    0     0     0     1    ; 
TABLE 
D(m,t) demand for m in t 
     1         2         3 
4   1500   6000   2500 
6   1500   6000   5000 
11  1500   3500   4500  ; 
TABLE 
H(l,t) uptime of l in t(in hrs) 
    1      2      3 
1  360  720  600 
2  360  720  720 
3  360  720  720 
4  360  720  720  ; 
TABLE 
RU(i,l) max rate of production for i on l 
      1    2    3    4 
1    20 
2         16   7 
3                   15 
4         10   5 
5                   20 
6    20 
7         16   7 
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8                   15   ; 
TABLE 
cc(i,l) changeover cost of i on l 
      1    2    3   4 
1    45 
2         50   45 
3                    70 
4         40   40 
5                    80 
6    50 
7         45   50 
8                    90    ; 
TABLE 
CL0(i,l) initial campaign length of i in final slot of l in t 
       1*4 
1*8  0    ; 
TABLE 
YS0(i,l) initial spillover of i in final slot of l in t 
       1*4 
1*8  0    ; 
TABLE 
hc(m,t)  holding cost of m per 1000 per day 
      1*3 
2    1.30 
3    1.23 
4    1.76 
5    1.36 
6    1.60 
7    1.40 
9    1.35 
10   1.28 
11   1.80    ; 
 
PARAMETER 
RL(i,l) min rate of production for i on l; 
RL(i,l) = RU(i,l)/4; 
PARAMETER 
ho1(m,t)   holding cost of m during t+1; 
ho1(m,t)  = hc(m,t)* period(t+1)/(1000*24); 
PARAMETER 
ho2(m,t)   holding cost of m during t; 
ho2(m,t)  = hc(m,t)* period(t)/(1000*24); 
PARAMETER 
a(m,t) penalty cost of m for dipping below IL(m) in t ; 
a(m,t)= 2*ho1(m,t) ; 
SCALAR 
MCL  minimum campaign length in hrs /100/  ; 
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B.1 GAMS files for Examples 1-3 
B.1.1 Profit Maximization 
VARIABLES 
P              profit 
DB(i,j,k)       amount that i consumed on j at Tk 
b(i,j,k)      residual amount of task i on j at Tk 
BE(i,j,k)     amount of batch discharged by task i on j at Tk 
SL(k)          slot length 
T(j,k)        remaining time on j at Tk 
INV(m,k)        inventory of m at Tk 
Y(i,j,k)       task assignment variable 1 
Z(j,k)         task assignment variable 2 
YR(i,j,k)      residual binary 
YE(i,j,k)      ending binary       ; 
POSITIVE VARIABLE DB,b,BE,SL,T,INV,Z,YR,YE ; 
BINARY VARIABLE Y ; 
 
EQUATIONS 
profit               profit to be maximized 
allocate1(j,k)       allocation constraint 1 
endj2(j,k)           ending time constraint 2 
endj3(j,k)           ending time constraint 3 
inventory(m,k)       inventory constraint 2 
residual1(i,j,k)     residual 1 
residual22(j,k)       residual 22 
material1(i,j,k)     material constraint 1 
material2(i,j,k)     material constraint 2 
material3(i,j,k)     material constraint 3 
material4(i,j,k)    material constraint 2 
sumslot              sum of slot lengths     ; 
 
profit.. P =e= sum((m,k)$(ord(k)=NK), g(m)*INV(m,k))  ; 
allocate1(j,k)$(ord(k) < NK).. sum(i$(ij1(i,j)), Y(i,j,k)) =e= Z(j,k); 
endj2(j,k)$(ord(k) > 1 and ord(k) < NK ).. T(j,k) =l= sum(i$(ij1(i,j)),alpha(i,j)* 
YR(i,j,k)) + sum(i$(ij1(i,j)), beta(i,j)*b(i,j,k)); 
endj3(j,k) $(ord(k) < NK).. T(j,k+1) =g= T(j,k)+ 
sum(i$(ij1(i,j)),alpha(i,j)*Y(i,j,k)+beta(i,j)*DB(i,j,k))-SL(k+1); 
inventory(m,k).. INV(m,k)  =e= (INV(m,k-1)$(ord(k)>1)+I0(m)$(ord(k)=1))+ 
sum(i$(OI(m,i) and ord(i) < NI), (sigma(m,i)/meu(i))* 
sum(j$ij1(i,j),BE(i,j,k)))+sum(i$(II(m,i) and ord(i) < NI), (sigma(m,i)/meu(i))* 
sum(j$ij1(i,j),DB(i,j,k))); 
residual1(i,j,k)$(ij1(i,j) and ord(k) > 1 and ord(k) < NK).. YR(i,j,k) =e= YR(i,j,k-1) + 
Y(i,j,k-1) - YE(i,j,k); 
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residual22(j,k)$(ord(k) > 1 and ord(k) < NK).. sum(i$ij1(i,j), YE(i,j,k)) =e= Z(j,k); 
material1(i,j,k)$(ij1(i,j) and ord(i) < NI and ord(k) gt 1).. b(i,j,k) =e= b(i,j,k-1) + 
DB(i,j,k-1) -  BE(i,j,k); 
material2(i,j,k) $( ij1(i,j) and ord(i) < NI and ord(k) gt 1 and ord(k) lt NK).. BE(i,j,k) 
=l= bmax(j)* YE(i,j,k); 
material3(i,j,k) $( ij1(i,j) and  ord(i) < NI and ord(k) lt NK).. DB(i,j,k) =l= 
bmax(j)*Y(i,j,k); 
material4(i,j,k)$(ij1(i,j) and ord(i) < NI and ord(k) > 1 and ord(k) < NK).. b(i,j,k) =l= 
bmax(j)* YR(i,j,k); 
sumslot.. sum(k, SL(k)) =l= H; 
 
DB.lo(i,j,k) = 0; 
DB.up(i,j,k) = bmax(j); 
DB.fx(i,j,klast) = 0; 
BE.lo(i,j,k) = 0; 
BE.up(i,j,k) = bmax(j); 
BE.fx(izero,j,k) = 0; 
BE.fx(i,j,kzero) = 0; 
b.lo(i,j,k) = 0; 
b.up(i,j,k) = bmax(j); 
b.fx(i,j,kzero) = 0; 
b.fx(i,j,klast) = 0; 
b.fx(izero,j,k) = 0; 
SL.lo(k) = 0; 
SL.up(k) = smax((i,j)$(ij1(i,j)and ord(i) < NI), alpha(i,j)+beta(i,j)*bmax(j)); 
T.lo(j,k) = 0; 
T.up(j,k) = smax(i$(ij1(i,j)and ord(i) < NI), alpha(i,j)+beta(i,j)*bmax(j)); 
T.fx(j,klast) = 0; 
T.fx(j,kzero) = 0; 
INV.lo(m,k) = 0; 
INV.up(m,k) = IL(m); 
Z.lo(j,k) = 0; 
Z.up(j,k) = 1; 
z.fx(j,klast) = 1; 
YR.lo(i,j,k) = 0; 
YR.up(i,j,k) = 1; 
YR.fx(i,j,kzero) = 0; 
YR.fx(i,j,klast) = 0; 
YE.lo(i,j,k) = 0; 
YE.up(i,j,k) = 1; 
YE.fx(i,j,kzero) = 0; 
 
OPTION 
SOLPRINT = OFF 
limrow = 20 
limcol = 10 
optcr = 0 
reslim = 10000 
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mip = cplex ; 
 
MODEL planning /all/ ; 
 
SOLVE  planning using mip maximizing P ; 
 
DISPLAY P.l,SL.l,T.l,Y.l,Z.l,YR.l, YE.l,DB.l,b.l,BE.l,INV.l ; 
 
B.1.2 Makespan Minimization 
VARIABLES 
MS             makespan 
DB(i,j,k)      amount that i consumed on j at Tk 
b(i,j,k)       residual amount of task i on j at Tk 
BE(i,j,k)     amount of batch discharged by task i on j at Tk 
SL(k)          slot length 
T(j,k)        remaining time on j at Tk 
INV(m,k)        inventory of m at Tk 
Y(i,j,k)       task assignment variable 1 
Z(j,k)         task assignment variable 2 
YR(i,j,k)      residual binary 
YE(i,j,k)      ending binary     ; 
POSITIVE VARIABLE DB,b,BE,SL,T,INV,Z,YR,YE ; 
BINARY VARIABLE Y ; 
 
EQUATIONS 
makespan             profit to be minimized 
allocate1(j,k)       allocation constraint 1 
endj2(j,k)           ending time constraint 2 
endj3(j,k)           ending time constraint 3 
inventory(m,k)       inventory constraint 2 
residual1(i,j,k)     residual 1 
residual22(j,k)      residual 22 
material1(i,j,k)     material constraint 1 
material2(i,j,k)     material constraint 2 
material3(i,j,k)     material constraint 3 
material4(i,j,k)     material constraint 2 
demand(m,k)          demand constraint        ; 
 
makespan.. MS =e= sum(k, SL(k))  ; 
allocate1(j,k)$(ord(k) < NK).. sum(i$(ij1(i,j)), Y(i,j,k)) =e= Z(j,k); 
endj2(j,k)$(ord(k) > 1 and ord(k) < NK ).. T(j,k) =l= sum(i$(ij1(i,j)),alpha(i,j)* 
YR(i,j,k)) + sum(i$(ij1(i,j)), beta(i,j)*b(i,j,k)); 
endj3(j,k) $(ord(k) < NK).. T(j,k+1) =g= T(j,k)+ 
sum(i$(ij1(i,j)),alpha(i,j)*Y(i,j,k)+beta(i,j)*DB(i,j,k))-SL(k+1); 
inventory(m,k).. INV(m,k)  =e= (INV(m,k-1)$(ord(k)>1)+I0(m)$(ord(k)=1))+ 
sum(i$(OI(m,i) and ord(i) < NI), (sigma(m,i)/meu(i))* 
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sum(j$ij1(i,j),BE(i,j,k)))+sum(i$(II(m,i) and ord(i) < NI), (sigma(m,i)/meu(i))* 
sum(j$ij1(i,j),DB(i,j,k))); 
residual1(i,j,k)$(ij1(i,j) and ord(k) > 1 and ord(k) < NK).. YR(i,j,k) =e= YR(i,j,k-1) + 
Y(i,j,k-1) - YE(i,j,k); 
residual22(j,k)$(ord(k) > 1 and ord(k) < NK).. sum(i$ij1(i,j), YE(i,j,k)) =e= Z(j,k); 
material1(i,j,k)$(ij1(i,j) and ord(i) < NI and ord(k) gt 1).. b(i,j,k) =e= b(i,j,k-1) + 
DB(i,j,k-1) -  BE(i,j,k); 
material2(i,j,k) $( ij1(i,j) and ord(i) < NI and ord(k) gt 1 and ord(k) lt NK).. BE(i,j,k) 
=l= bmax(j)* YE(i,j,k); 
material3(i,j,k) $( ij1(i,j) and  ord(i) < NI and ord(k) lt NK).. DB(i,j,k) =l= 
bmax(j)*Y(i,j,k); 
material4(i,j,k)$(ij1(i,j) and ord(i) < NI and ord(k) > 1 and ord(k) < NK).. b(i,j,k) =l= 
bmax(j)* YR(i,j,k); 
demand(m,k)$(ord(k)=NK).. INV(m,k) =g= dem(m); 
 
DB.lo(i,j,k) = 0; 
DB.up(i,j,k) = bmax(j); 
DB.fx(i,j,klast) = 0; 
BE.lo(i,j,k) = 0; 
BE.up(i,j,k) = bmax(j); 
BE.fx(izero,j,k) = 0; 
BE.fx(i,j,kzero) = 0; 
b.lo(i,j,k) = 0; 
b.up(i,j,k) = bmax(j); 
b.fx(i,j,kzero) = 0; 
b.fx(i,j,klast) = 0; 
b.fx(izero,j,k) = 0; 
SL.lo(k) = 0; 
SL.up(k) = smax((i,j)$(ij1(i,j)and ord(i) < NI), alpha(i,j)+beta(i,j)*bmax(j)); 
T.lo(j,k) = 0; 
T.up(j,k) = smax(i$(ij1(i,j)and ord(i) < NI), alpha(i,j)+beta(i,j)*bmax(j)); 
T.fx(j,klast) = 0; 
T.fx(j,kzero) = 0; 
INV.lo(m,k) = 0; 
INV.up(m,k) = IL(m); 
Z.lo(j,k) = 0; 
Z.up(j,k) = 1; 
z.fx(j,klast) = 1; 
YR.lo(i,j,k) = 0; 
YR.up(i,j,k) = 1; 
YR.fx(i,j,kzero) = 0; 
YR.fx(i,j,klast) = 0; 
YE.lo(i,j,k) = 0; 
YE.up(i,j,k) = 1; 
YE.fx(i,j,kzero) = 0; 
 
OPTION 
SOLPRINT = OFF 
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limrow = 20 
limcol = 10 
optcr = 0 
reslim = 200000 
mip = cplex ; 
 
MODEL planning /all/ ; 
 
SOLVE  planning using mip minimizing MS ; 
 
DISPLAY MS.l,SL.l,T.l,Y.l,Z.l,YR.l, YE.l,DB.l,b.l,BE.l,INV.l ; 
 
B.1.3 Constant Batch Processing Times 
VARIABLES 
P              profit 
DB(i,j,k)      amount that i consumed on j at k 
b(i,j,k)       residual amount of task i on j at k 
BE(i,j,k)     amount of batch discharged by task i on j at k 
SL(k)          slot length 
T(j,k)        remaining time on j in k 
INV(m,k)        inventory of m at k 
Y(i,j,k)       task assignment variable 1 
Z(j,k)         task assignment variable 2 
YR(i,j,k)      residual binary 
YE(i,j,k)      ending binary       ; 
POSITIVE VARIABLE DB,b,BE,SL,T,INV,Z,YR,YE ; 
BINARY VARIABLE Y ; 
 
EQUATIONS 
profit               profit to be maximized 
allocate1(j,k)       allocation constraint 1 
endj2(j,k)           ending time constraint 2 
endj3(j,k)           ending time constraint 3 
inventory(m,k)       inventory constraint 2 
residual1(i,j,k)     residual 1 
residual22(j,k)       residual 22 
material1(i,j,k)     material constraint 1 
material2(i,j,k)     material constraint 2 
material3(i,j,k)    material constraint 3 
material4(i,j,k)    material constraint 2 
sumslot              sum of slot lengths    ; 
 
profit.. P =e= sum((m,k)$(ord(k)=NK), g(m)*INV(m,k))  ; 
allocate1(j,k)$(ord(k) < NK).. sum(i$(ij1(i,j)), Y(i,j,k)) =e= Z(j,k); 
endj2(j,k)$(ord(k) > 1 and ord(k) < NK ).. T(j,k) =l= sum(i$(ij1(i,j)),tau(i,j)* YR(i,j,k)) 
; 
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endj3(j,k) $(ord(k) < NK).. T(j,k+1) =g= T(j,k)+ sum(i$(ij1(i,j)),tau(i,j)*Y(i,j,k))-
SL(k+1); 
inventory(m,k).. INV(m,k)  =e= (INV(m,k-1)$(ord(k)>1)+I0(m)$(ord(k)=1))+ 
sum(i$(OI(m,i) and ord(i) < NI), (sigma(m,i)/meu(i))* 
sum(j$ij1(i,j),BE(i,j,k)))+sum(i$(II(m,i) and ord(i) < NI), (sigma(m,i)/meu(i))* 
sum(j$ij1(i,j),DB(i,j,k))); 
residual1(i,j,k)$(ij1(i,j) and ord(k) > 1 and ord(k) < NK).. YR(i,j,k) =e= YR(i,j,k-1) + 
Y(i,j,k-1) - YE(i,j,k); 
residual22(j,k)$(ord(k) > 1 and ord(k) < NK).. sum(i$ij1(i,j), YE(i,j,k)) =e= Z(j,k); 
material1(i,j,k)$(ij1(i,j) and ord(i) < NI and ord(k) gt 1).. b(i,j,k) =e= b(i,j,k-1) + 
DB(i,j,k-1) -  BE(i,j,k); 
material2(i,j,k) $( ij1(i,j) and ord(i) < NI and ord(k) gt 1 and ord(k) lt NK).. BE(i,j,k) 
=l= bmax(j)* YE(i,j,k); 
material3(i,j,k) $( ij1(i,j) and  ord(i) < NI and ord(k) lt NK).. DB(i,j,k) =l= 
bmax(j)*Y(i,j,k); 
material4(i,j,k)$(ij1(i,j) and ord(i) < NI and ord(k) > 1 and ord(k) < NK).. b(i,j,k) =l= 
bmax(j)* YR(i,j,k); 
sumslot.. sum(k, SL(k)) =l= H; 
 
DB.lo(i,j,k) = 0; 
DB.up(i,j,k) = bmax(j); 
DB.fx(i,j,klast) = 0; 
BE.lo(i,j,k) = 0; 
BE.up(i,j,k) = bmax(j); 
BE.fx(izero,j,k) = 0; 
BE.fx(i,j,kzero) = 0; 
b.lo(i,j,k) = 0; 
b.up(i,j,k) = bmax(j); 
b.fx(i,j,kzero) = 0; 
b.fx(i,j,klast) = 0; 
b.fx(izero,j,k) = 0; 
SL.lo(k) = 0; 
SL.up(k) = smax((i,j)$(ij1(i,j)and ord(i) < NI), tau(i,j)); 
T.lo(j,k) = 0; 
T.up(j,k) = smax(i$(ij1(i,j)and ord(i) < NI), tau(i,j)); 
T.fx(j,klast) = 0; 
T.fx(j,kzero) = 0; 
INV.lo(m,k) = 0; 
INV.up(m,k) = IL(m); 
Z.lo(j,k) = 0; 
Z.up(j,k) = 1; 
z.fx(j,klast) = 1; 
YR.lo(i,j,k) = 0; 
YR.up(i,j,k) = 1; 
YR.fx(i,j,kzero) = 0; 
YR.fx(i,j,klast) = 0; 
YE.lo(i,j,k) = 0; 
YE.up(i,j,k) = 1; 
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YE.fx(i,j,kzero) = 0; 
 
OPTION 
SOLPRINT = OFF 
limrow = 20 
limcol = 10 
optcr = 0 
reslim = 200000 
mip = cplex ; 
 
MODEL planning /all/ ; 
 
SOLVE  planning using mip maximizing P ; 
 
DISPLAY P.l,SL.l,T.l,Y.l,Z.l,YR.l, YE.l,DB.l,b.l,BE.l,INV.l ; 
 
B.2 DATA files for Examples 1-3 
B.2.1 Profit Maximization 
* We provide the data file for Example 1 only. However, the data for Examples 2-3 
can be inputted using the following file 
 
SETS 
m materials /1*4/ 
i tasks /1*4/ 
j units /1*5/ 
k slots /k0*k8/ 
ij1(i,j) suitability of tasks to units /1.(1,2), 2.3, 3.(4,5)/    
OI(m,i)  tasks that produce materials /2.1, 3.2, 4.3/ 
II(m,i)  tasks that consume materials /1.1, 2.2, 3.3/   ; 
ALIAS    (k,kk) ; 
SCALAR 
H    scheduling horizon in hrs /12/ 
NK   total number of k(including k0) per unit /9/ 
NI   total number of tasks /4/                 ; 
SET kzero(k), klast(k),izero(i); 
kzero(k) $(ord(k) eq 1) = yes; 
klast(k) $(ord(k) eq card(k)) = yes; 
izero(i) $(ord(i) eq ni) = yes; 
ij1(izero,j) = yes; 
 
PARAMETERS 
I0(m) initial inventory of m 
/1 1000000, 2*4 0/ 
IL(m) storage limit of m 
/1 1000000, 2 200, 3 250, 4 1000000/ 
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g(m)   revenue per unit of m 
/1*3 0, 4 5/ 
bmax(j) max capacity of j 
/1 100, 2 150, 3 200, 4*5 150/  
meu(i) primary material of task i 
/1*3 1/ ; 
 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
       1     2     3 
1    -1 
2     1    -1 
3            1    -1 
4                   1     ; 
TABLE 
alpha(i,j) constant production term 
        1         2        3    4         5 
1      1.333  1.333 
2                           1 
3                                 0.667  0.667     ; 
TABLE 
beta(i,j) constant production term 
       1              2            3        4             5 
1      0.01333  0.01333 
2                                   0.005 
3                                             0.00445  0.00445     ; 
 
 
B.2.2 Makespan Minimization 
* We provide the data file for Example 2 only. However, the data for Examples 1 & 3 
can be inputted using the following file 
 
SETS 
m materials /1*9/ 
i tasks /1*6/ 
j units /1*4/ 
k slots /k0*k8/ 
ij1(i,j) suitability of tasks to units /1.1,(2,3,4).(2,3),5.4/  
OI(m,i)  tasks that produce materials /4.1, 5.(3,5), 6.2, 7.4, 8.3, 9.5/ 
II(m,i)  tasks that consume materials /1.1, 2.2, 3.(2,4), 4.3, 5.4, 6.3, 7.5/  ; 
ALIAS (k,kk) ; 
SCALAR 
NK   total number of k(including k0) per unit /9/ 
NI   total number of tasks /6/                 ; 
SET kzero(k), klast(k),izero(i) ; 
kzero(k) $(ord(k) eq 1) = yes; 
klast(k) $(ord(k) eq card(k)) = yes; 
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izero(i) $(ord(i) eq ni) = yes; 
ij1(izero,j) = yes; 
 
PARAMETERS 
I0(m) initial inventory of m 
/1*3 1000000, 4*9 0/ 
IL(m) storage limit of m 
/1*3 1000000, 4 100, 5 200, 6 150, 7 200, 8*9 1000000/ 
g(m)  revenue per unit of m 
/1*7 0, 8*9 10/ 
dem(m) demand of m 
/1*7 0, 8*9 200/ 
bmax(j) max capacity of j 
/1 100, 2 50, 3 80, 4 200/        
meu(i) primary material of task i 
/1*5 1/        ; 
 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
        1     2     3      4       5 
1     -1 
2          -0.5 
3          -0.5          -0.2 
4      1         -0.4 
5                  0.6   -0.8    0.1 
6           1    -0.6 
7                           1      -1 
8                  0.4 
9                                    0.9     ; 
TABLE 
alpha(i,j) constant production term 
        1        2          3        4 
1      0.667 
2                1.334  1.334 
3                1.334  1.334 
4                0.667  0.667 
5                                     1.3342       ; 
TABLE 
beta(i,j) constant production term 
        1             2               3            4 
1      0.00667 
2                     0.02664   0.01665 
3                    0.02664   0.01665 
4                    0.01332   0.008325 
5                                                    0.00666           ; 
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B.2.3 Constant Batch Processing Times 
* We provide the data file for Example 3 only. However, the data for Examples 1-2 
can be inputted using the following file 
 
SETS 
m materials /1*13/ 
i tasks /1*8/ 
j units /1*6/ 
k slots /k0*k7/ 
ij1(i,j) suitability of tasks to units /(1,5).1, (2,3,7).(2,3), 4.4, 6.(5,6)/  
OI(m,i)  tasks that produce materials /3.1, 4.(2,4), 5.3, 6.4, 7.4, 9.5, 10.7, 12.6, 13.7/ 
II(m,i)  tasks that consume materials /1.1, 2.2, 3.3, 4.3, 5.4, 6.5, 7.6, 8.5, 9.7, 10.6, 
11.6/  ; 
ALIAS (k,kk) ; 
SCALAR 
H    scheduling horizon in hrs /12/ 
NK   total number of k(including k0) per unit /8/ 
NI   total number of tasks /8/                 ; 
SET kzero(k), klast(k),izero(i) ; 
kzero(k) $(ord(k) eq 1) = yes; 
klast(k) $(ord(k) eq card(k)) = yes; 
izero(i) $(ord(i) eq ni) = yes; 
ij1(izero,j) = yes; 
 
PARAMETERS 
I0(m) initial inventory of m 
/1*2 1000000, 3*4 0,5 0,6*7 50, 8 1000000, 9*10 0, 11 1000000, 12*13 0/ 
IL(m) storage limit of m 
/1*2 1000000, 3*4 100, 5 300, 6*7 150, 8 1000000, 9*10 150, 11*13 1000000/ 
g(m)  revenue per unit of m 
/1*11 0, 12 5, 13 5/ 
bmin(j) min capacity of j 
/1 0, 2*4 0, 5*6 20/ 
bmax(j) max capacity of j 
/1 100, 2 100, 3 150, 4 300, 5*6 200/              
meu(i) primary material of task i 
/1*7 1/        ; 
 
TABLE 
sigma(m,i) mass balance coefficient of m to i 
        1    2    3    4        5         6         7 
1     -1 
2          -1 
3      1       -0.5 
4           1  -0.5   0.1 
5                1      -1 
6                        0.4    -0.25 
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7                        0.5              -0.4 
8                                 -0.75 
9                                  1                  -1 
10                                         -0.4      0.6 
11                                         -0.2 
12                                          1 
13                                                     0.4       ; 
TABLE 
tau(i,j) constant production term 
       1     2      3      4      5      6 
1      1 
2            2      2 
3            1      1 
4                          3 
5      1.5 
6                                 2      2 
7            2      2                                   ; 
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